[go: up one dir, main page]

WO2018074432A1 - Cell culture substrate and method for producing same, and cell culture container and cell culture method using same - Google Patents

Cell culture substrate and method for producing same, and cell culture container and cell culture method using same Download PDF

Info

Publication number
WO2018074432A1
WO2018074432A1 PCT/JP2017/037424 JP2017037424W WO2018074432A1 WO 2018074432 A1 WO2018074432 A1 WO 2018074432A1 JP 2017037424 W JP2017037424 W JP 2017037424W WO 2018074432 A1 WO2018074432 A1 WO 2018074432A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
substrate
cell culture
culture
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/037424
Other languages
French (fr)
Japanese (ja)
Inventor
洋 堀川
将人 今瀬
雅也 能木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shokubai Co Ltd
University of Osaka NUC
Original Assignee
Nippon Shokubai Co Ltd
Osaka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shokubai Co Ltd, Osaka University NUC filed Critical Nippon Shokubai Co Ltd
Priority to JP2018546335A priority Critical patent/JP6758621B2/en
Publication of WO2018074432A1 publication Critical patent/WO2018074432A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Definitions

  • the present invention relates to a cell culture substrate and a method for producing the same, and a cell culture container and a cell culture method using the same.
  • the cells that form organs such as the liver, pancreas, skin, and blood vessels are three-dimensionally networked in the living body to express their functions.
  • a culture in which cells can form a three-dimensional network (that is, three-dimensional culture) is required.
  • a spheroid is a tissue in which cells form a three-dimensional network.
  • the cells when cells are cultured on the surface of a general resin-made cell culture substrate, the cells spread in a plane and proliferate (two-dimensional culture), and a three-dimensional network is not formed.
  • Japanese Patent Application Publication No. 2013-54156 US Patent Application Publication No. 2013/330379, US Patent Application Publication No. 2013/344036, US Patent Application Publication No. 2014/010790. And corresponding to US Pat. No. 9631177) mechanically disrupted fine cellulose fibers (CNF) derived from living cells and plants in the form of hydrogels or membranes forming hydrogels and / or A cell culture matrix containing the derivative is reported.
  • CNF fine cellulose fibers
  • Japanese translations of PCT publication No. 2013-54156 U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177
  • PCT publication No. 2013-54156 U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.
  • the present invention has been made in view of the above circumstances, and an object thereof is to provide a technique for performing spheroid-selective cell culture.
  • Another object of the present invention is to provide a technique for simultaneously realizing cell observability required for performing spheroid-selective cell culture and performing image analysis or the like in an in vitro test.
  • the present inventors have conducted intensive research to solve the above problems. As a result, the inventors have found that the above problems can be solved by culturing cells on a cell culture substrate containing cellulose fibers and having a specific surface roughness, and have completed the present invention.
  • the above object can be achieved by a cell culture substrate containing cellulose fibers and having an arithmetic average height (Sa) of the culture surface of less than 210 nm.
  • FIG. 1 is a photomicrograph showing the growth state of HepG2 cells on the substrate 1, comparative substrates 4 and 5, multiwell cell culture plate and NanoCulture (registered trademark) Plate in the evaluation of HepG2 cell adhesion behavior.
  • FIG. 2 is a photomicrograph showing the growth state of MCF-7 cells on the substrate 1, comparative substrates 4 and 5, multiwell cell culture plate and NanoCulture (registered trademark) Plate in the evaluation of MCF-7 cell adhesion behavior. It is.
  • FIG. 3 is a graph showing the amount of albumin produced on the substrate 1, the multiwell cell culture plate, and the NanoCulture (registered trademark) Plate in HepG2 cell culture.
  • FIG. 4 is a diagram schematically showing the cell culture container of the present invention. In FIG.
  • FIG. 5 is a photomicrograph showing the growth state of rat primary hepatocytes on the substrate 1 in the evaluation of rat primary hepatocyte adhesion behavior.
  • One embodiment of the present invention is a cell culture substrate that contains cellulose fibers and has an arithmetic average height (Sa) of a culture surface of less than 210 nm. According to the cell culture substrate according to one embodiment of the present invention, spheroids can be selectively formed.
  • the cell culture substrate is also simply referred to as “substrate of the present invention” or “substrate”.
  • the arithmetic average height (Sa) is also simply referred to as “surface roughness” or “Sa”.
  • a substrate conventionally used for culturing adherent cells in vitro is plasma-treated polystyrene.
  • adherent cells grow by attaching to the substrate in a single layer (two-dimensional culture).
  • the cell growth is good, but various functions of the cell are lowered, and there is a problem that the function in the living body cannot be reproduced in vitro.
  • methods for suppressing cell functional deterioration by forming and culturing cell aggregates have been studied.
  • Japanese translations of PCT publication No. 2013-54156 U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No.
  • an opaque membrane is prepared by vacuum filtration of the CNF aqueous dispersion or by drying the filtration membrane under a weight. (Paragraph “0071”). Since the membrane obtained by such a method passes through a filtration membrane used during vacuum filtration, the surface is very rough (Sa is 210 nm or more) and becomes an opaque membrane in which cell observation is difficult. Use in in vitro tests that require observation is difficult.
  • spheroids are selectively obtained by culturing cells on the culture surface of a cell culture substrate (for example, cellulose fiber membrane) having a specific surface roughness and containing cellulose fibers. Furthermore, the spheroids can be formed selectively and without adhering to the substrate (without floating).
  • the base material of the present invention is a cellulose fiber membrane whose culture surface has a specific surface roughness (0 nm ⁇ Sa ⁇ 210 nm).
  • Such a cellulose fiber membrane having moderate irregularities has a balance of appropriate hydrophilicity and hydrophobicity on the surface.
  • the cells when cells are cultured on the membrane (culture surface), the cells adhere to the substrate with an appropriate strength due to the unevenness of the culture surface. For this reason, the cells grow three-dimensionally rather than planarly. Therefore, spheroids can be selectively formed by using the substrate of the present invention.
  • the surface roughness (Sa) of the culture surface is 210 nm or more, the roughness (unevenness) becomes too large and the cell adheres strongly to the base material, so that the cells spread easily and proliferate. In other words, since the seeded cells adhere firmly to the substrate, the cells cannot migrate and cannot form cell aggregates. Therefore, if it culture
  • the surface of the base material (the culture surface) can be used without requiring pretreatment (for example, a coat of a component that suppresses protein adhesion or a protein coat that promotes or suppresses cell adhesion).
  • a coat of a component that suppresses protein adhesion or a protein coat that promotes or suppresses cell adhesion can be directly cultured to selectively form spheroids.
  • the cell adheres to the culture surface of the base material without floating with an appropriate adhesive force the size of the spheroid can be controlled. For this reason, necrosis of the central part of the spheroid, and hence cell functional deterioration can be suppressed / prevented. Therefore, when the base material of the present invention is used, cells (spheroids) having a high function can be obtained. Therefore, the cells (spheroids) cultured using the base material of the present invention can be suitably used for in vitro tests such as regenerative medicine applications, drug efficacy tests during drug development, and toxicity tests.
  • the cells cultured using the base material of the present invention appropriately adhere to the base material. For this reason, even when the medium is exchanged during the cell culture, the cells are rarely removed together with the medium, and therefore the cell loss can be reduced. For example, the culture can be performed for a long period of one week or longer.
  • the culture can be performed for a long period of one week or longer.
  • cells of uniform size spheroids
  • the function of the cells can be maintained high.
  • cells are cultured on a substrate having a haze of 40% or less, cell observation is easy and J. Biomaterial. Sci. Polymer Edn, Vol. 17, No. 8, pp.
  • HepG2 rat primary hepatocytes, etc.
  • MCF-7 three-dimensional
  • spheroids can be formed using cellulose with low cytotoxicity and without using a heterologous protein, safe and highly functional spheroids can be obtained, and can be suitably used for regenerative medicine.
  • X to Y indicating a range includes X and Y, and means “X or more and Y or less”. Unless otherwise specified, measurements such as operation and physical properties are performed under conditions of room temperature (20 to 25 ° C.) / Relative humidity 40 to 50% RH.
  • the cell culture substrate of the present invention has an arithmetic average height (Sa) of the culture surface of less than 210 nm.
  • Sa arithmetic average height
  • the arithmetic average height (Sa) of the culture surface is preferably less than 200 nm, more preferably 150 nm or less, and particularly preferably less than 130 nm.
  • the lower limit of the arithmetic average height (Sa) of the culture surface is not particularly limited, but is more than 0 nm, preferably more than 5 nm, more preferably more than 10 nm, still more preferably more than 15 nm. Even more preferably, it is more than 60 nm, particularly preferably 90 nm or more.
  • the Sa of the other surface is not particularly limited, and may be 210 nm or more. That is, the present invention relates to a form in which the arithmetic average height (Sa) of one surface (culture surface) of the substrate is less than 210 nm and the arithmetic average height (Sa) of the other surface is 210 nm or more, and It includes both forms in which the arithmetic average height (Sa) of both sides of the material is less than 210 nm.
  • Sa is a value at a location where cells adhere substantially
  • Sa at a location where cells do not adhere may be any value. That is, the substrate of the present invention only needs to have a Sa of the culture surface at least substantially to which the cells adhere, of less than 210 nm.
  • arithmetic average height (Sa) is a parameter obtained by extending the center average roughness (Ra) defined in JIS B0601 (2001) to a plane.
  • arithmetic mean height (Sa) is a confocal laser microscope (manufactured by Ryoka Systems Co., Ltd.) for a range of 235.3 ⁇ m ⁇ 470.6 ⁇ m of a predetermined surface of a sample (base material or support). The average value of the values measured by the product name: Vert Scan 2.0) is adopted.
  • the culture surface of the cell culture substrate exhibits hydrophilicity and hydrophobicity (hydrophobicity) with an appropriate balance. Thereby, spheroid formation on a base material can be promoted more.
  • the hydrophilicity / hydrophobicity of the culture surface is defined by the static water contact angle.
  • the static water contact angle of the culture surface of the cell culture substrate is 30 ° or more, preferably 40 ° or more, more preferably more than 45 °.
  • the upper limit of the static water contact angle is not particularly limited, but is, for example, less than 70 °, preferably less than 65 °, more preferably less than 60 °, and even more preferably less than 55 °.
  • the said static water contact angle is a value measured by the method described in the following Example.
  • the cell culture substrate is preferably transparent. Thereby, the cell in culture can be easily observed visually.
  • the transparency can be evaluated by total light transmittance and haze (turbidity).
  • the total light transmittance is preferably 80% or more, more preferably 85% or more (upper limit: 100%).
  • the haze (turbidity) is preferably 40% or less. That is, according to a preferred embodiment of the present invention, the haze of the cell culture substrate is 40% or less.
  • the haze of the cell culture substrate is more preferably 20% or less, still more preferably less than 16%, still more preferably 12% or less, and particularly preferably less than 10%. With such a total light transmittance and / or haze (turbidity), cells in culture can be more easily visually observed.
  • the haze of the cell culture substrate is preferably as low as possible, the lower limit is not particularly limited, but is usually 0.1% or more, and 1% or more is sufficient.
  • the said total light transmittance or haze is a value measured by the method described in the following Example.
  • the cell culture substrate is a membrane containing cellulose fibers, preferably a membrane composed only of cellulose fibers. Since the cellulose fiber has high safety, for example, it is safe to be implanted in the body. In addition, when cells cultured on cellulose fibers are transplanted into the body, safety can be ensured even if trace amounts of cellulose fibers are included.
  • the cells can be applied to the body together with the substrate.
  • the average diameter (diameter) of the cellulose fiber is not particularly limited, but is, for example, 2 to 20 nm.
  • the base material produced using such a cellulose fiber is excellent in transparency and has a low haze, the visibility of cells during culture can be further improved.
  • the value measured according to the following method is employ
  • a cellulose fiber means the elongate cellulose whose aspect-ratio (average length / average diameter (average diameter)) exceeds 1.
  • the content of thick cellulose fibers having a diameter of 1 ⁇ m or more is preferably small. That is, according to the preferable form of this invention, the content rate of the cellulose fiber which has a diameter of 1 micrometer or more (with respect to a base material) is less than 10%. More preferably, the content of cellulose fibers having a diameter of 1 ⁇ m or more is more preferably 5% or less, and particularly preferably less than 1% (lower limit: 0%). If the content of thick cellulose fibers is in the above range, the substrate is further excellent in transparency (especially the haze of the substrate can be significantly reduced), and cells in culture can be more easily visually observed.
  • the value measured according to the following method is employ
  • the content (%) of cellulose fibers having a diameter of 1 ⁇ m or more is also referred to as “thick fiber content (%)”.
  • the area of the fiber having a thickness (diameter) of 1 ⁇ m or more is also referred to as “area occupied by the thick fiber (cm 2 )”.
  • the fiber when the thickness of a fiber (cellulose fiber) is not uniform, when the thickness (diameter) is 1 ⁇ m or more over 60% or more of the total length of the fiber, the fiber is a fiber having a thickness (diameter) of 1 ⁇ m or more. I reckon. Further, when the cross section of the fiber is irregular, the maximum diameter is regarded as “thickness (diameter)”.
  • the thickness of the cell culture substrate is not particularly limited, but the thickness (dry film thickness) of the cell culture substrate is preferably 10 to 100 ⁇ m, more preferably 20 to 60 ⁇ m.
  • the base material of the present invention is characterized in that at least a surface to be a culture surface has a specific surface roughness (Sa).
  • the method for forming such a surface is not particularly limited, but is preferably controlled by the surface roughness of the coated surface of the support on which the cellulose fiber dispersion is coated. That is, when a coating solution containing cellulose is applied to a support and dried to form a coating film, the coating surface on the support surface side is affected by the surface roughness of the coating surface of the support. For this reason, the present inventors thought that the base material of the present invention could be easily obtained by appropriately adjusting the surface roughness of the support.
  • this invention also provides the manufacturing method of the base material for cell cultures which has apply
  • coating liquid containing cellulose fibers (hereinafter also simply referred to as “coating liquid”) is prepared.
  • the production method of the cellulose fiber is not particularly limited, and a method of mechanically defibrating cellulose (cellulose fiber raw material) can be used.
  • a method of mechanically defibrating cellulose cellulose fiber raw material
  • known methods such as those described in JP-A-2016-87877, JP-A-2015-218299, JP-A-2015-140403 and the like can be used similarly or appropriately. Can be used with modification.
  • this invention is not limited to the following form.
  • Cellulose is not particularly limited, and may be plant-derived or bacterial-derived cellulose. From the viewpoint of availability, cost, etc., plant-derived cellulose may be used as the cellulose fiber raw material. preferable. For example, various woods obtained from larch, cedar, oil palm, cypress, etc .; pulps; papers such as newspapers, cardboard, magazines, fine papers; plant shells such as rice husks, palm husks, coconut husks, etc. May be. Here, the pulp is selected from wood pulp, non-wood pulp, and deinked pulp.
  • the wood pulp is not limited to the following, but hardwood bleached kraft pulp, hardwood unbleached kraft pulp, conifer bleached kraft pulp, softwood unbleached kraft pulp, sulfite wood pulp, soda pulp, unbleached kraft pulp, oxygen bleach Chemically modified pulp such as kraft pulp and hydrolyzed kraft pulp; Semi-chemical pulp such as semi-chemical pulp (SCP) and Chemi-ground wood pulp (CGP); such as groundwood pulp (GP) and thermomechanical pulp (TMP, BCTMP) Examples include mechanical pulp.
  • SCP semi-chemical pulp
  • CGP Chemi-ground wood pulp
  • TMP thermomechanical pulp
  • BCTMP thermomechanical pulp
  • Non-wood pulp is not limited to the following, but cotton pulp such as cotton linter and cotton lint (cotton cellulose), hemp (hemp cellulose), straw (straw cellulose), bagasse (sugar cane squeezed), empty Non-wood pulp such as fruit bunches (EFB), rice straw, corn stalks, cellulose isolated from sea squirts, seaweeds, and the like.
  • the deinking pulp is not limited to the following, and examples include deinking pulp made from waste paper.
  • the said cellulose fiber raw material may be used individually by 1 type, or may be used with the form of a 2 or more types of mixture. Among these, wood pulp and chemically modified pulp containing cellulose are preferable from the viewpoints of availability, ease of control of fiber diameter, fiber refinement (defibration), and the like. Alternatively, commercially available cellulose fiber raw materials may be used.
  • the cellulose fiber raw material may be subjected to physical or chemical treatment in advance before mechanical defibration. Specifically, degreasing treatment, delignification treatment (holocellulose conversion), alkali treatment, oxidation treatment and the like can be mentioned. Two or more of the above treatments may be used in combination.
  • the degreasing treatment method is not particularly limited, and a known method can be used. Specifically, it can be performed by immersing the cellulose fiber raw material in a degreasing solution.
  • the solvent used for the preparation of the degreasing solution is not particularly limited, and may be appropriately selected depending on the type of the cellulose fiber raw material to be used. For example, water, acetone, alcohol, etc. are mentioned. The said solvent may be used individually by 1 type, or may be used with the form of 2 or more types of mixed solutions.
  • the degreasing conditions are not particularly limited and may be appropriately selected depending on the type of cellulose fiber raw material to be used.
  • the degreasing temperature is usually 10 to 100 ° C., preferably 15 to 50 ° C.
  • the degreasing time is usually 1 to 30 hours, preferably 15 to 20 hours.
  • the said degreasing process may be performed under stirring.
  • the delignification (holocellulose) method is not particularly limited, and a known method can be used. Specifically, the cellulose fiber raw material is added to a delignification solution containing an acid (eg, sulfuric acid, hydrochloric acid, acetic acid, acetic anhydride) and an oxidizing agent (bleaching agent) (eg, sodium chlorite, hydrogen peroxide). And the method of heating this can be used preferably.
  • the heating conditions are not particularly limited, and may be appropriately selected depending on the type of cellulose fiber raw material used and the type of acid or oxidizing agent.
  • the heating temperature is usually 50 to 120 ° C., preferably 60 to 100 ° C.
  • the heating time is usually 0.5 to 5 hours, preferably 1 to 3 hours.
  • the alkali treatment method is not particularly limited, and a known method can be used. Specifically, it can be performed by immersing the cellulose fiber raw material in an alkaline solution.
  • the alkali used for preparing the alkaline solution is not particularly limited, and may be inorganic or organic.
  • examples thereof include hydroxides, carbonates and phosphates of alkali metals or alkaline earth metals such as lithium phosphate, potassium phosphate, trisodium phosphate, disodium hydrogen phosphate, calcium phosphate, and calcium hydrogen phosphate. It is done.
  • organic substance examples include ammonia; hydrazine, methylamine, ethylamine, diethylamine, triethylamine, propylamine, dipropylamine, butylamine, diaminoethane, diaminopropane, diaminobutane, diaminopentane, diaminohexane, cyclohexyl.
  • the solvent used for preparation of an alkaline solution will not be specifically limited if an alkali can be melt
  • it contains water, that is, an aqueous sodium hydroxide solution and an aqueous potassium hydroxide solution can be preferably used as the alkaline solution.
  • the alkali concentration in the alkali solution is not particularly limited, but is, for example, 1 to 15% by weight, preferably 3 to 7% by weight.
  • the alkali treatment conditions are not particularly limited, and may be appropriately selected depending on the cellulose raw material to be used and the type of alkali.
  • the alkali treatment temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C.
  • the alkali treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours.
  • the said alkali treatment may be performed under stirring.
  • the cleaning liquid that can be used for cleaning is not particularly limited, but the same solvent as that used for the alkaline solution can be used.
  • the oxidation treatment method is not particularly limited, and a known method can be used. Specifically, there is a method using an N-oxyl compound as an oxidation catalyst. Thereby, the cellulose surface can be selectively oxidized and the cellulose can be easily refined. Moreover, the oxidation reaction can be carried out in an aqueous system and under relatively mild conditions (normal pressure near room temperature). In addition, the oxidation reaction of cellulose in wood also proceeds selectively on the crystal surface from the inside of the crystal, and the alcoholic primary carbon possessed by the cellulose molecular chain can be selectively converted into a carboxyl group. For this reason, cellulose fibers can be dispersed one by one in an aqueous solvent by mechanical defibration in the next step.
  • the aqueous dispersion of cellulose fibers obtained by this embodiment has high transparency.
  • the N-oxyl compound is not particularly limited, and a known catalyst used for the oxidation of cellulose can be used.
  • 2,2,6,6-tetramethylpiperidine 1-oxyl TEMPO
  • 2,2,6,6-tetramethyl-4-hydroxypiperidine-1-oxyl 4-methoxy-2,2 , 6,6-Tetramethylpiperidine-N-oxyl, 4-ethoxy-2,2,6,6-tetramethylpiperidine-N-oxyl, 4-acetamido-2,2,6,6-tetramethylpiperidine-N -Oxyl, 4-carboxy-2,2,6,6-tetramethylpiperidine-N-oxyl, 4-phosphonooxy-2,2,6,6-tetramethylpiperidine-N-oxyl and the like.
  • TEMPO 2,2,6,6-tetramethylpiperidine 1-oxyl
  • 4-methoxy-2,2 , 6,6-Tetramethylpiperidine-N-oxyl 4-ethoxy-2,2,6,6-tetramethylpiperidine-N-oxyl
  • TEMPO and 4-acetamido-2,2,6,6-tetramethylpiperidine-N-oxyl are preferable and TEMPO is more preferable from the viewpoint of the oxidation efficiency of cellulose.
  • the amount of the N-oxyl compound used is not particularly limited as long as it is an amount capable of proceeding with the cellulose oxidation.
  • the amount of the catalyst used is preferably about 0.1 to 5% by weight, more preferably about 0.5 to 3% by weight, based on the cellulose fiber raw material.
  • the oxidation treatment may be performed in the presence of an oxidizing agent.
  • an oxidizing agent in combination, the introduction efficiency of the carboxy group can be further improved.
  • the oxidation reaction can be performed under mild conditions, it is easy to maintain the crystal structure of cellulose.
  • the oxidizing agent is not particularly limited.
  • halogen chlorine, bromine, iodine, etc.
  • hypohalous acid or a salt thereof hypohalous acid or a salt thereof (hypochlorous acid or a salt thereof, hypobromous acid or a salt thereof, Hypoiodic acid or a salt thereof)
  • halogenous acid or a salt thereof chlorous acid or a salt thereof, bromous acid or a salt thereof, iodic acid or a salt thereof
  • a perhalogenic acid or a salt thereof peroxide
  • hypohalous acid and hypohalite are preferable, and sodium hypochlorite (NaClO) is more preferable.
  • the said oxidizing agent may be used independently or may use 2 or more types together. Further, the oxidizing agent may be added as it is or in the form of a solution dissolved in an appropriate solvent (for example, water).
  • the amount of the oxidizing agent to be used is not particularly limited as long as it can promote the oxidation reaction. For example, it is preferably about 1 to 30 mmol, more preferably about 5 to 20 mmol with respect to 1 g of the cellulose fiber raw material.
  • the oxidation treatment when the oxidation treatment is performed in the presence of the oxidant, the oxidation treatment may be further performed in the presence of bromide and / or iodide.
  • the bromide include, but are not limited to, ammonium bromide, sodium bromide, lithium bromide and the like.
  • examples of iodide include, but are not limited to, ammonium iodide, sodium iodide, lithium iodide, and the like. Of these, sodium bromide (NaBr) is preferable from the viewpoint of cost and stability.
  • the bromide and iodide may be used alone or in combination of two or more.
  • bromide and iodide may be used in combination.
  • the amount of bromide and / or iodide used is not particularly limited as long as it can promote the oxidation reaction. For example, it is preferably 0.5 to 30% by weight, more preferably 1 to 10%, based on the cellulose fiber raw material. It is about wt%.
  • the oxidation treatment conditions are not particularly limited, and may be appropriately selected depending on the cellulose fiber raw material to be used, the oxidation catalyst, and the oxidizing agent when used and the type of bromide / iodide (when used).
  • the oxidation treatment temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C.
  • the oxidation treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours.
  • the oxidation treatment may be performed with stirring.
  • the reducing agent is not particularly limited and a known reducing agent such as sodium borohydride (NaBH 4) can be used.
  • the amount of the reducing agent to be used is not particularly limited as long as the reduction can proceed to a desired level.
  • the amount of the reducing agent is preferably 1 to 30% by weight, more preferably with respect to the initial charge amount of the cellulose fiber material. Is about 5 to 20% by weight.
  • the reduction reaction conditions are not particularly limited, and may be appropriately selected depending on the cellulose fiber raw material to be used and the type of the reducing agent.
  • the reduction reaction temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C.
  • the oxidation treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours.
  • the said reduction process may be performed under stirring.
  • Oxidized cellulose having a carboxylate content of 0.1 to 3.0 mmol / g, preferably 0.2 to 2.0 mmol / g is obtained.
  • Oxidized cellulose having such a carboxylate content can be finely divided and uniformly dispersed by electrostatic repulsion between celluloses.
  • the cellulose obtained as described above is mechanically defibrated. Thereby, a cellulose further refines
  • the method for mechanical fibrillation (miniaturization) of cellulose is not particularly limited, and a known method can be used. Specifically, a method of refining (defibrating) an aqueous dispersion of cellulose using a defibrating apparatus can be used.
  • examples of the aqueous medium used for obtaining the aqueous dispersion include water and lower alcohols (methanol, ethanol, propanol, isopropanol) and the like.
  • the aqueous medium may be used alone or in the form of a mixture of two or more.
  • the cellulose concentration in the aqueous dispersion is not particularly limited, but is preferably about 0.1 to 20% by weight, more preferably about 0.3 to 10% by weight, from the viewpoint of mechanical defibration (miniaturization) efficiency and the like. It is. If necessary, the pH of the dispersion may be adjusted to improve the dispersibility of cellulose. Next, the aqueous dispersion is subjected to a mechanical defibrating treatment to refine the cellulose.
  • the mechanical defibrating treatment is not limited to the following, but is a high pressure homogenizer, an ultra high pressure homogenizer, a ball mill, a roll mill, a bead mill, a cutter mill, a planetary mill, a jet mill, an attritor, a grinder, a juicer mixer, a homomixer, an ultra mixer.
  • Examples include mechanical processing such as a sonic homogenizer, a nanogenizer, an underwater collision, a disk refiner, and a conical refiner.
  • a wet pulverizing apparatus such as a twin-screw kneader, a vibration mill, a homomixer under high-speed rotation, an ultrasonic disperser, and a beater can be used as appropriate.
  • a wet pulverizing apparatus such as a twin-screw kneader, a vibration mill, a homomixer under high-speed rotation, an ultrasonic disperser, and a beater can be used as appropriate.
  • the cellulose fiber dispersion thus obtained may be used as it is as a coating liquid containing cellulose fibers (coating liquid).
  • the cellulose fibers may be separated from the cellulose fiber dispersion obtained as described above, and then dispersed in an appropriate solvent to form a coating solution.
  • the solvent that can be used in the latter case is not particularly limited, but is preferably a solvent that does not adversely affect cell culture.
  • water, lower alcohols (methanol, ethanol, propanol, isopropanol) and the like can be mentioned.
  • the said solvent may be used independently or may be used with the form of a 2 or more types of liquid mixture. Of these, water is preferred.
  • the cellulose fiber concentration in the coating solution is not particularly limited, but is preferably about 0.1 to 20% by weight, more preferably about 0.5 to 10% by weight, from the viewpoints of ease of coating, easy visual observation, and the like. It is. You may concentrate the cellulose fiber dispersion liquid obtained above so that it may become the said density
  • the coating solution may contain only cellulose fibers (that is, the substrate may be composed only of cellulose fibers) or may contain other components (that is, the substrate may contain other components in addition to the cellulose fibers). ) Good.
  • Other components in the latter case are not particularly limited, but include components used in cell culture (eg, serum, various growth factors, differentiation-inducing factors, antibiotics, hormones, amino acids, sugars, salts, etc.) Can be mentioned.
  • the amount of other components added is not particularly limited as long as it does not adversely affect the cultured cells. For example, 0.01 to 100 with respect to cellulose fibers. % By weight.
  • the coating solution prepared as described above is applied to the surface (culture surface or coated surface) where Sa of the support is less than 30 nm.
  • the coating liquid containing cellulose fibers is applied to the support surface having an arithmetic average height (Sa) of 30 nm or more
  • the arithmetic average height (Sa) on the support side of the obtained base material is 210 nm or more ( See Comparative Example 1 below).
  • the arithmetic average height (Sa) of the cellulose fiber-coated surface of the support is preferably 5 nm or more from the viewpoint of obtaining a substrate that can form spheroids more selectively.
  • the arithmetic average height (Sa) of at least the coated surface (cotton to which the coating solution is coated) of the support is less than 30 nm, Sa on the other surface is not particularly limited, and may be 30 nm or more.
  • the present invention provides an embodiment in which the arithmetic average height (Sa) of one surface (application surface) of the support is less than 30 nm and the arithmetic average height (Sa) of the other surface is 30 nm or more, and the support It includes both forms in which the arithmetic mean height (Sa) of both sides of the body is less than 30 nm.
  • the material of the support is not particularly limited as long as it can form a surface with Sa of less than 30 nm.
  • inorganic glass carbon; metal such as silicon; polyolefin resin such as polyethylene, polypropylene and cyclic olefin; polyester resin such as polyethylene terephthalate (PET); acrylic resin such as polymethyl methacrylate; epoxy resin; Vinyl chloride, polyvinylidene chloride, polystyrene resin, polyvinyl acetate, ABS (acrylonitrile-butadiene-styrene) resin, polycarbonate resin, vinyl ether, polyacetal, polyphenylene ether (PPE), polyaryl ether, polyphenylene sulfide (PPS), polyether Ether ketone (PEEK), polyaryl ether ketone, phenol resin, polyether nitrile (PEN), polyamide resin, polyimide resin, fluorinated poly Bromide resin (fluorine-containing polyimide resin), fluorine resin
  • the thickness of the support is not particularly limited, but is usually 1 to 10 mm, preferably 1.5 mm or more and less than 5 mm.
  • the surface of the support is polished by a polishing machine or the like so that the Sa value of the support surface becomes a predetermined value. Also good.
  • Application method is not particularly limited, natural coater, knife belt coater, floating knife, roll coat, air knife coat, knife over roll, knife on blanket, spray, dip, kiss roll, squeeze roll, reverse roll, air blade, Various coating methods using apparatuses such as a curtain flow coater, a doctor blade, a wire bar, a die coater, a comma coater, a spin coater, an applicator, a baker applicator, a gravure coater, and a screen printing machine may be mentioned. The application may be repeated several times to dozens of times. Further, the amount of the coating solution applied to the support is not particularly limited, but it is preferably an amount that provides the thickness of the substrate as described above.
  • the Sa of the other surface is not particularly limited, and may be 210 nm or more. For this reason, you may further laminate
  • the drying conditions after application are not particularly limited, and can be appropriately selected mainly considering the boiling point of the solvent.
  • the drying temperature is preferably 20 to 100 ° C., more preferably 40 to 70 ° C.
  • the drying time is preferably 10 to 30 hours, preferably 15 to 20 hours.
  • the cell culture substrate of the present invention can be obtained by peeling the coating film formed by such a method from the support.
  • the substrate for cell culture according to the present invention is a membrane containing cellulose fibers having an arithmetic average height (Sa) of less than 210 nm on the culture surface, in particular, a portion to which cells substantially adhere.
  • Sa arithmetic average height
  • the substrate of the present invention a state in which spheroids are selectively and directly attached to the substrate surface (culture surface) without the need for pretreatment (for example, a coat of a component that suppresses protein adhesion). Can be formed. For this reason, when the base material of the present invention is used, a highly functional cell mass (spheroid) is obtained.
  • the cell culture substrate of the present invention is preferably sterilized before use for culturing and then used for culturing.
  • known sterilization methods such as autoclave sterilization, dry heat sterilization, ethylene oxide gas sterilization, gamma ray sterilization, and electron beam sterilization can be used.
  • gamma ray sterilization is preferable because it can be applied to sterilization of instruments having low heat and pressure resistance and there is no problem of residual gas such as ethylene oxide gas.
  • the amount of protein attached to the substrate and the adhesion / form of cells are closely related, and the amount of protein adsorbed to the substrate is also controlled in the cell culture substrate of the present invention.
  • a three-dimensional cultured cell can be obtained more suitably.
  • the amount of albumin adsorbed on the substrate is preferably 1000 ng / cm 2 or more.
  • the upper limit of the amount of adsorption of albumin is not particularly limited, from the viewpoint of formation of spheroids is better, preferably it is preferably 2000 ng / cm 2 or less, more preferably 1500 ng / cm 2 or less .
  • the substrate proteoglycan adsorption amount is preferably 160 ng / cm 2 or more.
  • the upper limit of the adsorption amount of proteoglycan is not particularly limited, but is preferably 300 ng / cm 2 or less, more preferably 200 ng / cm 2 or less, from the viewpoint of better spheroid formation.
  • the adsorption amount of albumin and the adsorption amount of proteoglycan are values measured by the methods described in the following examples.
  • the cell culture substrate of the present invention can be suitably used for a culture vessel. That is, in one embodiment of the present invention, a culture container having the cell culture substrate of the present invention is provided. As long as cells are cultured on the base material of the present invention, the culture container (cell culture container) of the present invention may be configured by combining the cell culture base material of the present invention and other members, The cell culture substrate of the present invention and the other member may be integrated, or may be composed only of the cell culture substrate of the present invention. When the cell culture substrate of the present invention is a flexible substrate such as a film, it may be formed in combination with an appropriate support member having rigidity.
  • FIG. 4 illustrates one embodiment of the cell culture container according to the present invention.
  • the cell culture vessel may be composed of the cell culture substrate 1 as shown in FIG. 4 (A), or the cell culture substrate 1 and the support member 20 as shown in FIGS. 4 (B) and (C). It may consist of.
  • the inner shape and the outer shape when the cell culture container is viewed in plan from the opened side can be any shape such as a circle, a polygon (square, triangle, etc.), for example.
  • Examples of the material constituting the support member 20 include inorganic glass; carbon; metal such as silicon; polyolefin resin such as polyethylene, polypropylene and cyclic olefin; polyester resin such as polyethylene terephthalate (PET); acrylic such as polymethyl methacrylate.
  • inorganic glass carbon
  • metal such as silicon
  • polyolefin resin such as polyethylene, polypropylene and cyclic olefin
  • polyester resin such as polyethylene terephthalate (PET)
  • acrylic such as polymethyl methacrylate.
  • Resin epoxy resin; polyvinyl chloride, polyvinylidene chloride, polystyrene resin, polyvinyl acetate, ABS (acrylonitrile-butadiene-styrene) resin, polycarbonate resin, vinyl ether, polyacetal, polyphenylene ether (PPE), polyaryl ether, polyphenylenesulfur Examples include fido (PPS), polyether ether ketone (PEEK), polyaryl ether ketone, phenol resin, polyether nitrile (PEN), and the like.Or you may use the said support body as a supporting member.
  • the cell culture container of the present invention may have any shape as a whole as long as it includes the cell culture substrate of the present invention.
  • it can be in the form of various containers such as plates for culture such as single or multiwell plates, petri dishes, dishes, flasks, bags and the like.
  • the cell culture container of the present invention may also be in the form of a cell culture container in a culture apparatus such as a mass culture apparatus or a perfusion culture apparatus.
  • a cell culture method comprising culturing cells (adherent cells) on the culture surface of the cell culture substrate of the present invention.
  • the cell culture substrate can selectively form spheroids by culturing cells on the culture surface according to the surface roughness (Sa).
  • Sa surface roughness
  • the cells adhere to the culture surface of the substrate with an appropriate adhesive force, the size of the spheroid can be controlled. For this reason, necrosis of the central part, and hence the decrease in cell function can be suppressed / prevented.
  • the cells cultured using the substrate of the present invention adhere appropriately to the substrate, even when the medium is changed during cell culture, the cells are rarely removed together with the medium. Loss can be reduced.
  • a cell culture method in which cells (particularly adherent cells) are three-dimensionally cultured in the culturing step. That is, in one embodiment of the present invention, the culture is three-dimensional culture.
  • the type of cells cultured by the cell culture method of the present invention is not particularly limited, and normal cells, cancer cells, stem cells, and fused cells such as hybridomas can be used, and cells that have been subjected to artificial treatment such as gene transfer It may be.
  • artificial pluripotent stem cells Induced pluripotent stem cells: iPS cells
  • embryonic stem cells Embryonic stem cells: ES cells
  • mesenchymal stem cells etc.
  • Adipose cells hepatocytes, kidney cells, pancreatic cells, mammary cells, endothelial cells, epithelial cells, smooth muscle cells, myoblasts, cardiomyocytes, nerve cells, including the required cells and various progenitor cells and stem cells, Glial cells, dendritic cells, chondrocytes, osteoblasts, osteoclasts, bone cells, fibroblasts, various blood cells, retinal cells, cornea-derived cells, gonad-derived cells, various line cells, other mesenchymal precursors And cells such as cells and various cancer cells.
  • the biological species from which these cells are derived is not particularly limited, and various cells derived from humans and non-human animals can be used.
  • Examples of the biological species from which the cells are derived include, for example, primates such as humans, rhesus monkeys, green monkeys, cynomolgus monkeys, chimpanzees, tamarins and marmosets, rodents such as mice, rats, hamsters and guinea pigs, dogs, cats, rabbits, pigs, Examples include cows, goats, sheep, horses, chickens, quails, minks, pineapples, and zebrafish.
  • primates such as humans, rhesus monkeys, green monkeys, cynomolgus monkeys, chimpanzees, tamarins and marmosets
  • rodents such as mice, rats, hamsters and guinea pigs, dogs, cats, rabbits, pigs
  • Examples include cows, goats, sheep, horses, chickens, quails, minks, pineapples, and zebrafish.
  • the medium used for cell culture may be appropriately selected according to the cells.
  • the type of medium is not particularly limited.
  • any cell culture basic medium, differentiation medium, primary culture medium, or the like can be used.
  • Eagle Minimum Essential Medium (EMEM), Dulbecco's Modified Eagle Medium (DMEM), ⁇ -MEM, Glasgow MEM (GMEM), IMDM, RPMI 1640, Ham F-12, MCDB Medium, Williams Medium E and these Examples thereof include, but are not limited to, a mixed medium, and any medium can be used as long as the medium contains components necessary for cell growth and differentiation.
  • a medium supplemented with serum, various growth factors, differentiation-inducing factors, antibiotics, hormones, amino acids, sugars, salts and the like may be used.
  • the culture temperature is not particularly limited, but is usually about 25 to 40 ° C.
  • tissues formed by three-dimensional culture include spheroids and three-dimensional cell aggregates.
  • a spheroid or a three-dimensional cell aggregate is a spheroid or a three-dimensional cell aggregate formed of a single cell such as a hepatocyte. It may be a spheroid mixed with cell types or a three-dimensional cell aggregate.
  • Examples of cells that can be used include the various cells described above.
  • the cell culture substrate there is provided the cell culture substrate, wherein the cell culture substrate has a spheroid selectively adhered to the cell culture surface.
  • a cell culture container having a cell culture substrate having spheroids selectively adhered to the cell culture surface is provided.
  • the substrate of the present invention By using the substrate of the present invention, a three-dimensional cultured cell having a function close to that of a living body can be obtained. Although the reason is not clear, as shown in the following [Albumin quantification], the three-dimensional cultured cells cultured on the base material of the present invention can exhibit higher functions than conventional culture plates. It is different from three-dimensional cultured cells cultured on a substrate. Therefore, the present invention also provides a three-dimensional cultured cell formed (cultured) on the cell culture substrate of the present invention. It is known that when a three-dimensional cultured cell (spheroid) has a diameter exceeding 200 ⁇ m in diameter, nutrients and oxygen in the medium do not reach the central part of the spheroid, and the cells in the central part are necrotic.
  • the function of the cultured cells can be improved by forming spheroids using the substrate of the present invention.
  • the usefulness of the three-dimensional cultured cell formed on the cell culture substrate according to the present invention is as shown in the Examples, it is compared with the three-dimensional cultured cell cultured on the conventional culture substrate. However, it is very difficult to specify the feature points on the structure and characteristics.
  • the present invention also provides a method for testing a drug in vitro, comprising using the three-dimensional cultured cell of the present invention.
  • a method for testing a drug in vitro comprising using the three-dimensional cultured cell of the present invention.
  • a method such as MultiTox-Fluor Multiplex Cytotoxicity Assay kit (Promega) for measuring the survival rate as an index, RubyGlowTM A method using ATP as an index, such as Luminescent Cell Viability Assay Kit (Cosmo Bio Inc.), a method of nucleic acid staining with a fluorescent reagent using Cytotoxic Fluoro-test wako (Wako Pure Chemical Industries), trypan blue using trypan blue Methods for measuring cell viability such as dye exclusion test methods can be used.
  • MultiTox-Fluor Multiplex Cytotoxicity Assay kit Promega
  • RubyGlowTM A method using ATP as an index such as Luminescent Cell Viability Assay Kit (Cosmo Bio Inc.)
  • a method of nucleic acid staining with a fluorescent reagent using Cytotoxic Fluoro-test wako (Wako Pure Chemical Industries)
  • trypan blue using trypan blue
  • the present invention since a three-dimensional cultured cell having a function similar to that of a living body can be obtained by using the base material of the present invention, the three-dimensional cultured cell obtained using the base material described in this specification. Can also be used for regenerative medical applications for various diseases such as diseases in the ophthalmic field such as heart disease, liver disease, and age-related macular degeneration.
  • diseases in the ophthalmic field such as heart disease, liver disease, and age-related macular degeneration.
  • cellulose that is safe for living bodies is used as a cell culture substrate, safer three-dimensional cultured cells can be obtained, which is suitable for use in regenerative medicine. That is, the present invention also provides a regenerative medical material containing the three-dimensional cultured cell of the present invention.
  • the present invention also provides a method for treating heart disease, liver disease or ophthalmological disease using the three-dimensional cultured cells of the present invention.
  • the present invention also provides a cell delivery material comprising the cell culture substrate of the present invention and a three-dimensional cultured cell formed on the substrate.
  • Example 1 cedar wood chips (40 g) were degreased by stirring in a mixture of acetone and water (900 mL: 100 mL (acetone: water)) overnight (15 hours) at room temperature (25 ° C.). It was. Next, this defatted wood chip is delignified by heating in a mixed solution of acetic anhydride and hydrogen peroxide (500 mL: 500 mL (acetic anhydride: hydrogen peroxide)) at 90 ° C. for 2 hours, A holocellulose pulp was obtained. Finally, this holocellulose pulp was immersed in a 5 wt% potassium hydroxide (KOH) aqueous solution at 20 ° C. for 2 hours to obtain an alkali-treated holocellulose pulp suspension.
  • KOH potassium hydroxide
  • a high-pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber was used for 2000 mL of the alkali-treated holocellulose pulp suspension (solid content 0.5 wt%) thus obtained. , Ltd.) was used for high-pressure homogenization (mechanical fibrillation) to obtain a homogenized slurry.
  • This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The extrusion was repeated 50 times to obtain a high-pressure homogenized cellulose fiber suspension having a concentration of 0.3% by weight, which was designated as coating solution 1 (cellulose fiber / water dispersion).
  • the coating solution 1 (high-pressure homogenized cellulose fiber concentration: 0.3% by weight) was concentrated to a concentration of 0.8% by weight to prepare a coating solution 1 '.
  • a glass frame 1 as a support made by Matsunami Glass Industry Co., Ltd., Sa value: 11.23 nm, thickness: 2 mm
  • coating plate 1 On which a metal frame material with a 7 cm ⁇ 7 cm hole is mounted was prepared (hereinafter referred to as coating plate 1).
  • the coating solution 1 'prepared above was poured into the holes of the coating plate 1 in an amount of 40 mL / hole.
  • the coating solution 1 ′ was extended all over the hole with a glass rod.
  • the coating film was recovered from the coating plate 1 to prepare a substrate 1 having a thickness of 30 ⁇ m.
  • the Sa value on the glass plate 1 'surface side of the substrate 1 was measured, it was 125.7 nm (culture surface).
  • Example 2 In Example 1, instead of the glass plate 1, the same procedure as in Example 1 was used except that an acrylic plate 2 (manufactured by Nippon Test Panel, Sa value: 8.30 nm, thickness: 2 mm) was used as a support. A substrate 2 having a thickness of 30 ⁇ m was prepared.
  • an acrylic plate 2 manufactured by Nippon Test Panel, Sa value: 8.30 nm, thickness: 2 mm
  • Example 3 In Example 1, instead of the glass plate 1, the same procedure as in Example 1 was used except that an acrylic plate 3 (manufactured by Nippon Test Panel, Sa value: 8.17 nm, thickness: 2 mm) was used as a support. A substrate 3 having a thickness of 30 ⁇ m was produced.
  • an acrylic plate 3 manufactured by Nippon Test Panel, Sa value: 8.17 nm, thickness: 2 mm
  • the Sa value on the surface side of the acrylic plate 3 of the base material 3 obtained in this way was measured and found to be 66.5 nm (culture surface).
  • Comparative Example 1 In Example 1, it replaced with the glass plate 1, and it carried out similarly to Example 1 except using the acrylic board 4 (The Japan Test Panel company make, Sa value: 30.53 nm, thickness: 2 mm) as a support body. A comparative substrate 4 having a thickness of 30 ⁇ m was prepared.
  • the Sa value on the surface of the acrylic plate 4 of the comparative substrate 4 obtained in this way was measured and found to be 210.7 nm (culture surface).
  • the coating solution 2 (high-pressure homogenized cellulose fiber concentration: 0.3% by weight) was concentrated to a concentration of 0.8% by weight to prepare a coating solution 2 '.
  • Comparative Example 1 a comparative substrate 5 having a thickness of 30 ⁇ m was produced in the same manner as in Comparative Example 1, except that the coating liquid 2 ′ prepared above was used instead of the coating liquid 1 ′.
  • Haze (%) Haze was measured using a haze meter (“HZ-V3” manufactured by Murakami Color Research Laboratory Co., Ltd.) in accordance with JIS standard K7136: 2000.
  • HepG2 human hepatoma cell
  • FBS fetal bovine serum
  • 1/100 volume (volume ratio) of non-essential amino acid for 100 ⁇ MEM DS Pharma Biomedical Co., Ltd.
  • HepG2 was cultured using an EMEM medium (DS Pharma Biomedical Co., Ltd.) (serum-added EMEM medium) supplemented with a 2 mM glutamine solution (manufactured by DS Pharma Biomedical Co., Ltd.).
  • HepG2 was seeded in a 100 mm cell culture dish (BD Falcon) so as to be 2.0 ⁇ 10 4 cells / cm 2 and cultured at 37 ° C. under 5 vol% CO 2 conditions. HepG2 cultured to a confluent state of 70% in a 100 mm cell culture dish was treated with a 0.25% trypsin / 50 mM EDTA solution, and then the serum-added EMEM medium similar to the above was added to stop the trypsin reaction. A suspension cell suspension was obtained.
  • BD Falcon 100 mm cell culture dish
  • NanoCulture registered trademark
  • MS pattern / low adhesion / 24 wells (Organogenix) have fine irregularities nano-imprinted. For this reason, before seeding the cell suspension, the following deaeration operation was performed to remove bubbles in the irregularities. Specifically, the same serum-added EMEM medium as described above was dispensed at 500 ⁇ L per well. This was centrifuged at 300 to 500 ⁇ g for 3 minutes and then allowed to stand at room temperature (25 ° C.) for 30 minutes.
  • HepG2 was treated with 0.25% trypsin / 50 mM EDTA solution, and then the total cell number was measured using a 0.4 w / v% trypan blue solution (Wako Pure Chemical Industries, Ltd.) and a hemocytometer. Went. Further, the culture solution on the seventh day of culture was sampled and stored at -20 ° C.
  • Fig. 1 shows cell growth conditions (micrographs) on the substrate 1, the comparison substrate 4, the comparison substrate 5, the multiwell cell culture plate and the NanoCulture (registered trademark) Plate on the seventh day of culture.
  • the growth state (micrograph) of the cells on the base material 1 on the seventh day of culture is shown in FIG. 1, but the other base materials 2 and 3 had similar results.
  • spheroids of appropriate size cell aggregation
  • MCF-7 human breast cancer cells
  • FBS fetal bovine serum
  • MCF-7 was cultured using EMEM medium (DS Pharma Biomedical) (serum-added EMEM medium) supplemented with 2 mM glutamine solution (manufactured by DS Pharma Biomedical).
  • MCF-7 was seeded in a 100 mm cell culture dish (BD Falcon) at 2.0 ⁇ 10 4 cells / cm 2 and cultured at 37 ° C. under 5 vol% CO 2 conditions. MCF-7 cultured to a confluent state of 70% in a 100 mm cell culture dish was treated with a 0.25% trypsin / 50 mM EDTA solution, and then the serum-added EMEM medium similar to the above was added to stop the trypsin reaction. A suspension of MCF-7 suspension was obtained.
  • NanoCulture registered trademark
  • MS pattern / low adhesion / 24 wells (Organogenix) have fine irregularities nano-imprinted. For this reason, before seeding the cell suspension, the following deaeration operation was performed to remove bubbles in the irregularities. Specifically, the same serum-added EMEM medium as described above was dispensed at 500 ⁇ L per well. This was centrifuged at 300 to 500 ⁇ g for 3 minutes and then allowed to stand at room temperature (25 ° C.) for 30 minutes.
  • FIG. 2 shows cell growth conditions (micrographs) on the substrate 1, the comparison substrate 4, the comparison substrate 5, the multiwell cell culture plate and the NanoCulture (registered trademark) Plate on the seventh day of culture.
  • the cell growth state (micrograph) on the base material 1 on the seventh day of culture is shown in FIG. 2, but the other base materials 2 and 3 had similar results.
  • spheroids of appropriate size cell aggregation
  • the cells were uniformly distributed throughout the well, and the expanded cells were hardly observed.
  • the MCF-7 cells used here are less likely to be three-dimensional than the HepG2 cells used in “4. Evaluation of HepG2 cell attachment behavior” above, but these cells are also difficult to make three-dimensional. It is considered that by culturing on the base material of the present invention, spheroids (cell aggregates) having an appropriate size can be formed while attached to the base material.
  • multiwell cell culture plate 24well (BD Falcon) (multiwell cell culture plate in FIG. 2) generally used for culturing adherent cells, MCF-7 cells proliferate in a single layer, and spheroids ( The formation of cell aggregates was not observed.
  • NanoCulture registered trademark
  • MS pattern / low adhesion / 24 wells Organic Cellogenix
  • nanoCulture Plate in FIG. 2 spheroids (cell aggregates) were formed, but spread and adhered to the substrate. Many cells were also observed.
  • the culture was performed for 7 days in the same manner as in “4. Evaluation of HepG2 cell adhesion behavior”.
  • Culture on Multiwell Cell Culture Plate 24well (BD Falcon) on Day 7 of Culture, NanoCulture (R) Plate MS Pattern / Low Adhesion / 24 Well (Organogenix), and Substrate 1 (Sa Value 15.7 nm)
  • the amount of albumin produced was measured.
  • Rat Albumin ELISA Quantitation Set (Bethyl Laboratories) was used, and quantification experiment of albumin was performed by double measurement according to the attached protocol.
  • the base material A thus obtained was measured for haze, which was 38.3%. Moreover, about this base material A, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 0.28%.
  • This alkali-treated holocellulose / water suspension (solid content 0.5% by weight) was subjected to a high-pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber. Using, high-pressure homogenate (mechanical fibrillation) to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The above extrusion (defibration treatment) was repeated 50 times to obtain a nanofiber suspension B. The nanofiber aqueous suspension B was suction filtered and dried to produce a substrate B having a thickness of 40 ⁇ m.
  • the haze was measured and found to be 5.5%. Moreover, about this base material B, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 0.05%.
  • the base material C thus obtained was measured for haze and found to be 86.6%. Moreover, about this base material C, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 10.19%.
  • substrates A to C were prepared in the same manner as in “7. Examination of relationship between content of cellulose fiber having diameter of 1 ⁇ m or more and transparency (haze)”.
  • HepG2 cells were cultured on the substrates A to C for 7 days in the same manner as in “4. Evaluation of HepG2 cell adhesion behavior”.
  • the HepG2 cell culture after culturing for a predetermined period was observed under a microscope (magnification: 40 times).
  • the substrates A and B are excellent in transparency, the growth state of the HepG2 cells can be easily observed visually, but the substrate C is inferior in transparency and the observation image is unclear, It was difficult to observe the growth state of HepG2 cells. From the above results, it is considered that the ease of visual observation of cells can be significantly improved by reducing the ratio of cellulose fibers having a diameter of 1 ⁇ m or more to the substrate.
  • Bovine serum albumin (Sigma; A8022-10G) was dissolved in Dulbecco's PBS (-) (Wako; 041-20211) to an albumin concentration of 20 ⁇ g / mL to obtain an albumin solution.
  • a film obtained by cutting the substrate 1 into a circle having a diameter of 14 mm was set on a pedestal on a petri dish, and 300 ⁇ L of an albumin solution was mounted on the film.
  • albumin concentration in the collected albumin solution was measured.
  • the concentration was measured using Albamin, Bovine, ELISA Quantification kit (Bethyl Laboratories), and the measurement protocol was in accordance with the attached manual. From the initial concentration (20 [mu] g / mL) area and the difference in the film between the albumin concentration after 7 hours (one per side 1.54cm 2 ⁇ 3.08cm 2 with two sheets), albumin adsorption amount per unit area ( ng / cm 2) was calculated, was 1037ng / cm 2.
  • Heparan sulfate proteoglycan (Sigma; H4777) was dissolved in Dulbecco's PBS (-) (Wako; 041-20211) so that the proteoglycan concentration was 5 ⁇ g / mL to obtain a proteoglycan solution.
  • a film obtained by cutting the substrate 1 into a circle having a diameter of 14 mm was set on a pedestal on a petri dish, and 300 ⁇ L of a proteoglycan solution was mounted on the film.
  • the proteoglycan concentration in the collected proteoglycan solution was measured.
  • the concentration was measured using Glycosaminoglycan Sulfurated Alcian Blue Binding Assay (Euro Diagnostics), and the measurement protocol was based on the attached manual. From the difference between the initial concentration (5 ⁇ g / mL) and the proteoglycan concentration after 20 hours and the area of the film (1.54 cm 2 ⁇ 2 sheets per sheet, 3.08 cm 2 ), the amount of proteoglycan adsorbed per unit area ( ng / cm 2) was calculated and found to be 162.6ng / cm 2.
  • Rat primary hepatocyte adhesion behavior A Wistar rat, male, 9 weeks old, 200 g body weight of Special Viral Pathogen Free was purchased from SLC Japan. Rat primary hepatocytes were obtained by referring to the method described in Chapter 10 of the Cultured Cell Experiment Handbook (Yodosha), “Hepatocytes”. Specifically, Wistar rats were laparotomized under isoflurane anesthesia, a catheter was inserted into the portal vein, and a preperfusion solution having the composition shown in Table 3 was injected. The chest cavity was then opened and the inferior vena cava entering the right atrium was incised to release blood.
  • the perfusion was stopped, and the perfusion solution was replaced with a collagenase solution having the composition shown in Table 3 for perfusion.
  • the perfusion was stopped.
  • the liver was cut off and transferred to a glass petri dish, cold EMEM High Glucose medium (Wako) was added to disperse the cells by pipetting.
  • undigested tissue was removed with a 150 mm filter.
  • the cell suspension was centrifuged at 50G for 1 minute several times to remove non-parenchymal cells.
  • the survival rate of the obtained hepatocytes was measured by the trypan blue exclusion method, and hepatocytes with a survival rate of 85% or more were used as rat primary hepatocytes in the culture test.
  • the rat primary hepatocytes obtained by the above-described method were suspended in a serum medium having the composition described below, and obtained in Example 1 above, which was sterilized with gamma rays so as to be 1.33 ⁇ 10 4 cells / cm 2 . were seeded on the substrate 1, 37 ° C., the cells were cultured under 5% CO 2. The medium was exchanged 4 hours after seeding, after removing the entire medium on the first day, the third day, and the fifth day of culture, and then adding 0.4 mL of serum medium. On day 5 of culture, spheroid formation and the presence or absence of extended cells were confirmed.
  • FIG. 5 shows the growth state (micrograph) of the cells on the substrate 1 on the fifth day of culture. In the substrate 1, almost no stretched cells were observed, and it was confirmed that spheroids (cell aggregates) having a diameter of 200 ⁇ m or less were uniformly distributed throughout the well in a state of adhering to the substrate.
  • composition of serum medium William's E medium (Wako Pure Chemical), 10% (w / v) FBS (Wako Pure Chemical), 8.6 nM insulin, 255 nM dexamethasone, 50 ng / mL EGF, 5KIU / mL aprotinin, antibiotics (penicillin (100 units / mL) / streptomycin (100 ⁇ g / mL) / amphotericin B (0.25 ⁇ g / mL)).
  • Substrate for cell culture (film), 20 ... support member, 100, 101, 102 ... Cell culture container.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Sustainable Development (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

[Problem] Provided is a technology which enables the selective formation of spheroids. [Solution] A cell culture substrate containing cellulose fibers, and wherein the arithmetic mean height (Sa) of the culture surface is less than 210 nm.

Description

細胞培養用基材およびその製造方法、ならびにこれを利用した細胞培養容器および細胞培養方法Cell culture substrate and method for producing the same, and cell culture container and cell culture method using the same

 本発明は、細胞培養用基材およびその製造方法、ならびにこれを利用した細胞培養容器および細胞培養方法に関する。 The present invention relates to a cell culture substrate and a method for producing the same, and a cell culture container and a cell culture method using the same.

 肝臓、膵臓、皮膚、血管等の各器官を形成する細胞は、生体内において、細胞同士が3次元的にネットワークを形成し機能を発現している。 The cells that form organs such as the liver, pancreas, skin, and blood vessels are three-dimensionally networked in the living body to express their functions.

 これらの器官の機能を再生する再生医療の研究において、これらの器官の細胞を培養する場合には、細胞同士が3次元的にネットワークを形成できるような培養(すなわち、3次元培養)が求められる。細胞同士が3次元的にネットワークを形成した組織としてスフェロイドがある。しかしながら一般的な樹脂製の細胞培養用基材の表面で細胞を培養する場合、細胞は平面状に広がって増殖(2次元培養)し、3次元的なネットワークは形成されない。 In research on regenerative medicine that regenerates the functions of these organs, when culturing cells of these organs, a culture in which cells can form a three-dimensional network (that is, three-dimensional culture) is required. . A spheroid is a tissue in which cells form a three-dimensional network. However, when cells are cultured on the surface of a general resin-made cell culture substrate, the cells spread in a plane and proliferate (two-dimensional culture), and a three-dimensional network is not formed.

 3次元培養を行うための手法として、特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)では、生細胞、ならびにヒドロゲルを形成しているヒドロゲル又は膜の形態の植物由来の機械的に崩壊させた微細セルロース繊維(CNF)及び/又はその誘導体を含む細胞培養マトリックスが報告される。特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)では、当該マトリックスにおいて、細胞が3次元の配置で存在すると記載される。 As a technique for performing three-dimensional culture, Japanese Patent Application Publication No. 2013-54156 (US Patent Application Publication No. 2013/330379, US Patent Application Publication No. 2013/344036, US Patent Application Publication No. 2014/010790). And corresponding to US Pat. No. 9631177) mechanically disrupted fine cellulose fibers (CNF) derived from living cells and plants in the form of hydrogels or membranes forming hydrogels and / or A cell culture matrix containing the derivative is reported. Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177) In the matrix), it is described that cells exist in a three-dimensional arrangement in the matrix.

 特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)では、確かに植物由来のCNFヒドロゲルが3次元細胞培養のための生体模倣ヒト細胞外基質(ECM)として使用できることが記載されている(段落「0012」、「0080」、「0081」)。しかしながら、特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)の技術をもっても、スフェロイドを選択的に形成することが困難であった。 Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177) In fact, plant-derived CNF hydrogels can be used as biomimetic human extracellular matrix (ECM) for three-dimensional cell culture (paragraphs “0012”, “0080”, “0081”). "). However, Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177). It was difficult to selectively form spheroids even with the technology of No. 1).

 したがって、本発明は、上記事情を鑑みてなされたものであり、スフェロイド選択的な細胞培養を行う技術を提供することを目的とする。 Therefore, the present invention has been made in view of the above circumstances, and an object thereof is to provide a technique for performing spheroid-selective cell culture.

 本発明の他の目的は、スフェロイド選択的な細胞培養を行い、かつin vitro試験で画像解析等を実施する際に必要となる細胞観察性を同時に実現する技術を提供することである。 Another object of the present invention is to provide a technique for simultaneously realizing cell observability required for performing spheroid-selective cell culture and performing image analysis or the like in an in vitro test.

 本発明者らは、上記の問題を解決すべく、鋭意研究を行った。その結果、セルロース繊維を含み、特定の表面粗さを有する細胞培養用基材上で細胞を培養することによって、上記課題を解決できることを見出し、本発明を完成させた。 The present inventors have conducted intensive research to solve the above problems. As a result, the inventors have found that the above problems can be solved by culturing cells on a cell culture substrate containing cellulose fibers and having a specific surface roughness, and have completed the present invention.

 すなわち、上記目的は、セルロース繊維を含み、かつ培養面の算術平均高さ(Sa)が210nm未満である細胞培養用基材によって達成できる。 That is, the above object can be achieved by a cell culture substrate containing cellulose fibers and having an arithmetic average height (Sa) of the culture surface of less than 210 nm.

図1は、HepG2細胞付着挙動の評価において、基材1、比較基材4及び5、マルチウェルセルカルチャープレートならびにNanoCulture(登録商標) PlateでのHepG2細胞の生育状態を示す顕微鏡写真である。FIG. 1 is a photomicrograph showing the growth state of HepG2 cells on the substrate 1, comparative substrates 4 and 5, multiwell cell culture plate and NanoCulture (registered trademark) Plate in the evaluation of HepG2 cell adhesion behavior. 図2は、MCF-7細胞付着挙動の評価において、基材1、比較基材4及び5、マルチウェルセルカルチャープレートならびにNanoCulture(登録商標) PlateでのMCF-7細胞の生育状態を示す顕微鏡写真である。FIG. 2 is a photomicrograph showing the growth state of MCF-7 cells on the substrate 1, comparative substrates 4 and 5, multiwell cell culture plate and NanoCulture (registered trademark) Plate in the evaluation of MCF-7 cell adhesion behavior. It is. 図3は、HepG2細胞培養において、基材1、マルチウェルセルカルチャープレートおよびNanoCulture(登録商標) Plateでのアルブミン生成量を示すグラフである。FIG. 3 is a graph showing the amount of albumin produced on the substrate 1, the multiwell cell culture plate, and the NanoCulture (registered trademark) Plate in HepG2 cell culture. 図4は、本発明の細胞培養容器を模式的に示す図である。図4において、100、101および102は細胞培養容器を、1は細胞培養用基材(フィルム)を、20は支持部材を、それぞれ表す。FIG. 4 is a diagram schematically showing the cell culture container of the present invention. In FIG. 4, reference numerals 100, 101 and 102 denote cell culture containers, 1 denotes a cell culture substrate (film), and 20 denotes a support member. 図5は、ラット初代肝細胞付着挙動の評価において、基材1でのラット初代肝細胞の生育状態を示す顕微鏡写真である。FIG. 5 is a photomicrograph showing the growth state of rat primary hepatocytes on the substrate 1 in the evaluation of rat primary hepatocyte adhesion behavior.

 本発明の一形態は、セルロース繊維を含み、かつ培養面の算術平均高さ(Sa)が210nm未満である、細胞培養用基材である。本発明の一形態に係る細胞培養用基材によれば、スフェロイドを選択的に形成することができる。 One embodiment of the present invention is a cell culture substrate that contains cellulose fibers and has an arithmetic average height (Sa) of a culture surface of less than 210 nm. According to the cell culture substrate according to one embodiment of the present invention, spheroids can be selectively formed.

 本明細書において、細胞培養用基材を、単に「本発明の基材」または「基材」とも称する。また、算術平均高さ(Sa)を、単に「表面粗さ」または「Sa」とも称する。 In the present specification, the cell culture substrate is also simply referred to as “substrate of the present invention” or “substrate”. The arithmetic average height (Sa) is also simply referred to as “surface roughness” or “Sa”.

 付着性細胞をin vitroで培養するのに従来一般的に用いられている基材はプラズマ処理ポリスチレンである。しかし、このようなプラズマ処理ポリスチレンを使用した場合には、付着性細胞は基材に1層の状態で付着して増殖する(2次元培養)。2次元培養では細胞の増殖は良好であるが、細胞の様々な機能が低下し、生体内の機能をin vitroで再現できない問題があった。本問題点を解決するために、近年、細胞の凝集体(スフェロイド)を形成して培養することで、細胞の機能低下を抑制する方法が検討されている。特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)では、組成物を膜の形態にする場合には、CNF水分散液を真空濾過することによって、または濾過膜を重りの下で乾燥することによって、不透明な膜を調製している(段落「0071」)。このような方法によって得られた膜は、真空濾過時に使用される濾過膜を介するため、表面が非常に粗く(Saが210nm以上に)、かつ細胞観察が困難な不透明な膜となり、明瞭な細胞観察が必要となるin vitro試験等での利用は困難となる。また、このようなCNF膜上で細胞を培養すると、下記比較例で示されるように、スフェロイドに加えて、2次元的に生育する(伸展した)細胞が混在する、またはスフェロイドが形成されず、細胞が平面的に広がって、2次元的な培養になる。事実、特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)の実施例では、ヒドロゲルは3次元培養に使用されているが、CNF膜は2次元培養にのみ使用されている(特に段落「0100」の実施例5参照)。 A substrate conventionally used for culturing adherent cells in vitro is plasma-treated polystyrene. However, when such plasma-treated polystyrene is used, adherent cells grow by attaching to the substrate in a single layer (two-dimensional culture). In the two-dimensional culture, the cell growth is good, but various functions of the cell are lowered, and there is a problem that the function in the living body cannot be reproduced in vitro. In order to solve this problem, in recent years, methods for suppressing cell functional deterioration by forming and culturing cell aggregates (spheroids) have been studied. Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177) When the composition is in the form of a membrane, an opaque membrane is prepared by vacuum filtration of the CNF aqueous dispersion or by drying the filtration membrane under a weight. (Paragraph “0071”). Since the membrane obtained by such a method passes through a filtration membrane used during vacuum filtration, the surface is very rough (Sa is 210 nm or more) and becomes an opaque membrane in which cell observation is difficult. Use in in vitro tests that require observation is difficult. In addition, when cells are cultured on such a CNF membrane, as shown in the following comparative example, in addition to spheroids, cells that grow two-dimensionally (extend) are mixed, or spheroids are not formed, Cells spread in a plane and become a two-dimensional culture. In fact, Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177). In the examples (corresponding to the specification), hydrogels are used for three-dimensional cultures, whereas CNF membranes are used only for two-dimensional cultures (see in particular Example 5 in paragraph "0100").

 これに対して、本発明に係る、特定の表面粗さを有する、セルロース繊維を含む細胞培養用基材(例えば、セルロース繊維膜)の培養面上で細胞を培養することにより、スフェロイドを選択的に形成でき、さらに、スフェロイドを選択的にかつ(浮遊することなく)基材上に付着した状態で形成できる。そのメカニズムは依然として明確ではないが、以下のように推測される。すなわち、本発明の基材は、培養面が特定の表面粗さ(0nm<Sa<210nm)を有するセルロース繊維膜である。このような適度な凹凸を有するセルロース繊維膜は表面が適度な親水性および疎水性のバランスを有する。このため、上記膜(培養面)上で細胞を培養すると、細胞は培養面の凹凸により適度な強度で基材に接着する。このため、細胞は、平面的によりも3次元的に増殖する。ゆえに、本発明の基材を用いることにより、スフェロイドを選択的に形成できる。一方、培養面の表面粗さ(Sa)が210nm以上であると、粗さ(凹凸)が大きくなりすぎて、細胞の基材への接着が強いため、細胞が平面的に広がって増殖しやすくなるか、または播種した細胞が強固に基材に接着するため、細胞が遊走できず細胞凝集体を形成できなくなる。ゆえに、このような基材で培養すると、3次元培養細胞のみを取得することは困難となる。 In contrast, according to the present invention, spheroids are selectively obtained by culturing cells on the culture surface of a cell culture substrate (for example, cellulose fiber membrane) having a specific surface roughness and containing cellulose fibers. Furthermore, the spheroids can be formed selectively and without adhering to the substrate (without floating). The mechanism is still unclear, but is presumed as follows. That is, the base material of the present invention is a cellulose fiber membrane whose culture surface has a specific surface roughness (0 nm <Sa <210 nm). Such a cellulose fiber membrane having moderate irregularities has a balance of appropriate hydrophilicity and hydrophobicity on the surface. For this reason, when cells are cultured on the membrane (culture surface), the cells adhere to the substrate with an appropriate strength due to the unevenness of the culture surface. For this reason, the cells grow three-dimensionally rather than planarly. Therefore, spheroids can be selectively formed by using the substrate of the present invention. On the other hand, if the surface roughness (Sa) of the culture surface is 210 nm or more, the roughness (unevenness) becomes too large and the cell adheres strongly to the base material, so that the cells spread easily and proliferate. In other words, since the seeded cells adhere firmly to the substrate, the cells cannot migrate and cannot form cell aggregates. Therefore, if it culture | cultivates with such a base material, it will become difficult to acquire only a three-dimensional cultured cell.

 したがって、本発明の基材によれば、前処理(例えば、タンパク質付着を抑制する成分のコートや細胞付着を促進または抑制するようなタンパク質のコート)を必要とせずに、基材表面(培養面)に直接細胞を培養して、スフェロイドを選択的に形成できる。また、細胞は適度な接着力で基材の培養面に浮遊することなく付着するため、スフェロイドの大きさを制御できる。このため、スフェロイド中心部の壊死、ゆえに細胞の機能低下を抑制・防止できる。したがって、本発明の基材を用いると、機能の高い細胞(スフェロイド)が得られる。ゆえに、本発明の基材を用いて培養される細胞(スフェロイド)は、再生医療用途や医薬品開発時の薬効試験や毒性試験等のin vitro試験にも好適に使用できる。 Therefore, according to the base material of the present invention, the surface of the base material (the culture surface) can be used without requiring pretreatment (for example, a coat of a component that suppresses protein adhesion or a protein coat that promotes or suppresses cell adhesion). ) Can be directly cultured to selectively form spheroids. Moreover, since the cell adheres to the culture surface of the base material without floating with an appropriate adhesive force, the size of the spheroid can be controlled. For this reason, necrosis of the central part of the spheroid, and hence cell functional deterioration can be suppressed / prevented. Therefore, when the base material of the present invention is used, cells (spheroids) having a high function can be obtained. Therefore, the cells (spheroids) cultured using the base material of the present invention can be suitably used for in vitro tests such as regenerative medicine applications, drug efficacy tests during drug development, and toxicity tests.

 加えて、上述したように、本発明の基材を用いて培養した細胞は、基材に適度に接着する。このため、細胞培養中に培地交換する際でも、細胞が培地と一緒に除去されることが少なくまたはなく、ゆえに細胞ロスを低減でき、例えば1週間以上の長期間の培養が可能となる。また、細胞の凝集を抑制するため、均一な大きさの細胞(スフェロイド)を形成でき、細胞の機能を高く維持できる。また、特にヘーズが40%以下である基材で細胞を培養すると、細胞観察がし易くかつ、J. Biomater. Sci. Polymer Edn, Vol. 17, No. 8, pp. 859-873 (2006)に記載のような意図的な凹凸加工を施さなくとも膜上でスフェロイド形成が可能となるため、様々な培養に伴う細胞の形態変化等を明瞭に観察することが可能となる。これにより、医薬品の薬効試験や毒性試験を実施する際に医薬品による細胞増殖への影響を画像解析によるスフェロイドの大きさの変化で測定するようなin vitro試験でも好適に利用することができる。ゆえに、このような基材を用いることによって、スフェロイドを選択的に形成でき、かつin vitro試験で画像解析等を実施する際に必要となる細胞観察性を向上できる(より容易に細胞を観察できる)。したがって、本発明の基材を用いて培養される細胞(スフェロイド)は、再生医療用途や医薬品開発時の薬効試験や毒性試験等のin vitro試験により好適に使用できる。 In addition, as described above, the cells cultured using the base material of the present invention appropriately adhere to the base material. For this reason, even when the medium is exchanged during the cell culture, the cells are rarely removed together with the medium, and therefore the cell loss can be reduced. For example, the culture can be performed for a long period of one week or longer. In addition, since cell aggregation is suppressed, cells of uniform size (spheroids) can be formed, and the function of the cells can be maintained high. In particular, when cells are cultured on a substrate having a haze of 40% or less, cell observation is easy and J. Biomaterial. Sci. Polymer Edn, Vol. 17, No. 8, pp. 859-873 (2006) allows spheroid formation on the membrane without intentional unevenness as described in the document, so that it is possible to clearly observe the morphological changes of cells accompanying various cultures. Become. Thereby, when conducting a drug efficacy test or a toxicity test of a pharmaceutical, it can be suitably used in an in vitro test in which the influence of the pharmaceutical on cell proliferation is measured by a change in spheroid size by image analysis. Therefore, by using such a base material, it is possible to selectively form spheroids and improve the cell observability required when performing image analysis or the like in an in vitro test (cells can be observed more easily) ). Therefore, the cells (spheroids) cultured using the substrate of the present invention can be suitably used for in vitro tests such as regenerative medicine applications, drug efficacy tests during drug development, and toxicity tests.

 さらに、特表2013-541956号公報(米国特許出願公開第2013/330379号明細書、米国特許出願公開第2013/344036号明細書、米国特許出願公開第2014/010790号明細書、米国特許第9631177号明細書に対応)に記載のヒドロゲルを使用する場合には、水を含んだ状態で輸送することになるが、輸送工程で水が培養容器の壁面や蓋等に付着し、微生物混入のリスクが高くなる。これに対して、本発明の基材は、乾燥状態で輸送できるため微生物混入のリスクを低減でき、かつγ線滅菌等の滅菌処理がし易い利点もある。また、本発明の基材はタンパク質のコーティング等の前処理無でも利用できる(スフェロイドを選択的に形成できる)ため、試験実施に掛かる時間や手間を削減できる。 Furthermore, Japanese translations of PCT publication No. 2013-54156 (U.S. Patent Application Publication No. 2013/330379, U.S. Patent Application Publication No. 2013/344036, U.S. Patent Application Publication No. 2014/010790, U.S. Pat. No. 9631177). In the case of using the hydrogel described in the specification, the water is transported in a state of containing water. However, the risk of contamination of microorganisms due to water adhering to the wall surface or lid of the culture vessel during the transportation process Becomes higher. On the other hand, since the base material of the present invention can be transported in a dry state, there is an advantage that the risk of microbial contamination can be reduced and sterilization such as γ-ray sterilization is easy. Moreover, since the base material of the present invention can be used without pretreatment such as protein coating (a spheroid can be selectively formed), it is possible to reduce the time and labor required for carrying out the test.

 また、培養細胞によっては3次元化しやすい細胞(HepG2、ラット初代肝細胞等)と3次元化しにくい細胞(MCF-7等)とが存在することが知られているが、本発明の基材を利用することで、3次元化し易い細胞はもちろん、3次元化しにくい細胞でも基材を細胞毎に変更することなく、容易に3次元化培養細胞を取得することが可能である。さらに、細胞毒性の低いセルロースを利用し、かつ異種タンパク質を利用することなくスフェロイド形成が可能なため、安全で高機能なスフェロイドが取得でき、再生医療用途でも好適に使用できる。 In addition, it is known that there are cells that are easily three-dimensional (HepG2, rat primary hepatocytes, etc.) and cells that are difficult to three-dimensional (MCF-7, etc.) depending on the cultured cells. By using the cells, it is possible to easily obtain three-dimensional cultured cells without changing the base material for each cell, as well as cells that are easily three-dimensionalized, as well as cells that are difficult to three-dimensionalize. Furthermore, since spheroids can be formed using cellulose with low cytotoxicity and without using a heterologous protein, safe and highly functional spheroids can be obtained, and can be suitably used for regenerative medicine.

 なお、以上のメカニズムは推測であり、本発明の技術的範囲を制限するものではない。 The above mechanism is speculation and does not limit the technical scope of the present invention.

 以下、本発明の実施の形態を説明する。なお、本発明は、以下の実施の形態のみには限定されない。本明細書において、範囲を示す「X~Y」は、XおよびYを含み、「X以上Y以下」を意味する。また、特記しない限り、操作および物性等の測定は室温(20~25℃)/相対湿度40~50%RHの条件で行われる。 Hereinafter, embodiments of the present invention will be described. In addition, this invention is not limited only to the following embodiment. In this specification, “X to Y” indicating a range includes X and Y, and means “X or more and Y or less”. Unless otherwise specified, measurements such as operation and physical properties are performed under conditions of room temperature (20 to 25 ° C.) / Relative humidity 40 to 50% RH.

 本発明の細胞培養用基材は、培養面の算術平均高さ(Sa)が210nm未満である。ここで、培養面のSaが210nm以上であると、表面粗さ(凹凸)が大きくなりすぎて、細胞が平面的に広がって増殖しやすくなるか、または播種した細胞が強固に基材に接着するため、細胞が遊走できず細胞凝集体を形成できなくなる。ゆえに、3次元培養細胞のみを選択的に取得することは困難となる。スフェロイド形成の選択性のさらなる向上効果を考慮すると、培養面の算術平均高さ(Sa)は、好ましくは200nm未満であり、より好ましくは150nm以下であり、特に好ましくは130nm未満である。なお、培養面の算術平均高さ(Sa)の下限は、特に制限されないが、0nm超であるが、好ましくは5nm以上であり、より好ましくは10nm以上であり、さらに好ましくは15nm超であり、さらにより好ましくは60nm超であり、特に好ましくは90nm以上である。このようなSaの培養面で培養することにより、スフェロイドをさらに選択的に形成できると共に、基材の透明性をさらに向上(特にヘーズをさらに低減)できるため、細胞の状態を目視によりより容易に観察できる。なお、本発明では、基材の少なくとも培養面となる面の算術平均高さ(Sa)が210nm未満であれば、他方の面のSaは特に限定されず、210nm以上であってもよい。すなわち、本発明は、基材の一方の面(培養面)の算術平均高さ(Sa)が210nm未満でありかつ他方の面の算術平均高さ(Sa)が210nm以上である形態、ならびに基材の双方の面の算術平均高さ(Sa)が210nm未満である形態の双方を包含する。さらに、Saは実質的に細胞が付着する箇所の値であり、細胞が付着しない箇所のSaはどんな値でも良い。すなわち、本発明の基材は、培養面のうち少なくとも実質的に細胞が付着する面のSaが210nm未満であればよい。 The cell culture substrate of the present invention has an arithmetic average height (Sa) of the culture surface of less than 210 nm. Here, when the Sa of the culture surface is 210 nm or more, the surface roughness (unevenness) becomes too large, and the cells spread flatly and easily proliferate, or the seeded cells firmly adhere to the substrate. Therefore, the cells cannot migrate and cannot form cell aggregates. Therefore, it is difficult to selectively acquire only the three-dimensional cultured cells. Considering the further improvement effect of the selectivity of spheroid formation, the arithmetic average height (Sa) of the culture surface is preferably less than 200 nm, more preferably 150 nm or less, and particularly preferably less than 130 nm. The lower limit of the arithmetic average height (Sa) of the culture surface is not particularly limited, but is more than 0 nm, preferably more than 5 nm, more preferably more than 10 nm, still more preferably more than 15 nm. Even more preferably, it is more than 60 nm, particularly preferably 90 nm or more. By culturing on such a culture surface of Sa, spheroids can be further selectively formed and the transparency of the substrate can be further improved (especially haze is further reduced), so that the state of the cells can be more easily visually observed. I can observe. In the present invention, as long as the arithmetic average height (Sa) of at least the culture surface of the substrate is less than 210 nm, the Sa of the other surface is not particularly limited, and may be 210 nm or more. That is, the present invention relates to a form in which the arithmetic average height (Sa) of one surface (culture surface) of the substrate is less than 210 nm and the arithmetic average height (Sa) of the other surface is 210 nm or more, and It includes both forms in which the arithmetic average height (Sa) of both sides of the material is less than 210 nm. Furthermore, Sa is a value at a location where cells adhere substantially, and Sa at a location where cells do not adhere may be any value. That is, the substrate of the present invention only needs to have a Sa of the culture surface at least substantially to which the cells adhere, of less than 210 nm.

 本明細書において、「算術平均高さ(Sa)」は、JIS B0601(2001年)で定義されている中心平均粗さ(Ra)を面に拡張したパラメーターである。本明細書において、「算術平均高さ(Sa)」は、サンプル(基材または支持体)の所定の面の235.3μm×470.6μmの範囲について、共焦点レーザー顕微鏡(菱化システム社製、商品名:Vert Scan 2.0)によって測定した値の平均値を採用する。 In this specification, “arithmetic average height (Sa)” is a parameter obtained by extending the center average roughness (Ra) defined in JIS B0601 (2001) to a plane. In this specification, “arithmetic mean height (Sa)” is a confocal laser microscope (manufactured by Ryoka Systems Co., Ltd.) for a range of 235.3 μm × 470.6 μm of a predetermined surface of a sample (base material or support). The average value of the values measured by the product name: Vert Scan 2.0) is adopted.

 上述したように、細胞培養用基材の培養面は、適度なバランスで親水性および疎水性(親疎水性)を発揮することが好ましい。これにより、基材上でのスフェロイド形成をより促進できる。ここで、培養面の親疎水性は、静的水接触角によって定義される。具体的には、細胞培養用基材の培養面の静的水接触角は、30°以上であり、好ましくは40°以上であり、より好ましくは45°超である。このような接触角を有する培養面を備える基材を用いることにより、基材上でのスフェロイド形成がより一層促進される。静的水接触角の上限は、特に制限されないが、例えば70°未満、好ましくは65°未満、より好ましくは60°未満、さらにより好ましくは55°未満である。なお、上記静的水接触角は、下記実施例に記載される方法で測定される値である。 As described above, it is preferable that the culture surface of the cell culture substrate exhibits hydrophilicity and hydrophobicity (hydrophobicity) with an appropriate balance. Thereby, spheroid formation on a base material can be promoted more. Here, the hydrophilicity / hydrophobicity of the culture surface is defined by the static water contact angle. Specifically, the static water contact angle of the culture surface of the cell culture substrate is 30 ° or more, preferably 40 ° or more, more preferably more than 45 °. By using a substrate having a culture surface having such a contact angle, spheroid formation on the substrate is further promoted. The upper limit of the static water contact angle is not particularly limited, but is, for example, less than 70 °, preferably less than 65 °, more preferably less than 60 °, and even more preferably less than 55 °. In addition, the said static water contact angle is a value measured by the method described in the following Example.

 また、細胞培養用基材は、透明であることが好ましい。これにより、培養中の細胞を目視により容易に観察できる。ここで、透明性は、全光線透過率およびヘーズ(濁度)によって評価できる。例えば、全光線透過率は、好ましくは80%以上、より好ましくは85%以上(上限:100%)である。また、ヘーズ(濁度)は、40%以下であることが好ましい。すなわち、本発明の好ましい形態によると、細胞培養用基材のヘーズが40%以下である。細胞培養用基材のヘーズは、より好ましくは20%以下であり、さらに好ましくは16%未満であり、さらにより好ましくは12%以下であり、特に好ましくは10%未満である。このような全光線透過率および/またはヘーズ(濁度)であれば、培養中の細胞をより容易に目視できる。なお、細胞培養用基材のヘーズは低いほど好ましいため、下限は特に限定されないが、通常、0.1%以上であり、1%以上であれば十分である。なお、上記全光線透過率またはヘーズは、下記実施例に記載される方法で測定される値である。 The cell culture substrate is preferably transparent. Thereby, the cell in culture can be easily observed visually. Here, the transparency can be evaluated by total light transmittance and haze (turbidity). For example, the total light transmittance is preferably 80% or more, more preferably 85% or more (upper limit: 100%). The haze (turbidity) is preferably 40% or less. That is, according to a preferred embodiment of the present invention, the haze of the cell culture substrate is 40% or less. The haze of the cell culture substrate is more preferably 20% or less, still more preferably less than 16%, still more preferably 12% or less, and particularly preferably less than 10%. With such a total light transmittance and / or haze (turbidity), cells in culture can be more easily visually observed. In addition, since the haze of the cell culture substrate is preferably as low as possible, the lower limit is not particularly limited, but is usually 0.1% or more, and 1% or more is sufficient. In addition, the said total light transmittance or haze is a value measured by the method described in the following Example.

 本発明において、細胞培養用基材は、セルロース繊維を含む膜であり、好ましくはセルロース繊維のみから構成される膜である。セルロース繊維は高い安全性を有しているため、例えば、体内に埋め込まれても安全である。また、セルロース繊維上で培養した細胞を体内に移植する際に、仮に微量のセルロース繊維が含まれていたとしても安全性を確保することができる。本発明の細胞培養基材を用いて培養することにより、細胞は基材と共に体内に適用できる。ここで、セルロース繊維の平均径(直径)は、特に制限されないが、例えば、2~20nmである。このようなセルロース繊維を用いて作製された基材は、透明性に優れ、ヘーズ(Haze)も低いため、培養中の細胞の視認性をより向上できる。本明細書において、セルロース繊維の平均径(直径)及び平均長さは、下記方法に従って測定された値を採用する。 In the present invention, the cell culture substrate is a membrane containing cellulose fibers, preferably a membrane composed only of cellulose fibers. Since the cellulose fiber has high safety, for example, it is safe to be implanted in the body. In addition, when cells cultured on cellulose fibers are transplanted into the body, safety can be ensured even if trace amounts of cellulose fibers are included. By culturing using the cell culture substrate of the present invention, the cells can be applied to the body together with the substrate. Here, the average diameter (diameter) of the cellulose fiber is not particularly limited, but is, for example, 2 to 20 nm. Since the base material produced using such a cellulose fiber is excellent in transparency and has a low haze, the visibility of cells during culture can be further improved. In this specification, the value measured according to the following method is employ | adopted for the average diameter (diameter) and average length of a cellulose fiber.

 (セルロース繊維の平均径(直径)及び平均長さの測定方法)
 1.0重量%のセルロース繊維を含む水溶液をアクリル板上に膜厚(乾燥膜厚)が20~50nmになるように塗布し、乾燥して、塗膜を作製する。次に、得られた塗膜について、2000倍の倍率で電子顕微鏡(SEM)画像による観察を行い、横:1280pixel、縦:800pixelの視野に存在するセルロース繊維について、直径及び長さを測り、これらの平均を求め、得られた値を、それぞれ、セルロース繊維の平均径(直径)及び平均長さとする。なお、セルロース繊維の断面が不定形である場合には、最大径を上記直径とする。なお、本明細書において、セルロース繊維とは、アスペクト比(平均長さ/平均径(平均直径))が1を超える長尺状のセルロースをいう。
(Measuring method of average diameter (diameter) and average length of cellulose fiber)
An aqueous solution containing 1.0% by weight of cellulose fibers is applied on an acrylic plate so that the film thickness (dry film thickness) is 20 to 50 nm and dried to prepare a coating film. Next, the obtained coating film was observed with an electron microscope (SEM) image at a magnification of 2000 times, and the diameter and length of the cellulose fibers existing in the field of width: 1280 pixels and length: 800 pixels were measured. And the obtained values are taken as the average diameter (diameter) and average length of the cellulose fibers, respectively. In addition, when the cross section of a cellulose fiber is an indeterminate form, let the maximum diameter be the said diameter. In addition, in this specification, a cellulose fiber means the elongate cellulose whose aspect-ratio (average length / average diameter (average diameter)) exceeds 1.

 基材の透明性を考慮すると、直径が1μm以上の太いセルロース繊維の含有量が少ないことが好ましい。すなわち、本発明の好ましい形態によると、(基材に対する)1μm以上の直径を有するセルロース繊維の含有率が10%未満である。より好ましくは、直径が1μm以上のセルロース繊維の含有率は、より好ましくは5%以下、特に好ましくは1%未満(下限:0%)である。太いセルロース繊維の含有量が上記範囲であれば、基材は透明性にさらに優れ(特に基材のヘーズを有意に低減でき)、培養中の細胞をより容易に目視でき、例えば、医薬品の薬効試験や毒性試験を実施する際に、医薬品による細胞増殖への影響を画像解析によるスフェロイドの大きさの変化で測定するようなin vitro試験で好適に利用することができる。本明細書において、直径が1μm以上のセルロース繊維の含有率は、下記方法に従って測定された値を採用する。 Considering the transparency of the substrate, the content of thick cellulose fibers having a diameter of 1 μm or more is preferably small. That is, according to the preferable form of this invention, the content rate of the cellulose fiber which has a diameter of 1 micrometer or more (with respect to a base material) is less than 10%. More preferably, the content of cellulose fibers having a diameter of 1 μm or more is more preferably 5% or less, and particularly preferably less than 1% (lower limit: 0%). If the content of thick cellulose fibers is in the above range, the substrate is further excellent in transparency (especially the haze of the substrate can be significantly reduced), and cells in culture can be more easily visually observed. When conducting a test or toxicity test, it can be suitably used in an in vitro test in which the influence of a pharmaceutical product on cell proliferation is measured by a change in the size of a spheroid by image analysis. In this specification, the value measured according to the following method is employ | adopted for the content rate of the cellulose fiber whose diameter is 1 micrometer or more.

 (直径が1μm以上のセルロース繊維の含有率の測定方法)
 各基材(大きさ:1.5cm×1.5cm、面積:Y(cm))を走査型電子顕微鏡で撮像(倍率:2000倍)し、得られた画像を画像解析ソフト(WinROOF2015(三谷商事株式会社))を用い、下記条件で太さ(直径)が1μm以上の繊維が占める面積(X(cm))を求める。当該面積(X(cm))を基材面積(Y(cm))で除して、基材面積に占める太さ(直径)が1μm以上の繊維の面積の割合[=(X/Y)×100(%)]を算出し、これを直径が1μm以上のセルロース繊維の含有率(%)とする。なお、本明細書では、直径が1μm以上のセルロース繊維の含有率(%)を「太繊維含有率(%)」とも称する。また、太さ(直径)が1μm以上の繊維の面積を「太繊維が占める面積(cm)」とも称する。なお、繊維(セルロース繊維)の太さが均一でない場合には、繊維全長の60%以上にわたって太さ(直径)が1μm以上では、その繊維は太さ(直径)が1μm以上の繊維であるとみなす。また、繊維の断面が不定形である場合には、最大径を「太さ(直径)」とみなす。
(Measurement method of content of cellulose fiber having a diameter of 1 μm or more)
Each substrate (size: 1.5 cm × 1.5 cm, area: Y (cm 2 )) was imaged with a scanning electron microscope (magnification: 2000 times), and the obtained image was image analysis software (WinROOF2015 (Mitani) Trading Co., Ltd.) is used to determine the area (X (cm 2 )) occupied by fibers having a thickness (diameter) of 1 μm or more under the following conditions. The area (X (cm 2 )) is divided by the substrate area (Y (cm 2 )), and the ratio of the area of the fibers having a thickness (diameter) of 1 μm or more in the substrate area [= (X / Y ) × 100 (%)] is calculated, and this is defined as the content (%) of cellulose fibers having a diameter of 1 μm or more. In the present specification, the content (%) of cellulose fibers having a diameter of 1 μm or more is also referred to as “thick fiber content (%)”. Further, the area of the fiber having a thickness (diameter) of 1 μm or more is also referred to as “area occupied by the thick fiber (cm 2 )”. In addition, when the thickness of a fiber (cellulose fiber) is not uniform, when the thickness (diameter) is 1 μm or more over 60% or more of the total length of the fiber, the fiber is a fiber having a thickness (diameter) of 1 μm or more. I reckon. Further, when the cross section of the fiber is irregular, the maximum diameter is regarded as “thickness (diameter)”.

Figure JPOXMLDOC01-appb-C000001
Figure JPOXMLDOC01-appb-C000001

 細胞培養用基材の厚みは、特に制限されないが、細胞培養用基材の厚み(乾燥膜厚)は、好ましくは10~100μm、より好ましくは20~60μmである。 The thickness of the cell culture substrate is not particularly limited, but the thickness (dry film thickness) of the cell culture substrate is preferably 10 to 100 μm, more preferably 20 to 60 μm.

 上述したように、本発明の基材は、少なくとも培養面となる面が特定の表面粗さ(Sa)を有することを特徴とする。このような面の形成方法は、特に制限されないが、セルロース繊維分散液を塗布する支持体の塗布面の表面粗さによって制御することが好ましい。すなわち、セルロースを含む塗布液を支持体に塗布・乾燥して塗膜を形成すると、支持体面側の塗膜表面は、支持体の塗布面の表面粗さの影響を受ける。このため、本発明者らは、支持体の表面粗さを適切に調節することによって、簡便に本発明の基材を得ることができるのではないかと考えた。上記推測に基づいて、さらに鋭意検討を行った結果、セルロース繊維を塗布する側の面(塗布面)の算術平均高さ(Sa)が30nm未満である支持体を使用することにより、本発明の基材を簡便に得ることができることを見出した。したがって、本発明は、培養面の算術平均高さ(Sa)が30nm未満である支持体上にセルロース繊維を含む塗布液を塗布することを有する、細胞培養用基材の製造方法をも提供する。 As described above, the base material of the present invention is characterized in that at least a surface to be a culture surface has a specific surface roughness (Sa). The method for forming such a surface is not particularly limited, but is preferably controlled by the surface roughness of the coated surface of the support on which the cellulose fiber dispersion is coated. That is, when a coating solution containing cellulose is applied to a support and dried to form a coating film, the coating surface on the support surface side is affected by the surface roughness of the coating surface of the support. For this reason, the present inventors thought that the base material of the present invention could be easily obtained by appropriately adjusting the surface roughness of the support. As a result of further intensive studies based on the above estimation, the use of a support having an arithmetic average height (Sa) of the surface (application surface) on which cellulose fibers are applied (less than 30 nm) of the present invention. It has been found that a substrate can be easily obtained. Therefore, this invention also provides the manufacturing method of the base material for cell cultures which has apply | coating the coating liquid containing a cellulose fiber on the support body whose arithmetic mean height (Sa) of a culture surface is less than 30 nm. .

 以下、上記好ましい細胞培養用基材の製造方法について説明する。なお、下記説明は、本発明の細胞培養用基材が他の方法によって製造されることを排除するものではない。 Hereinafter, a preferable method for producing the cell culture substrate will be described. The following description does not exclude that the cell culture substrate of the present invention is produced by other methods.

 まず、セルロース繊維を含む塗布液(以下、単に「塗布液」とも称する)を調製する。 First, a coating liquid containing cellulose fibers (hereinafter also simply referred to as “coating liquid”) is prepared.

 ここで、セルロース繊維の製造方法は特に制限されず、セルロース(セルロース繊維原料)を機械解繊する方法などが使用できる。なお、セルロース繊維の製造には、例えば、特開2016-87877号公報、特開2015-218299号公報、特開2015-140403号公報等に記載の方法などの公知の方法を同様にしてまたは適宜改変して使用できる。以下、セルロース繊維の製造方法の好ましい形態を説明するが、本発明は下記形態に限定されない。 Here, the production method of the cellulose fiber is not particularly limited, and a method of mechanically defibrating cellulose (cellulose fiber raw material) can be used. For the production of cellulose fibers, for example, known methods such as those described in JP-A-2016-87877, JP-A-2015-218299, JP-A-2015-140403 and the like can be used similarly or appropriately. Can be used with modification. Hereinafter, although the preferable form of the manufacturing method of a cellulose fiber is demonstrated, this invention is not limited to the following form.

 セルロース(セルロース繊維原料)は、特に制限されず、植物由来または細菌由来のセルロースであってもよいが、入手容易性、コスト等の観点から、植物由来のセルロースをセルロース繊維原料として使用することが好ましい。例えば、カラマツ、スギ、アブラヤシ、ヒノキ等から得られる各種木材;パルプ類;新聞紙、ダンボール、雑誌、上質紙などの紙類;籾殻、パーム殻、ココナッツ殻などの植物殻類をセルロース繊維原料として使用してもよい。ここで、パルプとしては、木材パルプ、非木材パルプ、脱墨パルプから選ばれる。ここで、木材パルプとしては、以下に制限されないが、広葉樹漂白クラフトパルプ、広葉樹未漂白クラフトパルプ、針葉樹漂白クラフトパルプ、針葉樹未漂白クラフトパルプ、亜硫酸木材パルプ、ソーダパルプ、未晒しクラフトパルプ、酸素漂白クラフトパルプ、加水分解クラフトパルプ等の化学修飾パルプ等;セミケミカルパルプ(SCP)、ケミグラウンドウッドパルプ(CGP)等の半化学パルプ;砕木パルプ(GP)、サーモメカニカルパルプ(TMP、BCTMP)等の機械パルプなどが挙げられる。また、非木材パルプとしては、以下に制限されないが、コットンリンター、コットンリント等の綿系パルプ(綿セルロース)、麻(麻セルロース)、麦わら(麦わらセルロース)、バガス(サトウキビの搾りかす)、空果房(EFB)、稲わら、とうもろこし茎等の非木材系パルプ、ホヤや海草等から単離されるセルロースなどが挙げられる。脱墨パルプとしては、以下に制限されないが、古紙を原料とする脱墨パルプなどが挙げられる。上記セルロース繊維原料は、1種を単独で使用しても、または2種以上の混合物の形態で使用してもよい。これらのうち、入手容易性、繊維径の制御しやすさ、繊維微細化(解繊)等の観点から、セルロースを含む木材パルプ、化学修飾パルプが好ましい。または、セルロース繊維原料は市販品を使用してよい。 Cellulose (cellulose fiber raw material) is not particularly limited, and may be plant-derived or bacterial-derived cellulose. From the viewpoint of availability, cost, etc., plant-derived cellulose may be used as the cellulose fiber raw material. preferable. For example, various woods obtained from larch, cedar, oil palm, cypress, etc .; pulps; papers such as newspapers, cardboard, magazines, fine papers; plant shells such as rice husks, palm husks, coconut husks, etc. May be. Here, the pulp is selected from wood pulp, non-wood pulp, and deinked pulp. Here, the wood pulp is not limited to the following, but hardwood bleached kraft pulp, hardwood unbleached kraft pulp, conifer bleached kraft pulp, softwood unbleached kraft pulp, sulfite wood pulp, soda pulp, unbleached kraft pulp, oxygen bleach Chemically modified pulp such as kraft pulp and hydrolyzed kraft pulp; Semi-chemical pulp such as semi-chemical pulp (SCP) and Chemi-ground wood pulp (CGP); such as groundwood pulp (GP) and thermomechanical pulp (TMP, BCTMP) Examples include mechanical pulp. Non-wood pulp is not limited to the following, but cotton pulp such as cotton linter and cotton lint (cotton cellulose), hemp (hemp cellulose), straw (straw cellulose), bagasse (sugar cane squeezed), empty Non-wood pulp such as fruit bunches (EFB), rice straw, corn stalks, cellulose isolated from sea squirts, seaweeds, and the like. The deinking pulp is not limited to the following, and examples include deinking pulp made from waste paper. The said cellulose fiber raw material may be used individually by 1 type, or may be used with the form of a 2 or more types of mixture. Among these, wood pulp and chemically modified pulp containing cellulose are preferable from the viewpoints of availability, ease of control of fiber diameter, fiber refinement (defibration), and the like. Alternatively, commercially available cellulose fiber raw materials may be used.

 セルロース繊維原料は、機械解繊前に予め物理的または化学的処理されてもよい。具体的には、脱脂処理、脱リグニン処理(ホロセルロース化)、アルカリ処理、酸化処理などが挙げられる。上記処理は2種以上を組み合わせて使用してもよい。 The cellulose fiber raw material may be subjected to physical or chemical treatment in advance before mechanical defibration. Specifically, degreasing treatment, delignification treatment (holocellulose conversion), alkali treatment, oxidation treatment and the like can be mentioned. Two or more of the above treatments may be used in combination.

 ここで、脱脂処理方法は、特に制限されず、公知の方法が使用できる。具体的には、セルロース繊維原料を脱脂用溶液中に浸漬することによって行われ得る。ここで、脱脂用溶液の調製に使用される溶媒は、特に制限されず、使用するセルロース繊維原料の種類によって適宜選択すればよい。例えば、水、アセトン、アルコールなどが挙げられる。上記溶媒は、1種を単独で使用してもまたは2種以上の混合溶液の形態で使用してもよい。また、脱脂条件は、特に制限されず、使用するセルロース繊維原料の種類によって適宜選択すればよい。例えば、脱脂処理温度は、通常、10~100℃、好ましくは15~50℃である。また、脱脂処理時間は、通常、1~30時間、好ましくは15~20時間である。また、上記脱脂処理は、撹拌下で行われてもよい。 Here, the degreasing treatment method is not particularly limited, and a known method can be used. Specifically, it can be performed by immersing the cellulose fiber raw material in a degreasing solution. Here, the solvent used for the preparation of the degreasing solution is not particularly limited, and may be appropriately selected depending on the type of the cellulose fiber raw material to be used. For example, water, acetone, alcohol, etc. are mentioned. The said solvent may be used individually by 1 type, or may be used with the form of 2 or more types of mixed solutions. The degreasing conditions are not particularly limited and may be appropriately selected depending on the type of cellulose fiber raw material to be used. For example, the degreasing temperature is usually 10 to 100 ° C., preferably 15 to 50 ° C. The degreasing time is usually 1 to 30 hours, preferably 15 to 20 hours. Moreover, the said degreasing process may be performed under stirring.

 脱リグニン処理(ホロセルロース化)方法は、特に制限されず、公知の方法が使用できる。具体的には、セルロース繊維原料を、酸(例えば、硫酸、塩酸、酢酸、無水酢酸)および酸化剤(漂白剤)(例えば、亜塩素酸ナトリウム、過酸化水素)を含む脱リグニン用溶液に添加し、これを加熱する方法が好ましく使用できる。ここで、加熱条件は、特に制限されず、使用するセルロース繊維原料の種類、ならびに酸や酸化剤の種類によって適宜選択すればよい。例えば、加熱温度は、通常、50~120℃、好ましくは60~100℃である。また、加熱時間は、通常、0.5~5時間、好ましくは1~3時間である。 The delignification (holocellulose) method is not particularly limited, and a known method can be used. Specifically, the cellulose fiber raw material is added to a delignification solution containing an acid (eg, sulfuric acid, hydrochloric acid, acetic acid, acetic anhydride) and an oxidizing agent (bleaching agent) (eg, sodium chlorite, hydrogen peroxide). And the method of heating this can be used preferably. Here, the heating conditions are not particularly limited, and may be appropriately selected depending on the type of cellulose fiber raw material used and the type of acid or oxidizing agent. For example, the heating temperature is usually 50 to 120 ° C., preferably 60 to 100 ° C. The heating time is usually 0.5 to 5 hours, preferably 1 to 3 hours.

 アルカリ処理方法は、特に制限されず、公知の方法が使用できる。具体的には、セルロース繊維原料をアルカリ溶液中に浸漬することによって行われ得る。ここで、アルカリ溶液の調製に使用されるアルカリは、特に制限されず、無機物でも有機物でもよい。例えば、無機物(無機アルカリ)としては、水酸化リチウム、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、炭酸リチウム、炭酸水素リチウム、炭酸カリウム、炭酸水素カリウム、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カルシウム、リン酸リチウム、リン酸カリウム、リン酸3ナトリウム、リン酸水素2ナトリウム、リン酸カルシウム、リン酸水素カルシウム等の、アルカリ金属またはアルカリ土類金属の、水酸化物、炭酸塩およびリン酸塩などが挙げられる。また、有機物(有機アルカリ)としては、例えば、アンモニア;ヒドラジン、メチルアミン、エチルアミン、ジエチルアミン、トリエチルアミン、プロピルアミン、ジプロピルアミン、ブチルアミン、ジアミノエタン、ジアミノプロパン、ジアミノブタン、ジアミノペンタン、ジアミノヘキサン、シクロヘキシルアミン、アニリン、テトラメチルアンモニウムヒドロキシド、テトラエチルアンモニウムヒドロキシド、テトラプロピルアンモニウムヒドロキシド、テトラブチルアンモニウムヒドロキシド、ベンジルトリメチルアンモニウムヒドロキシド、ピリジン、N,N-ジメチル-4-アミノピリジン、炭酸アンモニウム、炭酸水素アンモニウム、リン酸水素2アンモニウム等の、脂肪族アミン、芳香族アミン、脂肪族アンモニウム、芳香族アンモニウム、複素環式化合物、ならびにこれらの水酸化物、炭酸塩およびリン酸塩などが挙げられる。また、アルカリ溶液の調製に使用される溶媒は、アルカリを溶解できるものであれば特に限定されず、水やメタノール、エタノール等の低級アルコールを用いることができる。好ましくは、水を含むことが好ましい、すなわち、水酸化ナトリウム水溶液、水酸化カリウム水溶液をアルカリ溶液として好ましく使用できる。ここで、アルカリ溶液におけるアルカリ濃度は、特に制限されないが、例えば、1~15重量%、好ましくは3~7重量%である。また、アルカリ処理条件は、特に制限されず、使用するセルロース原料やアルカリの種類によって適宜選択すればよい。例えば、アルカリ処理温度は、通常、10~50℃、好ましくは15~40℃である。また、アルカリ処理時間は、通常、0.5~5時間、好ましくは1~3時間である。また、上記アルカリ処理は、撹拌下で行われてもよい。なお、アルカリ処理を行う場合には、アルカリ処理後のセルロースを洗浄して余分なアルカリを除去してもよい。ここで、洗浄に使用できる洗浄液としては、特に制限されないが、上記アルカリ溶液に使用したのと同様の溶媒を使用できる。 The alkali treatment method is not particularly limited, and a known method can be used. Specifically, it can be performed by immersing the cellulose fiber raw material in an alkaline solution. Here, the alkali used for preparing the alkaline solution is not particularly limited, and may be inorganic or organic. For example, as an inorganic substance (inorganic alkali), lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, lithium carbonate, lithium hydrogen carbonate, potassium carbonate, potassium hydrogen carbonate, sodium carbonate, sodium hydrogen carbonate, calcium carbonate, Examples thereof include hydroxides, carbonates and phosphates of alkali metals or alkaline earth metals such as lithium phosphate, potassium phosphate, trisodium phosphate, disodium hydrogen phosphate, calcium phosphate, and calcium hydrogen phosphate. It is done. Examples of the organic substance (organic alkali) include ammonia; hydrazine, methylamine, ethylamine, diethylamine, triethylamine, propylamine, dipropylamine, butylamine, diaminoethane, diaminopropane, diaminobutane, diaminopentane, diaminohexane, cyclohexyl. Amine, aniline, tetramethylammonium hydroxide, tetraethylammonium hydroxide, tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, benzyltrimethylammonium hydroxide, pyridine, N, N-dimethyl-4-aminopyridine, ammonium carbonate, carbonic acid Aliphatic amines, aromatic amines, aliphatic ammoniums, fragrances such as ammonium hydrogen and diammonium hydrogen phosphate Ammonium, heterocyclic compounds, and their hydroxides, and carbonates, and phosphate. Moreover, the solvent used for preparation of an alkaline solution will not be specifically limited if an alkali can be melt | dissolved, Lower alcohols, such as water, methanol, and ethanol, can be used. Preferably, it contains water, that is, an aqueous sodium hydroxide solution and an aqueous potassium hydroxide solution can be preferably used as the alkaline solution. Here, the alkali concentration in the alkali solution is not particularly limited, but is, for example, 1 to 15% by weight, preferably 3 to 7% by weight. The alkali treatment conditions are not particularly limited, and may be appropriately selected depending on the cellulose raw material to be used and the type of alkali. For example, the alkali treatment temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C. The alkali treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours. Moreover, the said alkali treatment may be performed under stirring. In addition, when performing an alkali treatment, you may wash | clean the cellulose after an alkali treatment and remove an excess alkali. Here, the cleaning liquid that can be used for cleaning is not particularly limited, but the same solvent as that used for the alkaline solution can be used.

 酸化処理方法は、特に制限されず、公知の方法が使用できる。具体的には、N-オキシル化合物を酸化触媒として用いる方法などがある。これにより、セルロース表面を選択的に酸化でき、また、セルロースを容易に微細化することができる。また、上記酸化反応は水系で、比較的緩やかな条件(室温付近で常圧で)行うことができる。また、木材中のセルロースに対しても、酸化反応は、結晶内部より結晶表面で選択的に進行し、セルロース分子鎖が持つアルコール性1級炭素を選択的にカルボキシル基に変換できる。このため、次工程の機械解繊によって、セルロース繊維を水系溶媒中で一本ずつ分散できる。ゆえに、本形態によって得られるセルロース繊維の水分散液は高い透明性を有する。このため、基材の透明性のさらなる向上効果の観点からは、酸化処理(カルボキシル化)セルロースをセルロース繊維原料として使用することが好ましい。ここで、N-オキシル化合物としては、特に制限されず、セルロースの酸化に使用される公知の触媒が使用できる。具体的には、2,2,6,6-テトラメチルピペリジン1-オキシル(TEMPO)、2,2,6,6-テトラメチル-4-ヒドロキシピペリジン-1-オキシル、4-メトキシ-2,2,6,6-テトラメチルピペリジン-N-オキシル、4-エトキシ-2,2,6,6-テトラメチルピペリジン-N-オキシル、4-アセトアミド-2,2,6,6-テトラメチルピペリジン-N-オキシル、4-カルボキシ-2,2,6,6-テトラメチルピペリジン-N-オキシル、4-ホスホノオキシ-2,2,6,6-テトラメチルピペリジン-N-オキシルなどが挙げられる。これらのうち、セルロースの酸化効率の観点から、TEMPO、4-アセトアミド-2,2,6,6-テトラメチルピペリジン-N-オキシルが好ましく、TEMPOがより好ましい。また、N-オキシル化合物の使用量は、セルロース酸化を進行できる量であれば、特に限定されない。例えば、触媒の使用量は、セルロース繊維原料に対して、好ましくは0.1~5重量%、より好ましくは0.5~3重量%程度である。 The oxidation treatment method is not particularly limited, and a known method can be used. Specifically, there is a method using an N-oxyl compound as an oxidation catalyst. Thereby, the cellulose surface can be selectively oxidized and the cellulose can be easily refined. Moreover, the oxidation reaction can be carried out in an aqueous system and under relatively mild conditions (normal pressure near room temperature). In addition, the oxidation reaction of cellulose in wood also proceeds selectively on the crystal surface from the inside of the crystal, and the alcoholic primary carbon possessed by the cellulose molecular chain can be selectively converted into a carboxyl group. For this reason, cellulose fibers can be dispersed one by one in an aqueous solvent by mechanical defibration in the next step. Therefore, the aqueous dispersion of cellulose fibers obtained by this embodiment has high transparency. For this reason, from the viewpoint of further improving the transparency of the substrate, it is preferable to use oxidized (carboxylated) cellulose as a cellulose fiber raw material. Here, the N-oxyl compound is not particularly limited, and a known catalyst used for the oxidation of cellulose can be used. Specifically, 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO), 2,2,6,6-tetramethyl-4-hydroxypiperidine-1-oxyl, 4-methoxy-2,2 , 6,6-Tetramethylpiperidine-N-oxyl, 4-ethoxy-2,2,6,6-tetramethylpiperidine-N-oxyl, 4-acetamido-2,2,6,6-tetramethylpiperidine-N -Oxyl, 4-carboxy-2,2,6,6-tetramethylpiperidine-N-oxyl, 4-phosphonooxy-2,2,6,6-tetramethylpiperidine-N-oxyl and the like. Of these, TEMPO and 4-acetamido-2,2,6,6-tetramethylpiperidine-N-oxyl are preferable and TEMPO is more preferable from the viewpoint of the oxidation efficiency of cellulose. The amount of the N-oxyl compound used is not particularly limited as long as it is an amount capable of proceeding with the cellulose oxidation. For example, the amount of the catalyst used is preferably about 0.1 to 5% by weight, more preferably about 0.5 to 3% by weight, based on the cellulose fiber raw material.

 酸化処理は、酸化剤の共存下で行ってもよい。酸化剤を併用することによって、カルボキシ基の導入効率をさらに向上できる。また、温和な条件で酸化反応できるため、セルロースの結晶構造を維持しやすい。ここで、酸化剤としては、特に制限されないが、例えば、ハロゲン(塩素、臭素、ヨウ素など)、次亜ハロゲン酸またはそれらの塩(次亜塩素酸またはその塩、次亜臭素酸またはその塩、次亜ヨウ素酸またはその塩など)、亜ハロゲン酸またはそれらの塩(亜塩素酸またはその塩、亜臭素酸またはその塩、亜ヨウ素酸またはその塩など)、過ハロゲン酸またはそれらの塩(過塩素酸またはその塩、過ヨウ素酸またはその塩など)、ハロゲン酸化物(ClO、ClO、Cl、BrO、Brなど)、窒素酸化物(NO、NO、Nなど)、過酸化物(過酸化水素、過酢酸、過硫酸、過安息香酸など)などが挙げられる。セルロースの酸化効率などの観点から、次亜ハロゲン酸および次亜ハロゲン酸塩が好ましく、次亜塩素酸ナトリウム(NaClO)がより好ましい。上記酸化剤は、単独で使用されてもまたは2種以上を併用してもよい。また、酸化剤は、そのままの形態で添加されても、または適当な溶媒(例えば、水)に溶解した溶液形態で添加されてもよい。酸化剤の使用量は、酸化反応を促進できる量であれば特に制限されないが、例えば、セルロース繊維原料1gに対して、好ましくは1~30ミリモル、より好ましくは5~20ミリモル程度である。 The oxidation treatment may be performed in the presence of an oxidizing agent. By using an oxidizing agent in combination, the introduction efficiency of the carboxy group can be further improved. Moreover, since the oxidation reaction can be performed under mild conditions, it is easy to maintain the crystal structure of cellulose. Here, the oxidizing agent is not particularly limited. For example, halogen (chlorine, bromine, iodine, etc.), hypohalous acid or a salt thereof (hypochlorous acid or a salt thereof, hypobromous acid or a salt thereof, Hypoiodic acid or a salt thereof), halogenous acid or a salt thereof (chlorous acid or a salt thereof, bromous acid or a salt thereof, iodic acid or a salt thereof), a perhalogenic acid or a salt thereof (peroxide) Chloric acid or its salt, periodic acid or its salt, etc.), halogen oxide (ClO, ClO 2 , Cl 2 O 6 , BrO 2 , Br 3 O 7 etc.), nitrogen oxide (NO, NO 2 , N 2) O 2 ), peroxides (hydrogen peroxide, peracetic acid, persulfuric acid, perbenzoic acid, etc.). From the viewpoint of the oxidation efficiency of cellulose and the like, hypohalous acid and hypohalite are preferable, and sodium hypochlorite (NaClO) is more preferable. The said oxidizing agent may be used independently or may use 2 or more types together. Further, the oxidizing agent may be added as it is or in the form of a solution dissolved in an appropriate solvent (for example, water). The amount of the oxidizing agent to be used is not particularly limited as long as it can promote the oxidation reaction. For example, it is preferably about 1 to 30 mmol, more preferably about 5 to 20 mmol with respect to 1 g of the cellulose fiber raw material.

 また、酸化処理を上記酸化剤の存在下で行う場合には、酸化処理をさらに臭化物および/またはヨウ化物の共存下で行ってもよい。これにより、酸化反応をさらに円滑に進行できる。ここで、臭化物としては、以下に制限されないが、臭化アンモニウム、臭化ナトリウム、臭化リチウムなどが挙げられる。同様にして、ヨウ化物としては、以下に制限されないが、ヨウ化アンモニウム、ヨウ化ナトリウム、ヨウ化リチウムなどが挙げられる。これらうち、コストや安定性の観点から、臭化ナトリウム(NaBr)が好ましい。上記臭化物およびヨウ化物は、それぞれ、単独で使用されてもまたは2種以上を併用してもよい。また、臭化物およびヨウ化物を併用してもよい。臭化物および/またはヨウ化物の使用量は、酸化反応を促進できる量であれば特に制限されないが、例えば、セルロース繊維原料に対して、好ましくは0.5~30重量%、より好ましくは1~10重量%程度である。 Further, when the oxidation treatment is performed in the presence of the oxidant, the oxidation treatment may be further performed in the presence of bromide and / or iodide. As a result, the oxidation reaction can proceed more smoothly. Here, examples of the bromide include, but are not limited to, ammonium bromide, sodium bromide, lithium bromide and the like. Similarly, examples of iodide include, but are not limited to, ammonium iodide, sodium iodide, lithium iodide, and the like. Of these, sodium bromide (NaBr) is preferable from the viewpoint of cost and stability. The bromide and iodide may be used alone or in combination of two or more. In addition, bromide and iodide may be used in combination. The amount of bromide and / or iodide used is not particularly limited as long as it can promote the oxidation reaction. For example, it is preferably 0.5 to 30% by weight, more preferably 1 to 10%, based on the cellulose fiber raw material. It is about wt%.

 酸化処理条件は、特に制限されず、使用するセルロース繊維原料ならびに酸化触媒および使用する場合には酸化剤や(使用する場合には)臭化物/ヨウ化物の種類によって適宜選択すればよい。例えば、酸化処理温度は、通常、10~50℃、好ましくは15~40℃である。また、酸化処理時間は、通常、0.5~5時間、好ましくは1~3時間である。また、上記酸化処理は、撹拌下で行われてもよい。 The oxidation treatment conditions are not particularly limited, and may be appropriately selected depending on the cellulose fiber raw material to be used, the oxidation catalyst, and the oxidizing agent when used and the type of bromide / iodide (when used). For example, the oxidation treatment temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C. The oxidation treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours. The oxidation treatment may be performed with stirring.

 なお、上記酸化後、必要であれば、還元反応を行ってもよい。ここで、還元剤としては、特に制限されず、水素化ホウ素ナトリウム(NaBH)等の公知の還元剤が使用できる。ここで、還元剤の使用量は、所望の程度に還元を進行できる量であれば特に制限されないが、例えば、セルロース繊維原料の初期仕込み量に対して、好ましくは1~30重量%、より好ましくは5~20重量%程度である。還元反応条件は、特に制限されず、使用するセルロース繊維原料ならびに還元剤の種類によって適宜選択すればよい。例えば、還元反応温度は、通常、10~50℃、好ましくは15~40℃である。また、酸化処理時間は、通常、0.5~5時間、好ましくは1~3時間である。また、上記還元処理は、撹拌下で行われてもよい。 In addition, after the oxidation, a reduction reaction may be performed if necessary. Here, the reducing agent is not particularly limited and a known reducing agent such as sodium borohydride (NaBH 4) can be used. Here, the amount of the reducing agent to be used is not particularly limited as long as the reduction can proceed to a desired level. For example, the amount of the reducing agent is preferably 1 to 30% by weight, more preferably with respect to the initial charge amount of the cellulose fiber material. Is about 5 to 20% by weight. The reduction reaction conditions are not particularly limited, and may be appropriately selected depending on the cellulose fiber raw material to be used and the type of the reducing agent. For example, the reduction reaction temperature is usually 10 to 50 ° C., preferably 15 to 40 ° C. The oxidation treatment time is usually 0.5 to 5 hours, preferably 1 to 3 hours. Moreover, the said reduction process may be performed under stirring.

 上記反応により、カルボキシレート含有量が0.1~3.0mmol/g、好ましくは0.2~2.0mmol/gの酸化セルロースが得られる。このようなカルボキシレート含有量の酸化セルロースは、セルロース間の静電反発により、微細化して均一に分散できる。 By the above reaction, oxidized cellulose having a carboxylate content of 0.1 to 3.0 mmol / g, preferably 0.2 to 2.0 mmol / g is obtained. Oxidized cellulose having such a carboxylate content can be finely divided and uniformly dispersed by electrostatic repulsion between celluloses.

 上記のようにして得られたセルロースを機械解繊する。これにより、セルロースがさらに微細化して、セルロース繊維が得られる。ここで、セルロースの機械解繊(微細化)方法としては、特に制限されず、公知の方法が使用できる。具体的には、セルロースの水性分散液を解繊処理装置を用いて微細化(解繊)処理する方法が使用できる。ここで、水性分散液を得るために使用される水性媒体としては、水、低級アルコール(メタノール、エタノール、プロパノール、イソプロパノール)などが挙げられる。上記水性媒体は、単独で使用されてもまたは2種以上の混合液の形態で使用されてもよい。これらのうち、水が好ましい。ここで、水性分散液におけるセルロース濃度は、特に制限されないが、機械解繊(微細化)効率などの観点から、好ましくは0.1~20重量%、より好ましくは0.3~10重量%程度である。必要に応じて、セルロースの分散性向上のために、分散液のpHを調整してもよい。次に、この水性分散液に機械解繊処理を施して、セルロースを微細化する。ここで、機械解繊処理としては、以下に制限されないが、高圧ホモジナイザー、超高圧ホモジナイザー、ボールミル、ロールミル、ビーズミル、カッターミル、遊星ミル、ジェットミル、アトライター、グラインダー、ジューサーミキサー、ホモミキサー、超音波ホモジナイザー、ナノジナイザー、水中対向衝突、ディスク型リファイナー、コニカルリファイナーなどの機械的処理などが挙げられる。また、二軸混練機、振動ミル、高速回転下でのホモミキサー、超音波分散機、ビーター等、湿式粉砕する装置等を適宜使用することができる。このような機械解繊処理を行うことにより、分散液中のセルロースが微細化され、セルロース繊維分散液を得ることができる。 The cellulose obtained as described above is mechanically defibrated. Thereby, a cellulose further refines | miniaturizes and a cellulose fiber is obtained. Here, the method for mechanical fibrillation (miniaturization) of cellulose is not particularly limited, and a known method can be used. Specifically, a method of refining (defibrating) an aqueous dispersion of cellulose using a defibrating apparatus can be used. Here, examples of the aqueous medium used for obtaining the aqueous dispersion include water and lower alcohols (methanol, ethanol, propanol, isopropanol) and the like. The aqueous medium may be used alone or in the form of a mixture of two or more. Of these, water is preferred. Here, the cellulose concentration in the aqueous dispersion is not particularly limited, but is preferably about 0.1 to 20% by weight, more preferably about 0.3 to 10% by weight, from the viewpoint of mechanical defibration (miniaturization) efficiency and the like. It is. If necessary, the pH of the dispersion may be adjusted to improve the dispersibility of cellulose. Next, the aqueous dispersion is subjected to a mechanical defibrating treatment to refine the cellulose. Here, the mechanical defibrating treatment is not limited to the following, but is a high pressure homogenizer, an ultra high pressure homogenizer, a ball mill, a roll mill, a bead mill, a cutter mill, a planetary mill, a jet mill, an attritor, a grinder, a juicer mixer, a homomixer, an ultra mixer. Examples include mechanical processing such as a sonic homogenizer, a nanogenizer, an underwater collision, a disk refiner, and a conical refiner. In addition, a wet pulverizing apparatus such as a twin-screw kneader, a vibration mill, a homomixer under high-speed rotation, an ultrasonic disperser, and a beater can be used as appropriate. By performing such mechanical fibrillation treatment, the cellulose in the dispersion is refined, and a cellulose fiber dispersion can be obtained.

 このようにして得られたセルロース繊維分散液をそのままセルロース繊維を含む塗布液(塗布液)として使用してもよい。または、上記のようにして得られたセルロース繊維分散液からセルロース繊維を分離した後、適当な溶媒に分散させて、塗布液としてもよい。後者の場合に使用できる溶媒としては、特に制限されないが、細胞培養に悪影響を及ぼさないものであることが好ましい。上記点を考慮すると、例えば、水、低級アルコール(メタノール、エタノール、プロパノール、イソプロパノール)などが挙げられる。上記溶媒は、単独で使用されてもまたは2種以上の混合液の形態で使用されてもよい。これらのうち、水が好ましい。ここで、塗布液におけるセルロース繊維濃度は、特に制限されないが、塗布しやすさ、目視容易性などの観点から、好ましくは0.1~20重量%、より好ましくは0.5~10重量%程度である。当該濃度範囲となるよう、上記で得られたセルロース繊維分散液を濃縮してもよい。必要に応じて、セルロースの分散性向上のために、分散液のpHを調整してもよい。 The cellulose fiber dispersion thus obtained may be used as it is as a coating liquid containing cellulose fibers (coating liquid). Alternatively, the cellulose fibers may be separated from the cellulose fiber dispersion obtained as described above, and then dispersed in an appropriate solvent to form a coating solution. The solvent that can be used in the latter case is not particularly limited, but is preferably a solvent that does not adversely affect cell culture. Considering the above points, for example, water, lower alcohols (methanol, ethanol, propanol, isopropanol) and the like can be mentioned. The said solvent may be used independently or may be used with the form of a 2 or more types of liquid mixture. Of these, water is preferred. Here, the cellulose fiber concentration in the coating solution is not particularly limited, but is preferably about 0.1 to 20% by weight, more preferably about 0.5 to 10% by weight, from the viewpoints of ease of coating, easy visual observation, and the like. It is. You may concentrate the cellulose fiber dispersion liquid obtained above so that it may become the said density | concentration range. If necessary, the pH of the dispersion may be adjusted to improve the dispersibility of cellulose.

 塗布液は、セルロース繊維のみを含んでも(即ち、基材がセルロース繊維のみから構成されても)、または他の成分を含んでも(即ち、基材がセルロース繊維に加えて他の成分を含んでも)よい。後者の場合の他の成分としては、特に制限されないが、細胞培養に使用される成分(例えば、血清、各種成長因子、分化誘導因子、抗生物質、ホルモン、アミノ酸、糖、塩類等など)などが挙げられる。また、塗布液が他の成分を含む場合の、他の成分の添加量は、培養細胞に悪影響を及ぼさない量であれば特に制限されないが、例えば、セルロース繊維に対して、0.01~100重量%である。 The coating solution may contain only cellulose fibers (that is, the substrate may be composed only of cellulose fibers) or may contain other components (that is, the substrate may contain other components in addition to the cellulose fibers). ) Good. Other components in the latter case are not particularly limited, but include components used in cell culture (eg, serum, various growth factors, differentiation-inducing factors, antibiotics, hormones, amino acids, sugars, salts, etc.) Can be mentioned. In addition, when the coating solution contains other components, the amount of other components added is not particularly limited as long as it does not adversely affect the cultured cells. For example, 0.01 to 100 with respect to cellulose fibers. % By weight.

 次に、上記したようにして調製された塗布液を、支持体のSaが30nm未満である面(培養面または塗布面)に塗布する。ここで、算術平均高さ(Sa)が30nm以上の支持体面にセルロース繊維を含む塗布液を塗布すると、得られる基材の支持体側の算術平均高さ(Sa)が210nm以上となってしまう(下記比較例1参照)。支持体のセルロース繊維塗布面の算術平均高さ(Sa)は、スフェロイドをより選択的に形成できる基材を得る観点から、5nm以上であることが好ましい。中でも、さらに好ましくは5~25nm、さらにより好ましくは8~20nm、特に好ましくは10~20nmである。このようなSaの面を有する支持体を用いることによって、基材の培養面のSaを上記したような好ましい範囲に制御できる。なお、支持体の少なくとも塗布面(塗布液を塗布する綿)の算術平均高さ(Sa)が30nm未満であれば、他方の面のSaは特に限定されず、30nm以上であってもよい。すなわち、本発明は、支持体の一方の面(塗布面)の算術平均高さ(Sa)が30nm未満でありかつ他方の面の算術平均高さ(Sa)が30nm以上である形態、ならびに支持体の双方の面の算術平均高さ(Sa)が30nm未満である形態の双方を包含する。 Next, the coating solution prepared as described above is applied to the surface (culture surface or coated surface) where Sa of the support is less than 30 nm. Here, when the coating liquid containing cellulose fibers is applied to the support surface having an arithmetic average height (Sa) of 30 nm or more, the arithmetic average height (Sa) on the support side of the obtained base material is 210 nm or more ( See Comparative Example 1 below). The arithmetic average height (Sa) of the cellulose fiber-coated surface of the support is preferably 5 nm or more from the viewpoint of obtaining a substrate that can form spheroids more selectively. Among these, it is more preferably 5 to 25 nm, still more preferably 8 to 20 nm, and particularly preferably 10 to 20 nm. By using a support having such a surface of Sa, Sa on the culture surface of the substrate can be controlled within the preferred range as described above. In addition, as long as the arithmetic average height (Sa) of at least the coated surface (cotton to which the coating solution is coated) of the support is less than 30 nm, Sa on the other surface is not particularly limited, and may be 30 nm or more. That is, the present invention provides an embodiment in which the arithmetic average height (Sa) of one surface (application surface) of the support is less than 30 nm and the arithmetic average height (Sa) of the other surface is 30 nm or more, and the support It includes both forms in which the arithmetic mean height (Sa) of both sides of the body is less than 30 nm.

 支持体の材質は、Saが30nm未満となる面を形成できるものであれば特に制限されない。具体的には、無機ガラス;カーボン;シリコン等の金属;ポリエチレン、ポリプロピレン、環状オレフィン等のポリオレフィン樹脂;ポリエチレンテレフタレート(PET)等のポリエステル樹脂;ポリメタクリル酸メチル等のアクリル系樹脂;エポキシ樹脂;ポリ塩化ビニル、ポリ塩化ビニリデン、ポリスチレン樹脂、ポリ酢酸ビニル、ABS(アクリロニトリル-ブタジエン-スチレン)樹脂、ポリカーボネート樹脂、ビニルエーテル、ポリアセタール、ポリフェニレンエーテル(PPE)、ポリアリールエーテル、ポリフェニレンスルファイド(PPS)、ポリエーテルエーテルケトン(PEEK)、ポリアリールエーテルケトン、フェノール樹脂、ポリエーテルニトリル(PEN)、ポリアミド樹脂、ポリイミド樹脂、フッ素化ポリイミド樹脂(含フッ素ポリイミド樹脂)、フッ素樹脂、ポリスルホン、ポリエーテルスルホン、ポリジメチルシロキサン等が例示できる。支持体の厚みは特に制限されないが、通常、1~10mm、好ましくは1.5mm以上5mm未満である。なお、支持体は、所定のSa値の表面粗さを有するものを購入しても、または支持体表面のSa値が所定の値になるように、研磨機などによって支持体表面を研磨してもよい。 The material of the support is not particularly limited as long as it can form a surface with Sa of less than 30 nm. Specifically, inorganic glass; carbon; metal such as silicon; polyolefin resin such as polyethylene, polypropylene and cyclic olefin; polyester resin such as polyethylene terephthalate (PET); acrylic resin such as polymethyl methacrylate; epoxy resin; Vinyl chloride, polyvinylidene chloride, polystyrene resin, polyvinyl acetate, ABS (acrylonitrile-butadiene-styrene) resin, polycarbonate resin, vinyl ether, polyacetal, polyphenylene ether (PPE), polyaryl ether, polyphenylene sulfide (PPS), polyether Ether ketone (PEEK), polyaryl ether ketone, phenol resin, polyether nitrile (PEN), polyamide resin, polyimide resin, fluorinated poly Bromide resin (fluorine-containing polyimide resin), fluorine resin, polysulfone, polyethersulfone, polydimethylsiloxane and the like. The thickness of the support is not particularly limited, but is usually 1 to 10 mm, preferably 1.5 mm or more and less than 5 mm. In addition, even if a support having a surface roughness of a predetermined Sa value is purchased, the surface of the support is polished by a polishing machine or the like so that the Sa value of the support surface becomes a predetermined value. Also good.

 塗布方法としては、特に制限されないが、ナチュラルコーター、ナイフベルトコーター、フローティングナイフ、ロールコート、エアーナイフコート、ナイフオーバーロール、ナイフオンブランケット、スプレー、ディップ、キスロール、スクイーズロール、リバースロール、エアブレード、カーテンフローコーター、ドクターブレード、ワイヤーバー、ダイコーター、カンマコーター、スピンコーター、アプリケーター、ベーカーアプリケーターおよびグラビアコーター、スクリーン印刷機等の装置を用いる種々の塗布方法が挙げられる。塗布は、数回から十数回繰り返し行ってもよい。また、塗布液の支持体への塗布量は、特に制限されないが、上記したような基材の厚みとなるような量であることが好ましい。また、上述したように、基材の少なくとも培養面となる面の算術平均高さ(Sa)が210nm未満であれば、他方の面のSaは特に限定されず、210nm以上であってもよい。このため、算術平均高さ(Sa)が210nm以上であるセルロース繊維製フィルムを、支持体上の塗布液の上にさらに積層してもよい。 Application method is not particularly limited, natural coater, knife belt coater, floating knife, roll coat, air knife coat, knife over roll, knife on blanket, spray, dip, kiss roll, squeeze roll, reverse roll, air blade, Various coating methods using apparatuses such as a curtain flow coater, a doctor blade, a wire bar, a die coater, a comma coater, a spin coater, an applicator, a baker applicator, a gravure coater, and a screen printing machine may be mentioned. The application may be repeated several times to dozens of times. Further, the amount of the coating solution applied to the support is not particularly limited, but it is preferably an amount that provides the thickness of the substrate as described above. In addition, as described above, as long as the arithmetic average height (Sa) of at least the culture surface of the substrate is less than 210 nm, the Sa of the other surface is not particularly limited, and may be 210 nm or more. For this reason, you may further laminate | stack the film made from a cellulose fiber whose arithmetic mean height (Sa) is 210 nm or more on the coating liquid on a support body.

 塗布後の乾燥条件も特に制限されず、主に溶媒の沸点等を考慮して適宜選択することができる。例えば、乾燥温度は、好ましくは20~100℃、より好ましくは40~70℃である。また、乾燥時間は、好ましくは10~30時間、好ましくは15~20時間である。 The drying conditions after application are not particularly limited, and can be appropriately selected mainly considering the boiling point of the solvent. For example, the drying temperature is preferably 20 to 100 ° C., more preferably 40 to 70 ° C. The drying time is preferably 10 to 30 hours, preferably 15 to 20 hours.

 このような方法に形成された塗膜を支持体から剥離することによって、本発明の細胞培養用基材が得られる。 The cell culture substrate of the present invention can be obtained by peeling the coating film formed by such a method from the support.

 上記した方法において、支持体の特定の粗さ(Sa)を有する面上に塗布液を塗布・乾燥して基材を作製する場合には、基材の一方の面(即ち、支持体への塗布面)のみが本発明で規定される表面粗さ(Sa)となる。一方、支持体の特定の粗さ(Sa)を有する面上に塗布液を塗布した後、(支持体が設置されていない)塗膜面に特定の粗さ(Sa)を有する支持体を載置することによって、両面が本発明で規定される表面粗さ(Sa)を有する基材を作製することができる。 In the above-described method, when a substrate is prepared by applying and drying a coating solution on a surface having a specific roughness (Sa) of the support, one surface of the substrate (ie, the surface of the support) Only the coated surface) has the surface roughness (Sa) defined in the present invention. On the other hand, after coating the coating liquid on the surface having the specific roughness (Sa) of the support, the support having the specific roughness (Sa) is placed on the coating surface (where no support is installed). By placing it, a base material having both surface roughness (Sa) defined in the present invention can be produced.

 上述したように、本発明の細胞培養用基材は、培養面、特に実質的に細胞が付着する部分の算術平均高さ(Sa)が210nm未満であるセルロース繊維を含む膜である。本発明の基材によれば、前処理(例えば、タンパク質付着を抑制する成分のコート)を必要とせずに、基材表面(培養面)に直接スフェロイドを選択的にかつ基材に付着した状態で形成できる。このため、本発明の基材を用いると、機能性の高い細胞塊(スフェロイド)が得られる。 As described above, the substrate for cell culture according to the present invention is a membrane containing cellulose fibers having an arithmetic average height (Sa) of less than 210 nm on the culture surface, in particular, a portion to which cells substantially adhere. According to the substrate of the present invention, a state in which spheroids are selectively and directly attached to the substrate surface (culture surface) without the need for pretreatment (for example, a coat of a component that suppresses protein adhesion). Can be formed. For this reason, when the base material of the present invention is used, a highly functional cell mass (spheroid) is obtained.

 本発明の細胞培養基材は、好ましくは培養に使用する前に滅菌処理を行ってから培養に使用する。細胞培養用器具類の滅菌処理としては、オートクレーブ滅菌、乾熱滅菌、エチレンオキサイドガス滅菌、ガンマ線滅菌、電子線滅菌などの公知の滅菌方法が利用可能である。これらのうち、耐熱耐圧性の低い器具類の滅菌にも適用でき、かつエチレンオキサイドガスのような残留ガスの問題も無い点で、ガンマ線滅菌が好ましい。 The cell culture substrate of the present invention is preferably sterilized before use for culturing and then used for culturing. As the sterilization treatment for cell culture instruments, known sterilization methods such as autoclave sterilization, dry heat sterilization, ethylene oxide gas sterilization, gamma ray sterilization, and electron beam sterilization can be used. Among these, gamma ray sterilization is preferable because it can be applied to sterilization of instruments having low heat and pressure resistance and there is no problem of residual gas such as ethylene oxide gas.

 基材へのタンパク質の付着量と細胞の付着・形態は密接に関連していることが知られており、本発明の細胞培養用基材においても、タンパク質の基材への吸着量をコントロールすることでより好適に3次元培養細胞を取得することができる。具体的には、基材のアルブミンの吸着量が1000ng/cm以上であることが好ましい。なお、アルブミンの吸着量の上限は特に制限されないが、スフェロイドの形成がより良好であるという観点から、好ましくは2000ng/cm以下であることが好ましく、1500ng/cm以下であることがより好ましい。上記アルブミンの吸着量に代えて、または、に加えて、基材のプロテオグリカンの吸着量が160ng/cm以上であることが好ましい。プロテオグリカンの吸着量の上限は特に制限されないが、スフェロイド形成がより良好であるという観点から、好ましくは300ng/cm以下であることが好ましく、200ng/cm以下であることがより好ましい。なお、上記アルブミンの吸着量およびプロテオグリカンの吸着量は、下記実施例に記載される方法で測定される値である。 It is known that the amount of protein attached to the substrate and the adhesion / form of cells are closely related, and the amount of protein adsorbed to the substrate is also controlled in the cell culture substrate of the present invention. Thus, a three-dimensional cultured cell can be obtained more suitably. Specifically, the amount of albumin adsorbed on the substrate is preferably 1000 ng / cm 2 or more. Although the upper limit of the amount of adsorption of albumin is not particularly limited, from the viewpoint of formation of spheroids is better, preferably it is preferably 2000 ng / cm 2 or less, more preferably 1500 ng / cm 2 or less . Instead of or in addition to the above-mentioned albumin adsorption amount, the substrate proteoglycan adsorption amount is preferably 160 ng / cm 2 or more. The upper limit of the adsorption amount of proteoglycan is not particularly limited, but is preferably 300 ng / cm 2 or less, more preferably 200 ng / cm 2 or less, from the viewpoint of better spheroid formation. The adsorption amount of albumin and the adsorption amount of proteoglycan are values measured by the methods described in the following examples.

 したがって、本発明の細胞培養用基材は培養容器に好適に使用できる。すなわち、本発明の一実施形態では、本発明の細胞培養用基材を有する培養容器が提供される。本発明の培養容器(細胞培養容器)は、本発明の基材上で細胞を培養する限り、本発明の細胞培養用基材と他の部材とが組み合わされて構成されていてもよいし、本発明の細胞培養用基材と他の部材とが一体化されて構成されていてもよいし、本発明の細胞培養用基材のみにより構成されていてもよい。本発明の細胞培養用基材がフィルム状等の柔軟な基材である場合は、剛性を有する適当な支持部材と組みあわせて形成してもよい。 Therefore, the cell culture substrate of the present invention can be suitably used for a culture vessel. That is, in one embodiment of the present invention, a culture container having the cell culture substrate of the present invention is provided. As long as cells are cultured on the base material of the present invention, the culture container (cell culture container) of the present invention may be configured by combining the cell culture base material of the present invention and other members, The cell culture substrate of the present invention and the other member may be integrated, or may be composed only of the cell culture substrate of the present invention. When the cell culture substrate of the present invention is a flexible substrate such as a film, it may be formed in combination with an appropriate support member having rigidity.

 図4に、本発明にかかる細胞培養容器の一実施形態を例示する。細胞培養容器は、図4(A)のように細胞培養用基材1からなるものでもよく、あるいは、図4(B)や(C)のように細胞培養用基材1と支持部材20とからなるものであってもよい。図4では、細胞培養容器を、開口した側から平面視したときの内郭形状及び外郭形状は、それぞれ例えば円、多角形(四角形、三角形等)などの任意の形状であることができる。支持部材20を構成する材料としては、例えば、無機ガラス;カーボン;シリコン等の金属;ポリエチレン、ポリプロピレン、環状オレフィン等のポリオレフィン樹脂;ポリエチレンテレフタレート(PET)等のポリエステル樹脂;ポリメタクリル酸メチル等のアクリル系樹脂;エポキシ樹脂;ポリ塩化ビニル、ポリ塩化ビニリデン、ポリスチレン樹脂、ポリ酢酸ビニル、ABS(アクリロニトリル-ブタジエン-スチレン)樹脂、ポリカーボネート樹脂、ビニルエーテル、ポリアセタール、ポリフェニレンエーテル(PPE)、ポリアリールエーテル、ポリフェニレンスルファイド(PPS)、ポリエーテルエーテルケトン(PEEK)、ポリアリールエーテルケトン、フェノール樹脂、ポリエーテルニトリル(PEN)等が例示できる。または、上記支持体を支持部材として使用してもよい。 FIG. 4 illustrates one embodiment of the cell culture container according to the present invention. The cell culture vessel may be composed of the cell culture substrate 1 as shown in FIG. 4 (A), or the cell culture substrate 1 and the support member 20 as shown in FIGS. 4 (B) and (C). It may consist of. In FIG. 4, the inner shape and the outer shape when the cell culture container is viewed in plan from the opened side can be any shape such as a circle, a polygon (square, triangle, etc.), for example. Examples of the material constituting the support member 20 include inorganic glass; carbon; metal such as silicon; polyolefin resin such as polyethylene, polypropylene and cyclic olefin; polyester resin such as polyethylene terephthalate (PET); acrylic such as polymethyl methacrylate. Resin; epoxy resin; polyvinyl chloride, polyvinylidene chloride, polystyrene resin, polyvinyl acetate, ABS (acrylonitrile-butadiene-styrene) resin, polycarbonate resin, vinyl ether, polyacetal, polyphenylene ether (PPE), polyaryl ether, polyphenylenesulfur Examples include fido (PPS), polyether ether ketone (PEEK), polyaryl ether ketone, phenol resin, polyether nitrile (PEN), and the like.Or you may use the said support body as a supporting member.

 本発明の細胞培養容器は、本発明の細胞培養用基材を備えていればよく、全体としてどのような形状であってもよい。例えば、シングル若しくはマルチウェルプレートなどの培養用のプレート、シャーレ、ディッシュ、フラスコ、バッグ等の各種容器の形状であることができる。本発明の細胞培養容器はまた、大量培養装置や潅流培養装置などの培養装置における細胞培養容器の形態であってもよい。 The cell culture container of the present invention may have any shape as a whole as long as it includes the cell culture substrate of the present invention. For example, it can be in the form of various containers such as plates for culture such as single or multiwell plates, petri dishes, dishes, flasks, bags and the like. The cell culture container of the present invention may also be in the form of a cell culture container in a culture apparatus such as a mass culture apparatus or a perfusion culture apparatus.

 本発明の一実施形態では、本発明の細胞培養用基材の培養面上で細胞(接着性細胞)を培養することを有する、細胞の培養方法が提供される。上記の細胞培養用基材は、その表面粗さ(Sa)により、培養面上で細胞を培養することによりスフェロイドを選択的に形成することができる。また、細胞は適度な接着力で基材の培養面に付着するため、スフェロイドの大きさを制御できる。このため、中心部の壊死、ゆえに細胞の機能低下を抑制・防止できる。また、本発明の基材を用いて培養した細胞は基材に適度に接着するため、細胞培養中に培地交換する際でも、細胞が培地と一緒に除去されることが少なくまたはなく、ゆえに細胞ロスを低減できる。また、細胞の凝集を抑制するため、均一な大きさの細胞(スフェロイド)を形成でき、細胞の機能を高く維持できる。本発明のさらなる実施形態では、上記培養する工程において、細胞(特に接着性細胞)を3次元培養する、細胞培養方法が提供される。すなわち、本発明の一形態では、培養が3次元培養である。 In one embodiment of the present invention, there is provided a cell culture method comprising culturing cells (adherent cells) on the culture surface of the cell culture substrate of the present invention. The cell culture substrate can selectively form spheroids by culturing cells on the culture surface according to the surface roughness (Sa). In addition, since the cells adhere to the culture surface of the substrate with an appropriate adhesive force, the size of the spheroid can be controlled. For this reason, necrosis of the central part, and hence the decrease in cell function can be suppressed / prevented. In addition, since the cells cultured using the substrate of the present invention adhere appropriately to the substrate, even when the medium is changed during cell culture, the cells are rarely removed together with the medium. Loss can be reduced. In addition, since cell aggregation is suppressed, cells of uniform size (spheroids) can be formed, and the function of the cells can be maintained high. In a further embodiment of the present invention, a cell culture method is provided in which cells (particularly adherent cells) are three-dimensionally cultured in the culturing step. That is, in one embodiment of the present invention, the culture is three-dimensional culture.

 本発明の細胞培養方法で培養される細胞の種類は特に限定されず、正常細胞、がん細胞、幹細胞、およびハイブリドーマ等の融合細胞等が使用でき、遺伝子導入等の人工的処理がされた細胞であってもよい。特に限定されないが、例えば、人工多能性幹細胞(Induced pluripotent stem cells:iPS細胞)、胚性幹細胞(Embryonic stem cells:ES細胞)、間葉系幹細胞等の一般的に3次元培養を行うことが求められている細胞や、各種前駆細胞及び幹細胞を含む、脂肪細胞、肝細胞、腎細胞、膵臓細胞、乳腺細胞、内皮細胞、上皮細胞、平滑筋細胞、筋芽細胞、心筋細胞、神経細胞、グリア細胞、樹状細胞、軟骨細胞、骨芽細胞、破骨細胞、骨細胞、線維芽細胞、各種血液系細胞、網膜細胞、角膜由来細胞、生殖腺由来細胞、各種線細胞、その他間葉系前駆細胞、各種癌細胞等の細胞が挙げられる。これらの細胞が由来する生物種も特に制限されず、ヒトおよび非ヒト動物由来の各種細胞を用いることができる。細胞が由来する生物種としては、例えば、ヒト、アカゲザル、ミドリザル、カニクイザル、チンパンジー、タマリンおよびマーモセット等の霊長類、マウス、ラット、ハムスターおよびモルモット等の齧歯類、イヌ、ネコ、ウサギ、ブタ、ウシ、ヤギ、ヒツジ、ウマ、ニワトリ、ウズラ、ミンク、ツパイ、ならびにゼブラフィッシュ等が例示できる。 The type of cells cultured by the cell culture method of the present invention is not particularly limited, and normal cells, cancer cells, stem cells, and fused cells such as hybridomas can be used, and cells that have been subjected to artificial treatment such as gene transfer It may be. Although not particularly limited, for example, three-dimensional culture of artificial pluripotent stem cells (Induced pluripotent stem cells: iPS cells), embryonic stem cells (Embryonic stem cells: ES cells), mesenchymal stem cells, etc. may be generally performed. Adipose cells, hepatocytes, kidney cells, pancreatic cells, mammary cells, endothelial cells, epithelial cells, smooth muscle cells, myoblasts, cardiomyocytes, nerve cells, including the required cells and various progenitor cells and stem cells, Glial cells, dendritic cells, chondrocytes, osteoblasts, osteoclasts, bone cells, fibroblasts, various blood cells, retinal cells, cornea-derived cells, gonad-derived cells, various line cells, other mesenchymal precursors And cells such as cells and various cancer cells. The biological species from which these cells are derived is not particularly limited, and various cells derived from humans and non-human animals can be used. Examples of the biological species from which the cells are derived include, for example, primates such as humans, rhesus monkeys, green monkeys, cynomolgus monkeys, chimpanzees, tamarins and marmosets, rodents such as mice, rats, hamsters and guinea pigs, dogs, cats, rabbits, pigs, Examples include cows, goats, sheep, horses, chickens, quails, minks, pineapples, and zebrafish.

 細胞培養に用いる培地は、細胞に合わせて適宜選択すればよい。培地の種類は特に限定されないが、例えば、任意の細胞培養基本培地や分化培地、初代培養専用培地等を用いることができる。具体的には、イーグル最小必須培地(EMEM)、ダルベッコ改変イーグル培地(DMEM)、α-MEM、グラスゴーMEM(GMEM)、IMDM、RPMI1640、ハムF-12、MCDB培地、ウィリアムス培地E、およびこれらの混合培地等が挙げられるが、これらには限定されず、細胞が増殖や分化に必要な成分が含まれる培地であれば利用可能である。さらに、血清、各種成長因子、分化誘導因子、抗生物質、ホルモン、アミノ酸、糖、塩類等を添加した培地を使用してもよい。培養温度も特に制限されないが、通常は25~40℃程度で行う。 The medium used for cell culture may be appropriately selected according to the cells. The type of medium is not particularly limited. For example, any cell culture basic medium, differentiation medium, primary culture medium, or the like can be used. Specifically, Eagle Minimum Essential Medium (EMEM), Dulbecco's Modified Eagle Medium (DMEM), α-MEM, Glasgow MEM (GMEM), IMDM, RPMI 1640, Ham F-12, MCDB Medium, Williams Medium E, and these Examples thereof include, but are not limited to, a mixed medium, and any medium can be used as long as the medium contains components necessary for cell growth and differentiation. Furthermore, a medium supplemented with serum, various growth factors, differentiation-inducing factors, antibiotics, hormones, amino acids, sugars, salts and the like may be used. The culture temperature is not particularly limited, but is usually about 25 to 40 ° C.

 3次元培養により形成される組織としては、スフェロイドや、3次元細胞集合体が挙げられる。スフェロイド又は3次元細胞集合体は肝細胞のような単一な細胞で形成されたスフェロイド又は3次元細胞集合体でも、各種線維芽細胞や血管内皮細胞等と肝細胞のような2種以上の異なる細胞種が混在したスフェロイド又は3次元細胞集合体でも良い。使用できる細胞としては、上記の各種細胞が挙げられる。一実施形態では、上記の細胞培養用基材であって、前記細胞培養面にスフェロイドが選択的に接着した、細胞培養用基材が提供される。他の実施形態では、当該前記細胞培養面にスフェロイドが選択的に接着した細胞培養用基材を有する、細胞培養容器が提供される。 Examples of tissues formed by three-dimensional culture include spheroids and three-dimensional cell aggregates. A spheroid or a three-dimensional cell aggregate is a spheroid or a three-dimensional cell aggregate formed of a single cell such as a hepatocyte. It may be a spheroid mixed with cell types or a three-dimensional cell aggregate. Examples of cells that can be used include the various cells described above. In one embodiment, there is provided the cell culture substrate, wherein the cell culture substrate has a spheroid selectively adhered to the cell culture surface. In another embodiment, a cell culture container having a cell culture substrate having spheroids selectively adhered to the cell culture surface is provided.

 本発明の基材を利用することで、生体に近い機能をもった3次元培養細胞を取得することができる。理由は明らかではないが、下記[アルブミン定量]にて示すように、本発明の基材で培養される3次元培養細胞は、従来の培養プレートに比して高い機能を発揮でき、従来の培養基材で培養される3次元培養細胞とは異なる。したがって、本発明は、本発明の細胞培養用基材上に形成されてなる(培養される)3次元培養細胞をも提供する。3次元培養細胞(スフェロイド)は直径200μmを超える大きさになると、スフェロイド中央部まで培地中の栄養や酸素が行き渡らなくなり、中央部の細胞が壊死することが知られているが、本発明の基材を利用してスフェロイドを形成することで、直径200μm以下のスフェロイドを容易に多数取得することが可能となる。したがって、本発明の基材を利用してスフェロイドを形成することにより、培養細胞の機能を向上することができる。なお、本発明に係る細胞培養用基材上に形成されてなる3次元培養細胞の有用性は実施例に示す通りであるが、従来の培養基材で培養される3次元培養細胞との比較においてその構造や特性上の特徴点を特定することは非常に困難である。 By using the substrate of the present invention, a three-dimensional cultured cell having a function close to that of a living body can be obtained. Although the reason is not clear, as shown in the following [Albumin quantification], the three-dimensional cultured cells cultured on the base material of the present invention can exhibit higher functions than conventional culture plates. It is different from three-dimensional cultured cells cultured on a substrate. Therefore, the present invention also provides a three-dimensional cultured cell formed (cultured) on the cell culture substrate of the present invention. It is known that when a three-dimensional cultured cell (spheroid) has a diameter exceeding 200 μm in diameter, nutrients and oxygen in the medium do not reach the central part of the spheroid, and the cells in the central part are necrotic. By forming a spheroid using a material, a large number of spheroids having a diameter of 200 μm or less can be easily obtained. Therefore, the function of the cultured cells can be improved by forming spheroids using the substrate of the present invention. In addition, although the usefulness of the three-dimensional cultured cell formed on the cell culture substrate according to the present invention is as shown in the Examples, it is compared with the three-dimensional cultured cell cultured on the conventional culture substrate. However, it is very difficult to specify the feature points on the structure and characteristics.

 本発明の細胞培養用基材を利用して取得した3次元培養細胞を用いて、医薬品開発時の薬効試験や毒性試験等を実施することも可能である。すなわち、本発明は、本発明の3次元培養細胞を用いることを有する、in vitroでの薬剤の試験方法をも提供する。具体的には、抗癌剤の開発において、ガン細胞に対する薬効試験をin vitroで実施することで、ハイスループットに有効な抗癌剤をスクリーニングすることが求められているが、本発明の基材を利用して取得したガン細胞(3次元培養細胞)は、生体内に近い抗癌剤への抵抗性を有するため、生体で実施した試験に近い抗癌剤の薬効データを取得することができる。また、本特許記載の細胞培養基材を利用して取得した3次元培養細胞を用いて、PLoS One. 2013 Oct 24;8(10)に記載のような抗癌剤の濃度を適時変更して、各抗癌剤濃度におけるガン細胞の生存率を測定するドーズレスポンスカーブのデータ取得も可能であり、より正確な抗癌剤の薬効データを得ることができる。生存率の測定方法には、公知の方法が利用可能であり、具体的には、MultiTox-Fluor Multiplex Cytotoxicity Assay kit (Promega社)のようなプロテアーゼ活性を指標として生存率を測定する方法や、RubyGlowTM Luminescent Cell Viability Assay Kit(コスモ・バイオ株式会社)のようなATPを指標とする方法、Cytotoxic Fluoro-test wako(和光純薬)を用いた蛍光試薬で核酸染色する方法、トリパンブルーを用いたトリパンブルー色素排除試験法等のような細胞の生存率を測定する方法が利用可能である。さらにcell3 imager(株式会社SCREENホールディングス)のようなイメージング装置を利用して抗癌剤添加後のスフェロイドの直径の変化を測定することで、抗癌剤による細胞増殖抑制効果を測定することも可能であり、MultiTox-Fluor Multiplex Cytotoxicity Assay kit (Promega社)のようなプロテアーゼ活性を指標として生存率を測定する他の細胞の生存率を測定する方法よりも、よりハイスループットに抗癌剤の薬効を評価できるためイメージング装置を利用した方法がより好適である。特に、本発明の基材が透明性に優れる場合には、イメージング装置等を利用した画像解析による細胞機能評価をより好適に(より簡便に)実施することが可能となる。 It is also possible to carry out drug efficacy tests and toxicity tests at the time of drug development using three-dimensional cultured cells obtained using the cell culture substrate of the present invention. That is, the present invention also provides a method for testing a drug in vitro, comprising using the three-dimensional cultured cell of the present invention. Specifically, in the development of anticancer agents, it is required to screen anticancer agents effective for high throughput by conducting in vitro drug efficacy tests on cancer cells. Since the acquired cancer cells (three-dimensional cultured cells) have resistance to an anticancer agent close to that in the living body, it is possible to acquire drug efficacy data of the anticancer agent that is close to the test performed in the living body. In addition, using three-dimensional cultured cells obtained using the cell culture substrate described in this patent, PLoS One. 2013 Oct 24: 8 As described in 8 (10), it is possible to obtain dose response curve data for measuring the survival rate of cancer cells at each anticancer drug concentration by changing the anticancer drug concentration as needed. Drug efficacy data can be obtained. As a method for measuring the survival rate, a known method can be used. Specifically, a method such as MultiTox-Fluor Multiplex Cytotoxicity Assay kit (Promega) for measuring the survival rate as an index, RubyGlowTM A method using ATP as an index, such as Luminescent Cell Viability Assay Kit (Cosmo Bio Inc.), a method of nucleic acid staining with a fluorescent reagent using Cytotoxic Fluoro-test wako (Wako Pure Chemical Industries), trypan blue using trypan blue Methods for measuring cell viability such as dye exclusion test methods can be used. Furthermore, by measuring changes in the diameter of spheroids after addition of an anticancer agent using an imaging device such as cell3 imager (SCREEN Holdings Co., Ltd.), it is also possible to measure the cell growth inhibitory effect of the anticancer agent. Use imaging devices to evaluate the efficacy of anticancer drugs at higher throughput than methods that measure the viability of other cells that measure the viability using protease activity as an index, such as Fluor Multiplex Cytotoxicity Assay Kit (Promega). This method is more preferable. In particular, when the substrate of the present invention is excellent in transparency, cell function evaluation by image analysis using an imaging apparatus or the like can be performed more suitably (more simply).

 また、本発明の基材を利用することで、生体に近い機能をもった3次元培養細胞を取得することができるため、本明細書に記載の基材を利用して取得した3次元培養細胞を、例えば心疾患、肝臓疾患、加齢黄斑変性等の眼科領域の疾患等の様々な疾患に対する再生医療用途で利用することも可能である。本発明では細胞培養基材として生体に安全なセルロースを利用しているため、より安全な3次元培養細胞を取得することができ、再生医療用途での利用に好適である。すなわち、本発明は、本発明の3次元培養細胞を含む再生医療材料をも提供する。また、本発明は、本発明の3次元培養細胞を用いた心疾患、肝臓疾患または眼科領域の疾患の治療方法をも提供する。 In addition, since a three-dimensional cultured cell having a function similar to that of a living body can be obtained by using the base material of the present invention, the three-dimensional cultured cell obtained using the base material described in this specification. Can also be used for regenerative medical applications for various diseases such as diseases in the ophthalmic field such as heart disease, liver disease, and age-related macular degeneration. In the present invention, since cellulose that is safe for living bodies is used as a cell culture substrate, safer three-dimensional cultured cells can be obtained, which is suitable for use in regenerative medicine. That is, the present invention also provides a regenerative medical material containing the three-dimensional cultured cell of the present invention. The present invention also provides a method for treating heart disease, liver disease or ophthalmological disease using the three-dimensional cultured cells of the present invention.

 さらに、本明細書に記載の基材および当該基材上に形成された3次元培養細胞の両者を患部に移植することも、セルロースという生体に安全な材を利用しているため、可能である。このように基材と基材上の3次元培養細胞の両者を患部に移植することで、細胞を基材から回収せずに患部に容易に移植することができ、かつ患部に細胞を長く留めさせることや、細胞の生存率を高く維持できる効果が期待できる。すなわち、本発明は、本発明の細胞培養用基材および前記基材上に形成されてなる3次元培養細胞を含む細胞送達材料をも提供する。 Furthermore, it is possible to transplant both the base material described in the present specification and the three-dimensional cultured cells formed on the base material into the affected part, because a biologically safe material called cellulose is used. . In this way, by transplanting both the base material and the three-dimensional cultured cells on the base material to the affected area, the cells can be easily transplanted to the affected area without being recovered from the base material, and the cells are kept long in the affected area. And the effect of maintaining a high cell survival rate can be expected. That is, the present invention also provides a cell delivery material comprising the cell culture substrate of the present invention and a three-dimensional cultured cell formed on the substrate.

 本発明の効果を、以下の実施例および比較例を用いて説明する。ただし、本発明の技術的範囲が以下の実施例のみに制限されるわけではない。なお、下記実施例において、特記しない限り、操作は室温(25℃)で行われた。また、特記しない限り、「%」および「部」は、それぞれ、「重量%」および「重量部」を意味する。 The effect of the present invention will be described using the following examples and comparative examples. However, the technical scope of the present invention is not limited only to the following examples. In the following examples, the operation was performed at room temperature (25 ° C.) unless otherwise specified. Unless otherwise specified, “%” and “part” mean “% by weight” and “part by weight”, respectively.

 実施例1
 スギウッドチップ(40g)を、まず、室温(25℃)で一晩(15時間)、アセトンと水との混合液(900mL:100mL(アセトン:水))中で撹拌することによって脱脂処理を行った。次に、この脱脂したウッドチップを、90℃で2時間、無水酢酸と過酸化水素との混合液(500mL:500mL(無水酢酸:過酸化水素))中で加熱することによって脱リグニンして、ホロセルロースパルプを得た。最後に、このホロセルロースパルプを、20℃で2時間、5重量%水酸化カリウム(KOH)水溶液に浸漬して、アルカリ処理ホロセルロースパルプ懸濁液を得た。
Example 1
First, cedar wood chips (40 g) were degreased by stirring in a mixture of acetone and water (900 mL: 100 mL (acetone: water)) overnight (15 hours) at room temperature (25 ° C.). It was. Next, this defatted wood chip is delignified by heating in a mixed solution of acetic anhydride and hydrogen peroxide (500 mL: 500 mL (acetic anhydride: hydrogen peroxide)) at 90 ° C. for 2 hours, A holocellulose pulp was obtained. Finally, this holocellulose pulp was immersed in a 5 wt% potassium hydroxide (KOH) aqueous solution at 20 ° C. for 2 hours to obtain an alkali-treated holocellulose pulp suspension.

 このようにして得られたアルカリ処理ホロセルロースパルプ懸濁液(固形分0.5重量%)2000mLをball-collisionチャンバーを備えた高圧ウォータージェットシステム(Star Burst, HJP-25005 E、Sugino Machine Co., Ltd.)を用いて、高圧ホモジネート(機械解繊)して、ホモジネート化スラリーを得た。このホモジネート化スラリーを、245MPaの圧力で直径0.17mmの小ノズルから押し出した。上記押し出しを50回繰り返し、0.3重量%濃度の高圧ホモジネート化セルロース繊維懸濁液を取得し、塗布液1(セルロース繊維/水分散液)とした。 A high-pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber was used for 2000 mL of the alkali-treated holocellulose pulp suspension (solid content 0.5 wt%) thus obtained. , Ltd.) was used for high-pressure homogenization (mechanical fibrillation) to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The extrusion was repeated 50 times to obtain a high-pressure homogenized cellulose fiber suspension having a concentration of 0.3% by weight, which was designated as coating solution 1 (cellulose fiber / water dispersion).

 この塗布液1(高圧ホモジネート化セルロース繊維濃度:0.3重量%)を0.8重量%濃度になるまで濃縮し、塗布液1’を調製した。別途、支持体としてのガラス板1(松浪硝子工業社製、Sa値:11.23nm、厚さ:2mm)の一方の面に7cm×7cmの穴の開いた金属製の枠材を載せたものを用意した(これを塗布板1と以下称する)。 The coating solution 1 (high-pressure homogenized cellulose fiber concentration: 0.3% by weight) was concentrated to a concentration of 0.8% by weight to prepare a coating solution 1 '. Separately, a glass frame 1 as a support (made by Matsunami Glass Industry Co., Ltd., Sa value: 11.23 nm, thickness: 2 mm) on which a metal frame material with a 7 cm × 7 cm hole is mounted Was prepared (hereinafter referred to as coating plate 1).

 上記にて調製した塗布液1’を上記塗布板1の穴に40mL/穴の量で流し込んだ。ガラス棒で塗布液1’を穴の中全体に伸ばした。枠材を外し、50℃で一晩(15時間)オーブンで乾燥した後、塗膜を塗布板1から回収して、30μm厚の基材1を作製した。この基材1のガラス板1’面側のSa値を測定したところ、125.7nm(培養面)であった。 The coating solution 1 'prepared above was poured into the holes of the coating plate 1 in an amount of 40 mL / hole. The coating solution 1 ′ was extended all over the hole with a glass rod. After removing the frame material and drying in an oven at 50 ° C. overnight (15 hours), the coating film was recovered from the coating plate 1 to prepare a substrate 1 having a thickness of 30 μm. When the Sa value on the glass plate 1 'surface side of the substrate 1 was measured, it was 125.7 nm (culture surface).

 実施例2
 実施例1において、ガラス板1の代わりに、アクリル板2(日本テストパネル社製、Sa値:8.30nm、厚さ:2mm)を支持体として使用する以外は、実施例1と同様にして、30μm厚の基材2を作製した。
Example 2
In Example 1, instead of the glass plate 1, the same procedure as in Example 1 was used except that an acrylic plate 2 (manufactured by Nippon Test Panel, Sa value: 8.30 nm, thickness: 2 mm) was used as a support. A substrate 2 having a thickness of 30 μm was prepared.

 このようにして得られた基材2のアクリル板2面側のSa値を測定したところ、86.5nm(培養面)であった。また、アクリル板2側面の二乗平均面粗さ(RMS値)を原子間力顕微鏡によって測定したところ、12.35nm(培養面)であった。 When the Sa value on the surface of the acrylic plate 2 of the base material 2 obtained in this way was measured, it was 86.5 nm (culture surface). Moreover, it was 12.35 nm (culture surface) when the root mean square roughness (RMS value) of the acrylic plate 2 side surface was measured with the atomic force microscope.

 実施例3
 実施例1において、ガラス板1の代わりに、アクリル板3(日本テストパネル社製、Sa値:8.17nm、厚さ:2mm)を支持体として使用する以外は、実施例1と同様にして、30μm厚の基材3を作製した。
Example 3
In Example 1, instead of the glass plate 1, the same procedure as in Example 1 was used except that an acrylic plate 3 (manufactured by Nippon Test Panel, Sa value: 8.17 nm, thickness: 2 mm) was used as a support. A substrate 3 having a thickness of 30 μm was produced.

 このようにして得られた基材3のアクリル板3面側のSa値を測定したところ、66.5nm(培養面)であった。 The Sa value on the surface side of the acrylic plate 3 of the base material 3 obtained in this way was measured and found to be 66.5 nm (culture surface).

 比較例1
 実施例1において、ガラス板1の代わりに、アクリル板4(日本テストパネル社製、Sa値:30.53nm、厚さ:2mm)を支持体として使用する以外は、実施例1と同様にして、30μm厚の比較基材4を作製した。
Comparative Example 1
In Example 1, it replaced with the glass plate 1, and it carried out similarly to Example 1 except using the acrylic board 4 (The Japan Test Panel company make, Sa value: 30.53 nm, thickness: 2 mm) as a support body. A comparative substrate 4 having a thickness of 30 μm was prepared.

 このようにして得られた比較基材4のアクリル板4面側のSa値を測定したところ、210.7nm(培養面)であった。 The Sa value on the surface of the acrylic plate 4 of the comparative substrate 4 obtained in this way was measured and found to be 210.7 nm (culture surface).

 比較例2
 湿潤状態の針葉樹溶解サルファイトパルプ(乾燥重量:20g)を、2,2,6,6-テトラメチルピペリジン1-オキシル(TEMPO)(0.16g)及びNaBr(1.0g)を含む蒸留水(1500mL)中に懸濁して、セルローススラリー1を調製した。このセルローススラリー1に、次亜塩素酸ナトリウム(NaClO)水溶液(4w/v%)を、撹拌しながら、10mmol/gセルロース濃度となるように、室温(25℃)で添加し、1M水酸化ナトリウムでpH10を維持しながら室温(25℃)で2時間撹拌して、TEMPO酸化セルロースを含むパルプを得た。
Comparative Example 2
Wet softwood-dissolved sulfite pulp (dry weight: 20 g) was added distilled water containing 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO) (0.16 g) and NaBr (1.0 g) ( (1500 mL) to prepare a cellulose slurry 1. To this cellulose slurry 1, an aqueous sodium hypochlorite (NaClO) solution (4 w / v%) was added at room temperature (25 ° C.) so as to obtain a cellulose concentration of 10 mmol / g while stirring, and 1M sodium hydroxide was added. The mixture was stirred at room temperature (25 ° C.) for 2 hours while maintaining pH 10 to obtain a pulp containing TEMPO-oxidized cellulose.

 このようにして得られたTEMPO酸化セルロース懸濁液(固形分0.5重量%) 2000gを、ball-collisionチャンバーを備えた高圧ウォータージェットシステム(Star Burst, HJP-25005 E、Sugino Machine Co., Ltd.)を用いて、高圧ホモジネート(機械解繊)して、ホモジネート化スラリーを得た。このホモジネート化スラリーを、245MPaの圧力で直径0.17mmの小ノズルから押し出した。上記押し出しを20回繰り返し、0.3重量%濃度となる塗布液2(セルロース繊維/水分散液)を調製した。 2000 g of the TEMPO oxidized cellulose suspension (solid content 0.5% by weight) thus obtained was added to a high-pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., equipped with a ball-collation chamber). Ltd.) was used for high-pressure homogenization (mechanical defibration) to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The extrusion was repeated 20 times to prepare a coating solution 2 (cellulose fiber / water dispersion) having a concentration of 0.3% by weight.

 この塗布液2(高圧ホモジネート化セルロース繊維濃度:0.3重量%)を0.8重量%濃度になるまで濃縮し、塗布液2’を調製した。 The coating solution 2 (high-pressure homogenized cellulose fiber concentration: 0.3% by weight) was concentrated to a concentration of 0.8% by weight to prepare a coating solution 2 '.

 比較例1において、塗布液1’の代わりに、上記にて調製された塗布液2’を使用する以外は、比較例1と同様にして、30μm厚の比較基材5を作製した。 In Comparative Example 1, a comparative substrate 5 having a thickness of 30 μm was produced in the same manner as in Comparative Example 1, except that the coating liquid 2 ′ prepared above was used instead of the coating liquid 1 ′.

 このようにして得られた比較基材5のアクリル板4(Sa値:30.53nm)面側のSa値を測定したところ、249.1nm(培養面)であった。 When the Sa value on the acrylic plate 4 (Sa value: 30.53 nm) side of the comparative substrate 5 obtained in this way was measured, it was 249.1 nm (culture surface).

 [性能評価]
 上記実施例1~3で得られた基材1~3および比較例1~2で得られた比較基材4~5について、下記方法に従って、全光線透過率(%)、ヘーズ(Haze)(%)、静的水接触角(°)および細胞付着挙動を評価した。
[Performance evaluation]
For the base materials 1 to 3 obtained in Examples 1 to 3 and the comparative base materials 4 to 5 obtained in Comparative Examples 1 and 2, the total light transmittance (%), haze ( %), Static water contact angle (°) and cell attachment behavior.

 1.全光線透過率(%)の測定
 JIS規格K7361-1:1997に準拠し、ヘーズメータ(村上色彩技術研究所社製、「HZ-V3」)を用いて全光線透過率を測定した。
1. Measurement of total light transmittance (%) The total light transmittance was measured using a haze meter (“HZ-V3” manufactured by Murakami Color Research Laboratory Co., Ltd.) in accordance with JIS standard K7361-1: 1997.

 2.ヘーズ(Haze)(%)の測定
 JIS規格K7136:2000に準拠し、ヘーズメータ(村上色彩技術研究所社製「HZ-V3」)を用いてヘーズを測定した。
2. Measurement of Haze (%) Haze was measured using a haze meter (“HZ-V3” manufactured by Murakami Color Research Laboratory Co., Ltd.) in accordance with JIS standard K7136: 2000.

 3.静的水接触角(°)の測定
 自動接触角計(協和界面科学製:DM-500)を用いて、各基材のSa値を測定した面(培養面)上に水2μlの滴下した直後の液滴の付着角度を測定した(測定温度:25℃)。なお、下記表1では、「接触角」と記載する。
3. Measurement of static water contact angle (°) Immediately after 2 μl of water was dropped on the surface (culture surface) on which the Sa value of each substrate was measured using an automatic contact angle meter (manufactured by Kyowa Interface Science: DM-500) The droplet attachment angle was measured (measurement temperature: 25 ° C.). In Table 1 below, it is described as “contact angle”.

 4.HepG2細胞付着挙動の評価
 HepG2(ヒト肝癌細胞)はDSファーマバイオメディカル株式会社より購入した。終濃度10(v/v)%ウシ胎児血清(FBS)(DSファーマバイオメディカル株式会社製)、培地の1/100量(体積比)の100×MEM用非必須アミノ酸(DSファーマバイオメディカル株式会社製)、および終濃度 2mMグルタミン溶液(DSファーマバイオメディカル株式会社製)を添加したEMEM培地(DSファーマバイオメディカル株式会社製)(血清添加EMEM培地)を用いて、HepG2の培養を行った。HepG2を、2.0×10cells/cmとなるように、100mmセルカルチャーディッシュ(BD Falcon社)に播種し、37℃で5体積%CO条件下で培養した。100mmセルカルチャーディッシュで70%コンフルエントの状態まで培養したHepG2を、0.25%トリプシン/50mM EDTA溶液で処理した後、上記と同様の血清添加EMEM培地を添加してトリプシン反応を停止させ、HepG2の浮遊細胞懸濁液を得た。0.4(w/v)% トリパンブルー溶液(和光純薬株式会社製)を用いてHepG2の浮遊細胞懸濁液中の生細胞数を測定し、3.13×10cells/cmとなるように、マルチウェルセルカルチャープレート 24well(BD Falcon社、ポリスチレン製)、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)、ならびに各基材に播種し、37℃で5体積%CO条件下で培養した。培養4日目に培地全量を除去した後、上記と同様の血清添加EMEM培地1mLを添加して培地交換を行った。培養は計7日間実施した。なお、各基材は予めγ線滅菌処理または乾熱滅菌処理(160℃×2時間)した後、上記細胞培養に使用した。
4). Evaluation of HepG2 cell adhesion behavior HepG2 (human hepatoma cell) was purchased from DS Pharma Biomedical Co., Ltd. Final concentration of 10 (v / v)% fetal bovine serum (FBS) (manufactured by DS Pharma Biomedical Co., Ltd.), 1/100 volume (volume ratio) of non-essential amino acid for 100 × MEM (DS Pharma Biomedical Co., Ltd.) HepG2 was cultured using an EMEM medium (DS Pharma Biomedical Co., Ltd.) (serum-added EMEM medium) supplemented with a 2 mM glutamine solution (manufactured by DS Pharma Biomedical Co., Ltd.). HepG2 was seeded in a 100 mm cell culture dish (BD Falcon) so as to be 2.0 × 10 4 cells / cm 2 and cultured at 37 ° C. under 5 vol% CO 2 conditions. HepG2 cultured to a confluent state of 70% in a 100 mm cell culture dish was treated with a 0.25% trypsin / 50 mM EDTA solution, and then the serum-added EMEM medium similar to the above was added to stop the trypsin reaction. A suspension cell suspension was obtained. Using 0.4 (w / v)% trypan blue solution (manufactured by Wako Pure Chemical Industries, Ltd.), the number of viable cells in the suspended cell suspension of HepG2 was measured, and 3.13 × 10 4 cells / cm 2 Multiwell cell culture plate 24well (BD Falcon, polystyrene), NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 well (Organogenix), and seeded on each substrate, Culturing was performed under volume% CO 2 conditions. On the fourth day of culture, the entire medium was removed, and 1 mL of serum-added EMEM medium similar to the above was added to exchange the medium. Culture was performed for a total of 7 days. Each substrate was preliminarily treated with γ-ray sterilization or dry heat sterilization (160 ° C. × 2 hours) and then used for the cell culture.

 また、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)にはナノインプリントされた微細な凹凸が存在する。このため、細胞懸濁液を播種する前に以下の脱気作業を実施して、凹凸内の気泡を除去した。詳細には、上記と同様の血清添加EMEM培地を1wellあたり500μLずつ分注した。これを、300~500×gで3分間遠心分離した後、室温(25℃)で30分間静置した。 Also, NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 wells (Organogenix) have fine irregularities nano-imprinted. For this reason, before seeding the cell suspension, the following deaeration operation was performed to remove bubbles in the irregularities. Specifically, the same serum-added EMEM medium as described above was dispensed at 500 μL per well. This was centrifuged at 300 to 500 × g for 3 minutes and then allowed to stand at room temperature (25 ° C.) for 30 minutes.

 培養7日目に、HepG2を0.25%トリプシン/50mM EDTA溶液で処理した後、0.4w/v%トリパンブルー溶液(和光純薬株式会社)および血球計算盤を用いて総細胞数の測定を行った。また、培養7日目の培養液をサンプリングし、-20℃で保存した。 On day 7 of culture, HepG2 was treated with 0.25% trypsin / 50 mM EDTA solution, and then the total cell number was measured using a 0.4 w / v% trypan blue solution (Wako Pure Chemical Industries, Ltd.) and a hemocytometer. Went. Further, the culture solution on the seventh day of culture was sampled and stored at -20 ° C.

 培養7日目の基材1、比較基材4、比較基材5、マルチウェルセルカルチャープレートおよびNanoCulture(登録商標) Plateでの細胞の生育状態(顕微鏡写真)を図1に示す。 Fig. 1 shows cell growth conditions (micrographs) on the substrate 1, the comparison substrate 4, the comparison substrate 5, the multiwell cell culture plate and the NanoCulture (registered trademark) Plate on the seventh day of culture.

 一例として、培養7日目の基材1での細胞の生育状態(顕微鏡写真)を図1に示しているが、他の基材2、3も同様の結果であった。基材1~3(それぞれ、Sa値=125.7nm(基材1)、86.5nm(基材2)、66.5nm(基材3))上では、適度な大きさのスフェロイド(細胞凝集塊)が基材に付着した状態でウェル全体に均一に分布して形成され、伸展した細胞はほとんど観察されなかった。 As an example, the growth state (micrograph) of the cells on the base material 1 on the seventh day of culture is shown in FIG. 1, but the other base materials 2 and 3 had similar results. On the substrates 1 to 3 (Sa value = 12.5 nm (substrate 1), 86.5 nm (substrate 2), 66.5 nm (substrate 3), respectively), spheroids of appropriate size (cell aggregation) In the state where the clumps were attached to the substrate, the cells were uniformly distributed throughout the well, and the expanded cells were hardly observed.

 これに対して、比較基材4(Sa値=210.7nm)上では、スフェロイドと伸展した細胞が混在した培養挙動を示した。また、比較基材5(Sa値=249.1nm)上では、スフェロイドの形成も細胞の伸展も確認されなかった。 On the other hand, on the comparative base material 4 (Sa value = 210.7 nm), a culture behavior in which spheroids and extended cells coexist was shown. Further, neither spheroid formation nor cell spreading was confirmed on the comparative substrate 5 (Sa value = 249.1 nm).

 また、一般的に付着細胞の培養で使用されるマルチウェルセルカルチャープレート 24well(BD Falcon社)(図1中のマルチウェルセルカルチャープレート)では、HepG2細胞が単層状に増殖し、スフェロイド(細胞凝集塊)の形成は見られなかった。また、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)(図1中のNanoCulture Plate)では、スフェロイド(細胞凝集塊)は形成されたが、大半の細胞凝集塊は基材には付着せずに培地中に浮遊しており、浮遊した細胞凝集塊同士がさらに大きな塊を形成していた。さらに、基材に付着した細胞凝集塊も会合して大きなスフェロイドを形成していた。 In addition, in a multiwell cell culture plate 24well (BD Falcon) (multiwell cell culture plate in FIG. 1) generally used for culturing adherent cells, HepG2 cells proliferate in a single layer, and spheroids (cell aggregation) The formation of a lump) was not observed. In addition, in NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 well (Organogenix) (NanoCulture Plate in FIG. 1), spheroids (cell aggregates) were formed, but most of the cell aggregates were base materials It floated in the medium without adhering to the cells, and the suspended cell aggregates formed a larger mass. Furthermore, cell aggregates attached to the base material were also associated to form a large spheroid.

 5.MCF-7細胞付着挙動の評価
 MCF-7(ヒト乳腺癌細胞)はDSファーマバイオメディカル株式会社より購入した。終濃度10(v/v)%ウシ胎児血清(FBS)(DSファーマバイオメディカル株式会社製)、培地の1/100量(体積比)の100×MEM用非必須アミノ酸(DSファーマバイオメディカル株式会社製)、および終濃度 2mMグルタミン溶液(DSファーマバイオメディカル株式会社製)を添加したEMEM培地(DSファーマバイオメディカル株式会社製)(血清添加EMEM培地)を用いて、MCF-7の培養を行った。MCF-7を、2.0×10cells/cmとなるように、100mmセルカルチャーディッシュ(BD Falcon社)に播種し、37℃で5体積%CO条件下で培養した。100mmセルカルチャーディッシュで70%コンフルエントの状態まで培養したMCF-7を、0.25%トリプシン/50mM EDTA溶液で処理した後、上記と同様の血清添加EMEM培地を添加してトリプシン反応を停止させ、MCF-7の浮遊細胞懸濁液を得た。0.4(w/v)% トリパンブルー溶液(和光純薬株式会社製)を用いてMCF-7の浮遊細胞懸濁液中の生細胞数を測定し、3.13×10cells/cmとなるように、マルチウェルセルカルチャープレート 24well(BD Falcon社、ポリスチレン製)、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)、ならびに各基材に播種し、37℃で5体積%CO条件下で培養した。培養4日目に培地全量を除去した後、上記と同様の血清添加EMEM培地1mLを添加して培地交換を行った。培養は計7日間実施した。なお、下記基材は予めγ線滅菌処理または乾熱滅菌処理(160℃×2時間)した後、上記細胞培養に使用した。
5). Evaluation of MCF-7 cell adhesion behavior MCF-7 (human breast cancer cells) was purchased from DS Pharma Biomedical Co., Ltd. Final concentration of 10 (v / v)% fetal bovine serum (FBS) (manufactured by DS Pharma Biomedical Co., Ltd.), 1/100 volume (volume ratio) of non-essential amino acid for 100 × MEM (DS Pharma Biomedical Co., Ltd.) MCF-7 was cultured using EMEM medium (DS Pharma Biomedical) (serum-added EMEM medium) supplemented with 2 mM glutamine solution (manufactured by DS Pharma Biomedical). . MCF-7 was seeded in a 100 mm cell culture dish (BD Falcon) at 2.0 × 10 4 cells / cm 2 and cultured at 37 ° C. under 5 vol% CO 2 conditions. MCF-7 cultured to a confluent state of 70% in a 100 mm cell culture dish was treated with a 0.25% trypsin / 50 mM EDTA solution, and then the serum-added EMEM medium similar to the above was added to stop the trypsin reaction. A suspension of MCF-7 suspension was obtained. Using a 0.4% (w / v)% trypan blue solution (manufactured by Wako Pure Chemical Industries, Ltd.), the number of viable cells in the suspended cell suspension of MCF-7 was measured, and 3.13 × 10 4 cells / cm 2 in a multi-well cell culture plate 24well (BD Falcon, polystyrene), NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 well (ORGANOGENIX), and each substrate, 37 ° C. And cultured under 5 vol% CO 2 conditions. On the fourth day of culture, the entire medium was removed, and 1 mL of serum-added EMEM medium similar to the above was added to exchange the medium. Culture was performed for a total of 7 days. In addition, the following base material was used for the cell culture after γ-ray sterilization treatment or dry heat sterilization treatment (160 ° C. × 2 hours) in advance.

 また、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)にはナノインプリントされた微細な凹凸が存在する。このため、細胞懸濁液を播種する前に以下の脱気作業を実施して、凹凸内の気泡を除去した。詳細には、上記と同様の血清添加EMEM培地を1wellあたり500μLずつ分注した。これを、300~500×gで3分間遠心分離した後、室温(25℃)で30分間静置した。 Also, NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 wells (Organogenix) have fine irregularities nano-imprinted. For this reason, before seeding the cell suspension, the following deaeration operation was performed to remove bubbles in the irregularities. Specifically, the same serum-added EMEM medium as described above was dispensed at 500 μL per well. This was centrifuged at 300 to 500 × g for 3 minutes and then allowed to stand at room temperature (25 ° C.) for 30 minutes.

 培養7日目の基材1、比較基材4、比較基材5、マルチウェルセルカルチャープレートおよびNanoCulture(登録商標) Plateでの細胞の生育状態(顕微鏡写真)を図2に示す。 FIG. 2 shows cell growth conditions (micrographs) on the substrate 1, the comparison substrate 4, the comparison substrate 5, the multiwell cell culture plate and the NanoCulture (registered trademark) Plate on the seventh day of culture.

 一例として、培養7日目の基材1での細胞の生育状態(顕微鏡写真)を図2に示しているが、他の基材2、3も同様の結果であった。基材1~3(それぞれ、Sa値=125.7nm(基材1)、86.5nm(基材2)、66.5nm(基材3))上では、適度な大きさのスフェロイド(細胞凝集塊)が基材に付着した状態でウェル全体に均一に分布して形成され、伸展した細胞はほとんど観察されなかった。ここで使用したMCF-7細胞は、上記「4.HepG2細胞付着挙動の評価」にて使用したHepG2細胞に比して、3次元化しにくいが、このような3次元化しにくい細胞に対しても、本発明の基材上で培養することによって、適度な大きさのスフェロイド(細胞凝集塊)を基材に付着した状態で形成できることが考察される。 As an example, the cell growth state (micrograph) on the base material 1 on the seventh day of culture is shown in FIG. 2, but the other base materials 2 and 3 had similar results. On the substrates 1 to 3 (Sa value = 12.5 nm (substrate 1), 86.5 nm (substrate 2), 66.5 nm (substrate 3), respectively), spheroids of appropriate size (cell aggregation) In the state where the clumps were attached to the substrate, the cells were uniformly distributed throughout the well, and the expanded cells were hardly observed. The MCF-7 cells used here are less likely to be three-dimensional than the HepG2 cells used in “4. Evaluation of HepG2 cell attachment behavior” above, but these cells are also difficult to make three-dimensional. It is considered that by culturing on the base material of the present invention, spheroids (cell aggregates) having an appropriate size can be formed while attached to the base material.

 これに対して、比較基材4(Sa値=210.7nm)上では、スフェロイドの形成はほとんど確認されず、大半が伸展した細胞であった。また、比較基材5(Sa値=249.1nm)上では、スフェロイドの形成も細胞の伸展も確認されなかった。 On the other hand, almost no spheroid formation was confirmed on the comparative substrate 4 (Sa value = 210.7 nm), and most of the cells were stretched cells. Further, neither spheroid formation nor cell spreading was confirmed on the comparative substrate 5 (Sa value = 249.1 nm).

 また、一般的に付着細胞の培養で使用されるマルチウェルセルカルチャープレート 24well(BD Falcon社)(図2中のマルチウェルセルカルチャープレート)では、MCF-7細胞が単層状に増殖し、スフェロイド(細胞凝集塊)の形成は見られなかった。また、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)(図2中のNanoCulture Plate)では、スフェロイド(細胞凝集塊)は形成されたが、基材に付着して伸展した細胞も多数観察された。 In addition, in the multiwell cell culture plate 24well (BD Falcon) (multiwell cell culture plate in FIG. 2) generally used for culturing adherent cells, MCF-7 cells proliferate in a single layer, and spheroids ( The formation of cell aggregates was not observed. In addition, in NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 wells (Organogenix) (NanoCulture Plate in FIG. 2), spheroids (cell aggregates) were formed, but spread and adhered to the substrate. Many cells were also observed.

 これらの結果を下記表1に要約する。 These results are summarized in Table 1 below.

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

 上記表1の結果から、実施例1~3の基材1~3上で細胞を培養することによって、スフェロイドを選択的にかつ基材に付着した状態で形成することができることが示される。これに対して、培養面のSa値が本発明の数値範囲から外れる比較例1~2の比較基材4~5上で細胞を培養すると、スフェロイドを選択的に形成することができない。 From the results of Table 1 above, it is shown that spheroids can be selectively formed on the substrate by culturing the cells on the substrates 1 to 3 of Examples 1 to 3. On the other hand, when cells are cultured on the comparative substrates 4 to 5 of Comparative Examples 1 and 2 in which the Sa value of the culture surface is outside the numerical range of the present invention, spheroids cannot be selectively formed.

 6.アルブミン定量
 上記実施例1で得られた基材1、ならびに市販のマルチウェルセルカルチャープレート 24well(BD Falcon社)およびNanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)について、下記方法に従って、アルブミン生成量を測定した。
6). Albumin Quantification Regarding the substrate 1 obtained in Example 1 above, and the commercially available multiwell cell culture plate 24well (BD Falcon) and NanoCulture (registered trademark) Plate MS pattern / low adhesion / 24 well (ORGANOGENIX) According to the method, the amount of albumin produced was measured.

 詳細には、上記「4.HepG2細胞付着挙動の評価」におけるのと同様にして培養を7日間行った。培養7日目のマルチウェルセルカルチャープレート 24well(BD Falcon社)、NanoCulture(登録商標) Plate MSパターン/低接着/24ウェル(ORGANOGENIX社)、ならびに基材1(Sa値=125.7nm)で培養した培養液を用いて、アルブミンの生成量(μg/10細胞)を測定した。なお、アルブミンの定量にはRat Albumin ELISA Quantitation Set (Bethyl Laboratories社)を使用し、添付されているプロトコールに従って2重測定でアルブミンの定量実験を行った。 Specifically, the culture was performed for 7 days in the same manner as in “4. Evaluation of HepG2 cell adhesion behavior”. Culture on Multiwell Cell Culture Plate 24well (BD Falcon) on Day 7 of Culture, NanoCulture (R) Plate MS Pattern / Low Adhesion / 24 Well (Organogenix), and Substrate 1 (Sa Value = 15.7 nm) Using the culture broth, the amount of albumin produced (μg / 10 6 cells) was measured. In addition, for the quantification of albumin, Rat Albumin ELISA Quantitation Set (Bethyl Laboratories) was used, and quantification experiment of albumin was performed by double measurement according to the attached protocol.

 結果を図3に示す。図3から、基材1(Sa値=125.7nm)で培養した培養液では、マルチウェルセルカルチャープレートおよびNanoCulture(登録商標) Plateで培養した培養液に比して、有意に高いアルブミン生成量が確認されたことが分かる。上記結果および上記4.HepG2細胞付着挙動の評価結果から、本発明の基材上で適切な大きさの細胞凝集塊が形成されたことによって、効率的に培地成分や酸素が細胞に供給され、高い細胞機能が維持できたと考察される。これらの結果から、本発明の基材で細胞を培養することで、細胞は高い機能を発現できることが期待される。 The results are shown in FIG. From FIG. 3, the amount of albumin produced in the culture medium cultured on the substrate 1 (Sa value = 125.7 nm) was significantly higher than the culture medium cultured on the multiwell cell culture plate and NanoCulture (registered trademark) Plate. It can be seen that was confirmed. The above results and 4. From the evaluation results of the HepG2 cell attachment behavior, medium components and oxygen can be efficiently supplied to the cells and high cell functions can be maintained by forming a cell aggregate of appropriate size on the substrate of the present invention. It is considered. From these results, it is expected that cells can express high functions by culturing the cells with the substrate of the present invention.

 7.直径が1μm以上のセルロース繊維の含有率と透明性(ヘーズ)との関係の検討
 本実験では、直径が1μm以上のセルロース繊維の含有率(%)と透明性(ヘーズ)との関係を検討した。
7). Examination of the relationship between the content of cellulose fibers having a diameter of 1 μm or more and transparency (haze) In this experiment, the relationship between the content (%) of cellulose fibers having a diameter of 1 μm or more and transparency (haze) was examined. .

 まず、下記のようにして作製した基材A~Cについて、上述した方法により直径が1μm以上のセルロース繊維の含有率を測定した。 First, the contents of cellulose fibers having a diameter of 1 μm or more were measured for the substrates A to C produced as described below by the method described above.

 (基材Aの作製)
 針葉樹溶解サルファイトパルプ/水懸濁液(固形分0.5wt%)を、ball-collisionチャンバーを備えた高圧ウォータージェットシステム(Star Burst, HJP-25005 E、Sugino Machine Co., Ltd.)を用いて、高圧ホモジネート(機械解繊)して、ホモジネート化スラリーを得た。このホモジネート化スラリーを、245MPaの圧力で直径0.17mmの小ノズルから押し出した。上記押し出し(解繊処理)を50回繰り返し、ナノファイバー懸濁液Aを得た。そのナノファイバー水懸濁液Aを吸引濾過、乾燥して、厚み40μmの基板Aを作製した。
(Preparation of substrate A)
Conifer dissolved sulfite pulp / water suspension (solid content 0.5 wt%) using a high pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber. Then, high-pressure homogenization (mechanical defibration) was performed to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The above extrusion (defibration treatment) was repeated 50 times to obtain a nanofiber suspension A. The nanofiber aqueous suspension A was suction filtered and dried to prepare a substrate A having a thickness of 40 μm.

 このようにして得られた基材Aについて、ヘーズを測定したところ、38.3%であった。また、この基材Aについて、直径が1μm以上のセルロース繊維の含有率を測定したところ、0.28%であった。 The base material A thus obtained was measured for haze, which was 38.3%. Moreover, about this base material A, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 0.28%.

 (基材Bの作製)
 実施例1と同様にして、アルカリ処理ホロセルロースパルプ懸濁液を作製した。このようにして得られた懸濁液からアルカリ処理ホロセルロースを分離し、0.5重量%濃度となるように水に懸濁して、アルカリ処理ホロセルロース/水懸濁液(固形分0.5重量%)を調製した。
(Preparation of base material B)
In the same manner as in Example 1, an alkali-treated holocellulose pulp suspension was produced. The alkali-treated holocellulose was separated from the suspension thus obtained, suspended in water to a concentration of 0.5% by weight, and the alkali-treated holocellulose / water suspension (solid content 0.5). % By weight) was prepared.

 このアルカリ処理ホロセルロース/水懸濁液(固形分0.5重量%)を、ball-collisionチャンバーを備えた高圧ウォータージェットシステム(Star Burst, HJP-25005 E、Sugino Machine Co., Ltd.)を用いて、高圧ホモジネート(機械解繊)して、ホモジネート化スラリーを得た。このホモジネート化スラリーを、245MPaの圧力で直径0.17mmの小ノズルから押し出した。上記押し出し(解繊処理)を50回繰り返し、ナノファイバー懸濁液Bを得た。そのナノファイバー水懸濁液Bを吸引濾過、乾燥して、厚み40μmの基板Bを作製した。 This alkali-treated holocellulose / water suspension (solid content 0.5% by weight) was subjected to a high-pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber. Using, high-pressure homogenate (mechanical fibrillation) to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The above extrusion (defibration treatment) was repeated 50 times to obtain a nanofiber suspension B. The nanofiber aqueous suspension B was suction filtered and dried to produce a substrate B having a thickness of 40 μm.

 このようにして得られた基材Bについて、ヘーズを測定したところ、5.5%であった。また、この基材Bについて、直径が1μm以上のセルロース繊維の含有率を測定したところ、0.05%であった。 For the base material B thus obtained, the haze was measured and found to be 5.5%. Moreover, about this base material B, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 0.05%.

 (基材Cの作製)
 セルロース粉末/水懸濁液(固形分0.5wt%)を、ball-collisionチャンバーを備えた高圧ウォータージェットシステム(Star Burst, HJP-25005 E、Sugino Machine Co., Ltd.)を用いて、高圧ホモジネート(機械解繊)して、ホモジネート化スラリーを得た。このホモジネート化スラリーを、245MPaの圧力で直径0.17mmの小ノズルから押し出した。上記押し出し(解繊処理)を50回繰り返し、ナノファイバー懸濁液Cを得た。そのナノファイバー水懸濁液Cを吸引濾過、乾燥して、厚み40μmの基板Cを作製した。なお、セルロース粉末として、KCフロック(登録商標)W100-GK(日本製紙グループ)使用した。
(Preparation of substrate C)
Cellulose powder / water suspension (solid content 0.5 wt%) was subjected to high pressure using a high pressure water jet system (Star Burst, HJP-25005 E, Sugino Machine Co., Ltd.) equipped with a ball-collation chamber. Homogenated (mechanical fibrillation) to obtain a homogenized slurry. This homogenized slurry was extruded from a small nozzle having a diameter of 0.17 mm at a pressure of 245 MPa. The extrusion (defibration treatment) was repeated 50 times to obtain a nanofiber suspension C. The nanofiber aqueous suspension C was suction filtered and dried to prepare a substrate C having a thickness of 40 μm. As the cellulose powder, KC Flock (registered trademark) W100-GK (Nippon Paper Group) was used.

 このようにして得られた基材Cについて、ヘーズを測定したところ、86.6%であった。また、この基材Cについて、直径が1μm以上のセルロース繊維の含有率を測定したところ、10.19%であった。 The base material C thus obtained was measured for haze and found to be 86.6%. Moreover, about this base material C, when the content rate of the cellulose fiber whose diameter is 1 micrometer or more was measured, it was 10.19%.

 結果を下記表2に要約する。下記表2から、直径が1μm以上のセルロース繊維の含有率とヘーズとは正の相関が認められる。以上の結果から、直径が1μm以上のセルロース繊維が基材に占める割合を低減することによって、基材の透明性を有意に向上できると考察される。 The results are summarized in Table 2 below. From Table 2 below, a positive correlation is recognized between the content of cellulose fibers having a diameter of 1 μm or more and haze. From the above results, it is considered that the transparency of the substrate can be significantly improved by reducing the ratio of cellulose fibers having a diameter of 1 μm or more to the substrate.

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

 8.直径が1μm以上のセルロース繊維の含有率と細胞培養物目視容易性との関係の検討
 本実験では、直径が1μm以上のセルロース繊維の含有率(%)と細胞培養物目視容易性との関係を検討した。
8). Examination of the relationship between the content of cellulose fibers having a diameter of 1 μm or more and the ease of visual observation of cell culture In this experiment, the relationship between the content (%) of cellulose fibers having a diameter of 1 μm or more and the ease of visual observation of cell cultures investigated.

 まず、上記「7.直径が1μm以上のセルロース繊維の含有率と透明性(ヘーズ)との関係の検討」と同様にして、基材A~Cを作製した。 First, substrates A to C were prepared in the same manner as in “7. Examination of relationship between content of cellulose fiber having diameter of 1 μm or more and transparency (haze)”.

 次に、上記「4.HepG2細胞付着挙動の評価」と同様にして、上記基材A~C上でHepG2細胞を7日間、培養した。所定期間培養した後のHepG2細胞培養物を顕微鏡(倍率:40倍)下で観察した。その結果、基材A及びBは透明性に優れているため、HepG2細胞の生育状態などを容易に目視にて観察できたものの、基材Cは透明性に劣り、観察像が不明瞭で、HepG2細胞の生育状態などの観察が困難であった。以上の結果から、直径が1μm以上のセルロース繊維が基材に占める割合を低減することによって、細胞を目視する際の容易性を有意に向上できると考察される。 Next, HepG2 cells were cultured on the substrates A to C for 7 days in the same manner as in “4. Evaluation of HepG2 cell adhesion behavior”. The HepG2 cell culture after culturing for a predetermined period was observed under a microscope (magnification: 40 times). As a result, since the substrates A and B are excellent in transparency, the growth state of the HepG2 cells can be easily observed visually, but the substrate C is inferior in transparency and the observation image is unclear, It was difficult to observe the growth state of HepG2 cells. From the above results, it is considered that the ease of visual observation of cells can be significantly improved by reducing the ratio of cellulose fibers having a diameter of 1 μm or more to the substrate.

 9.アルブミンの吸着量の測定
 実施例1と同様にして作製した基材1について、以下記載の方法に従って、アルブミンの吸着量を測定した。
9. Measurement of albumin adsorption amount With respect to the substrate 1 produced in the same manner as in Example 1, the albumin adsorption amount was measured according to the method described below.

 ウシ血清アルブミン(シグマ社;A8022-10G)をDulbecco’s PBS(-)(Wako社;041-20211)でアルブミン濃度が20μg/mLとなるように溶解し、アルブミン溶液を得た。シャーレの上の台座に上記の基材1を直径14mmの円形に切断したフィルムをセットし、当該フィルム上にアルブミン溶液を300μLマウントした。 Bovine serum albumin (Sigma; A8022-10G) was dissolved in Dulbecco's PBS (-) (Wako; 041-20211) to an albumin concentration of 20 μg / mL to obtain an albumin solution. A film obtained by cutting the substrate 1 into a circle having a diameter of 14 mm was set on a pedestal on a petri dish, and 300 μL of an albumin solution was mounted on the film.

 同じ種類のフィルム(直径14mmの円形)を、アルブミン溶液にさらに1枚被せてアルブミン溶液を2枚のフィルムで挟み、フィルムとアルブミン溶液とが接触する面積が一定になるようにセットし、ユニットを得た。これを、水を入れたバットを収容して加湿した37℃の5体積%COインキュベーター内に静置した。7時間後にユニットを取り出し、アルブミン溶液を回収した。回収した溶液は測定まで-20℃で保管した。 Put another film of the same type (circular with a diameter of 14 mm) on the albumin solution, sandwich the albumin solution between the two films, set the area where the film and the albumin solution contact each other, and set the unit Obtained. This was left still in a 5 volume% CO 2 incubator at 37 ° C. containing a vat containing water and humidified. After 7 hours, the unit was taken out and the albumin solution was recovered. The collected solution was stored at −20 ° C. until measurement.

 回収したアルブミン溶液中のアルブミン濃度を測定した。濃度の測定は、Albmin,Bovine,ELISA Quantitation kit(Bethyl Laboratories社)を用いて行い、測定プロトコルは添付のマニュアルに準拠した。初期濃度(20μg/mL)と7時間後のアルブミン濃度との差およびフィルムの面積(1枚片面当たり1.54cm×2枚分で3.08cm)から、単位面積当たりのアルブミン吸着量(ng/cm)を算出したところ、1037ng/cmであった。 The albumin concentration in the collected albumin solution was measured. The concentration was measured using Albamin, Bovine, ELISA Quantification kit (Bethyl Laboratories), and the measurement protocol was in accordance with the attached manual. From the initial concentration (20 [mu] g / mL) area and the difference in the film between the albumin concentration after 7 hours (one per side 1.54cm 2 × 3.08cm 2 with two sheets), albumin adsorption amount per unit area ( ng / cm 2) was calculated, was 1037ng / cm 2.

 10.プロテオグリカンの吸着量の測定
 実施例1と同様にして作製した基材1について、以下記載の方法に従って、プロテオグリカンの吸着量を測定した。
10. Measurement of adsorption amount of proteoglycan The adsorption amount of proteoglycan was measured for the substrate 1 produced in the same manner as in Example 1 according to the method described below.

 ヘパラン硫酸プロテオグリカン(シグマ社;H4777)をDulbecco’s PBS(-)(Wako社;041-20211)でプロテオグリカン濃度が5μg/mLとなるように溶解し、プロテオグリカン溶液を得た。シャーレの上の台座に上記の基材1を直径14mmの円形に切断したフィルムをセットし、当該フィルム上にプロテオグリカン溶液を300μLマウントした。 Heparan sulfate proteoglycan (Sigma; H4777) was dissolved in Dulbecco's PBS (-) (Wako; 041-20211) so that the proteoglycan concentration was 5 μg / mL to obtain a proteoglycan solution. A film obtained by cutting the substrate 1 into a circle having a diameter of 14 mm was set on a pedestal on a petri dish, and 300 μL of a proteoglycan solution was mounted on the film.

 同じ種類のフィルム(直径14mmの円形)を、プロテオグリカン溶液にさらに1枚被せてプロテオグリカン溶液を2枚のフィルムで挟み、フィルムとプロテオグリカン溶液とが接触する面積が一定になるようにセットし、ユニットを得た。これを、水を入れたバットを収容して加湿した37℃の5体積%COインキュベーター内に静置した。20時間後にユニットを取り出し、プロテオグリカン溶液を回収した。回収した溶液は測定まで-20℃で保管した。 Place the same type of film (circular with a diameter of 14 mm) on the proteoglycan solution, sandwich the proteoglycan solution between the two films, set the area where the film and the proteoglycan solution are in contact with each other, and set the unit. Obtained. This was left still in a 5 volume% CO 2 incubator at 37 ° C. containing a vat containing water and humidified. After 20 hours, the unit was taken out and the proteoglycan solution was recovered. The collected solution was stored at −20 ° C. until measurement.

 回収したプロテオグリカン溶液中のプロテオグリカン濃度を測定した。濃度の測定は、Glycosaminoglycan Sulpated Alcian Blue Binding Assay(Euro Diagnostica)を用いて行い、測定プロトコルは添付のマニュアルに準拠した。初期濃度(5μg/mL)と20時間後のプロテオグリカン濃度との差およびフィルムの面積(1枚片面当たり1.54cm×2枚分で3.08cm)から、単位面積当たりのプロテオグリカン吸着量(ng/cm)を算出したところ、162.6ng/cmであった。 The proteoglycan concentration in the collected proteoglycan solution was measured. The concentration was measured using Glycosaminoglycan Sulfurated Alcian Blue Binding Assay (Euro Diagnostics), and the measurement protocol was based on the attached manual. From the difference between the initial concentration (5 μg / mL) and the proteoglycan concentration after 20 hours and the area of the film (1.54 cm 2 × 2 sheets per sheet, 3.08 cm 2 ), the amount of proteoglycan adsorbed per unit area ( ng / cm 2) was calculated and found to be 162.6ng / cm 2.

 11.ラット初代肝細胞付着挙動の評価
 Specific viral pathogen freeのWistarラット、オス、9週齢、体重200gを日本エスエルシー株式会社より購入した。ラット初代肝細胞の取得は培養細胞実験ハンドブック(羊土社)第10章、「肝細胞」に記載の方法を参考に行った。具体的には、Wistarラットをイソフルラン麻酔下で開腹し、門脈にカテーテルを挿入して表3に記載の組成の前かん流液を注入した。次に胸腔を開き、右心房に入る下大静脈を切開し、血液を放出させた。肝臓からの脱血が十分になされたことを確認した後にかん流を止め、かん流液を表3に記載の組成のコラゲナーゼ溶液に換えて、かん流を行った。細胞間組織がコラゲナーゼにより消化されたことを確認した後、かん流を止めた。肝臓を切り離し、ガラスシャーレに移した後、冷したEMEM High Glucose培地(Wako社)を添加して、ピペッティングにより細胞を分散させた。次に150mm濾過器により未消化の組織を除去した。細胞懸濁液は、50G、1分の遠心分離を数回繰り返して非実質細胞を除去した。得られた肝細胞の生存率はトリパンブルー排除法で計測し、生存率85%以上の肝細胞をラット初代肝細胞として培養試験に使用した。
11. Evaluation of rat primary hepatocyte adhesion behavior A Wistar rat, male, 9 weeks old, 200 g body weight of Special Viral Pathogen Free was purchased from SLC Japan. Rat primary hepatocytes were obtained by referring to the method described in Chapter 10 of the Cultured Cell Experiment Handbook (Yodosha), “Hepatocytes”. Specifically, Wistar rats were laparotomized under isoflurane anesthesia, a catheter was inserted into the portal vein, and a preperfusion solution having the composition shown in Table 3 was injected. The chest cavity was then opened and the inferior vena cava entering the right atrium was incised to release blood. After confirming that blood removal from the liver was sufficiently performed, the perfusion was stopped, and the perfusion solution was replaced with a collagenase solution having the composition shown in Table 3 for perfusion. After confirming that the intercellular tissue was digested by collagenase, the perfusion was stopped. After the liver was cut off and transferred to a glass petri dish, cold EMEM High Glucose medium (Wako) was added to disperse the cells by pipetting. Next, undigested tissue was removed with a 150 mm filter. The cell suspension was centrifuged at 50G for 1 minute several times to remove non-parenchymal cells. The survival rate of the obtained hepatocytes was measured by the trypan blue exclusion method, and hepatocytes with a survival rate of 85% or more were used as rat primary hepatocytes in the culture test.

Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

 前述の方法で取得したラット初代肝細胞を、以下記載の組成の血清培地で懸濁し、1.33×10cells/cmとなるように、ガンマ線滅菌処理した上記実施例1で得られた基材1に播種し、37℃、5% CO条件下で培養を行った。培地交換は播種後4時間、培養1日目、3日目、5日目に培地を全量除去後、血清培地を0.4mL添加して行った。培養5日目にスフェロイド形成および伸展細胞の有無の確認を行った。培養5日目の基材1での細胞の生育状態(顕微鏡写真)を図5に示す。基材1において、伸展細胞はほとんど観察されず、直径200μm以下のスフェロイド(細胞凝集塊)が基材に付着した状態でウェル全体に均一に分布して形成されていることを確認した。 The rat primary hepatocytes obtained by the above-described method were suspended in a serum medium having the composition described below, and obtained in Example 1 above, which was sterilized with gamma rays so as to be 1.33 × 10 4 cells / cm 2 . were seeded on the substrate 1, 37 ° C., the cells were cultured under 5% CO 2. The medium was exchanged 4 hours after seeding, after removing the entire medium on the first day, the third day, and the fifth day of culture, and then adding 0.4 mL of serum medium. On day 5 of culture, spheroid formation and the presence or absence of extended cells were confirmed. FIG. 5 shows the growth state (micrograph) of the cells on the substrate 1 on the fifth day of culture. In the substrate 1, almost no stretched cells were observed, and it was confirmed that spheroids (cell aggregates) having a diameter of 200 μm or less were uniformly distributed throughout the well in a state of adhering to the substrate.

 (血清培地の組成)
 William’s E medium(和光純薬)、10%(w/v)FBS(和光純薬)、8.6nM インスリン、255nM デキサメサゾン、50ng/mL EGF、5KIU/mL アプロチニン、抗生物質(ペニシリン(100unit/mL)/ストレプトマイシン(100μg/mL)/アムホテリシンB(0.25μg/mL))。
(Composition of serum medium)
William's E medium (Wako Pure Chemical), 10% (w / v) FBS (Wako Pure Chemical), 8.6 nM insulin, 255 nM dexamethasone, 50 ng / mL EGF, 5KIU / mL aprotinin, antibiotics (penicillin (100 units / mL) / streptomycin (100 μg / mL) / amphotericin B (0.25 μg / mL)).

 本出願は、2016年10月17日に出願された日本特許出願番号2016-203818号に基づいており、その開示内容は、参照され、全体として、組み入れられている。 This application is based on Japanese Patent Application No. 2016-203818 filed on October 17, 2016, the disclosure of which is referenced and incorporated as a whole.

  1…細胞培養用基材(フィルム)、
  20…支持部材、
  100、101、102…細胞培養容器。
1 ... Substrate for cell culture (film),
20 ... support member,
100, 101, 102 ... Cell culture container.

Claims (9)

 セルロース繊維を含み、かつ培養面の算術平均高さ(Sa)が210nm未満である、細胞培養用基材。 A cell culture substrate containing cellulose fibers and having an arithmetic average height (Sa) of the culture surface of less than 210 nm.  ヘーズが40%以下である、請求項1に記載の基材。 The base material according to claim 1, wherein the haze is 40% or less.  1μm以上の直径を有するセルロース繊維の含有率が10%未満である、請求項1または2に記載の基材。 The substrate according to claim 1 or 2, wherein the content of cellulose fibers having a diameter of 1 µm or more is less than 10%.  培養面の算術平均高さ(Sa)が30nm未満である支持体上にセルロース繊維を含む塗布液を塗布することを有する、請求項1~3のいずれか1項に記載の細胞培養用基材の製造方法。 The cell culture substrate according to any one of claims 1 to 3, which comprises applying a coating solution containing cellulose fibers onto a support having an arithmetic average height (Sa) of the culture surface of less than 30 nm. Manufacturing method.  請求項1~3のいずれか1項に記載の細胞培養用基材を有する培養容器。 A culture container having the cell culture substrate according to any one of claims 1 to 3.  請求項1~3のいずれか1項に記載の細胞培養用基材の培養面上で細胞を培養することを有する、細胞の培養方法。 A method for culturing cells, comprising culturing cells on the culture surface of the cell culture substrate according to any one of claims 1 to 3.  前記培養は3次元培養である、請求項6に記載の方法。 The method according to claim 6, wherein the culture is a three-dimensional culture.  請求項1~3のいずれか1項に記載の細胞培養用基材上に形成されてなる3次元培養細胞。 A three-dimensional cultured cell formed on the cell culture substrate according to any one of claims 1 to 3.  請求項8に記載の3次元培養細胞を用いることを有する、in vitroでの薬剤の試験方法。 A method for testing a drug in vitro, comprising using the three-dimensional cultured cell according to claim 8.
PCT/JP2017/037424 2016-10-17 2017-10-16 Cell culture substrate and method for producing same, and cell culture container and cell culture method using same Ceased WO2018074432A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018546335A JP6758621B2 (en) 2016-10-17 2017-10-16 Substrate for cell culture and its manufacturing method, and cell culture container and cell culture method using this

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016203818 2016-10-17
JP2016-203818 2016-10-17

Publications (1)

Publication Number Publication Date
WO2018074432A1 true WO2018074432A1 (en) 2018-04-26

Family

ID=62018700

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/037424 Ceased WO2018074432A1 (en) 2016-10-17 2017-10-16 Cell culture substrate and method for producing same, and cell culture container and cell culture method using same

Country Status (2)

Country Link
JP (1) JP6758621B2 (en)
WO (1) WO2018074432A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020062009A (en) * 2018-10-16 2020-04-23 東ソー株式会社 Cell culture substrate, production method of cell culture substrate, and production method of spheroid
WO2020112003A1 (en) * 2018-11-29 2020-06-04 Rise Innventia Ab Method of producing holocellulose and paper strength agent, process for the production of paper, the paper produced and use of the produced paper
JP2021093945A (en) * 2019-12-17 2021-06-24 日本バイリーン株式会社 Cell culture carrier
JP2021170945A (en) * 2020-04-20 2021-11-01 三洋化成工業株式会社 Method for producing coating agent for cell culture substrate, cell culture substrate, cell culture kit and cell sheet
JP2021187907A (en) * 2020-05-27 2021-12-13 住友ゴム工業株式会社 Hydrophilic substrate and method for preparing hydrophilic substrate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013541956A (en) * 2010-10-27 2013-11-21 ユー ピー エム キュンメネ コーポレーション Plant-derived cell culture material
WO2015008868A1 (en) * 2013-07-19 2015-01-22 旭化成せんい株式会社 Fine cellulose fiber sheet
WO2015101711A1 (en) * 2013-12-30 2015-07-09 Upm-Kymmene Corporation Patterned membrane
JP2015149980A (en) * 2014-02-19 2015-08-24 凸版印刷株式会社 Cultivation apparatus and manufacturing method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013541956A (en) * 2010-10-27 2013-11-21 ユー ピー エム キュンメネ コーポレーション Plant-derived cell culture material
WO2015008868A1 (en) * 2013-07-19 2015-01-22 旭化成せんい株式会社 Fine cellulose fiber sheet
WO2015101711A1 (en) * 2013-12-30 2015-07-09 Upm-Kymmene Corporation Patterned membrane
JP2015149980A (en) * 2014-02-19 2015-08-24 凸版印刷株式会社 Cultivation apparatus and manufacturing method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EVENOU, F. ET AL.: "Microfibrillated cellulose sheets coating oxygen-permeable PDMS membranes induce rat hepatocytes 3D aggregation into stably-attached 3D hemispheroids", J. BIOMATER. SCI.POLYMEREDITION, vol. 22, 2011, pages 1509 - 1522, XP008151011 *
IJIMA, HIROYUKI ET AL.: "Three-dimensional culture of functional cells using Micocell(R), Result and consideration", TISSUE ENGINEERING REGENERATIVE MEDICINE, vol. 15, February 2016 (2016-02-01), pages 308 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020062009A (en) * 2018-10-16 2020-04-23 東ソー株式会社 Cell culture substrate, production method of cell culture substrate, and production method of spheroid
WO2020080364A1 (en) * 2018-10-16 2020-04-23 東ソー株式会社 Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids
US20210355424A1 (en) * 2018-10-16 2021-11-18 Tosoh Corporation Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids
WO2020112003A1 (en) * 2018-11-29 2020-06-04 Rise Innventia Ab Method of producing holocellulose and paper strength agent, process for the production of paper, the paper produced and use of the produced paper
US20220018065A1 (en) * 2018-11-29 2022-01-20 Rise Innventia Ab Method of producing holocellulose and paper strength agent, process for the production of paper, the paper produced and use of the produced paper
JP2021093945A (en) * 2019-12-17 2021-06-24 日本バイリーン株式会社 Cell culture carrier
JP7390612B2 (en) 2019-12-17 2023-12-04 日本バイリーン株式会社 Cell culture carrier
JP2021170945A (en) * 2020-04-20 2021-11-01 三洋化成工業株式会社 Method for producing coating agent for cell culture substrate, cell culture substrate, cell culture kit and cell sheet
JP7502888B2 (en) 2020-04-20 2024-06-19 三洋化成工業株式会社 Coating agent for cell culture substrate, cell culture substrate, cell culture kit, and method for producing cell sheet
JP2021187907A (en) * 2020-05-27 2021-12-13 住友ゴム工業株式会社 Hydrophilic substrate and method for preparing hydrophilic substrate
JP7639275B2 (en) 2020-05-27 2025-03-05 住友ゴム工業株式会社 Hydrophilic substrate and method for producing hydrophilic substrate
US12392693B2 (en) 2020-05-27 2025-08-19 Sumitomo Rubber Industries, Ltd. Hydrophilic substrate and method for preparing hydrophilic substrate

Also Published As

Publication number Publication date
JPWO2018074432A1 (en) 2019-07-18
JP6758621B2 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
Xu et al. On low-concentration inks formulated by nanocellulose assisted with gelatin methacrylate (GelMA) for 3D printing toward wound healing application
JP6758621B2 (en) Substrate for cell culture and its manufacturing method, and cell culture container and cell culture method using this
Cheng et al. Engineering aligned skeletal muscle tissue using decellularized plant-derived scaffolds
Bar-Shai et al. Seaweed cellulose scaffolds derived from green macroalgae for tissue engineering
Han et al. Co-electrospun blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular tissue engineering
CN102202771B (en) Irradiated membranes for cell expansion
KR102397717B1 (en) Cell culture plate, method for preparing thereof and method for detecting a substance
Kummala et al. Human dermal fibroblast viability and adhesion on cellulose nanomaterial coatings: influence of surface characteristics
US20160325006A1 (en) Patterned membrane
Hong et al. Three-dimensional scaffold of electrosprayed fibers with large pore size for tissue regeneration
JP7497981B2 (en) Supportive nanofibrillar cellulose scaffolds for proliferating cells
US20240052314A1 (en) A bioreactor and a method for extracting cell-derived products from cultured cells and a nanostructured cellulose product
Tronser et al. Bacterial cellulose promotes long-term stemness of mesc
EP4148071A1 (en) A method for preparing microbeads, microbeads, a cell culture, a method for providing cell-derived products, the microbeads for use for providing bioactive substances to a target, and use of chemically anionically modified nanofibrillar cellulose
WO2021079931A1 (en) Cell-culturing substrate and cell-provided cell-culturing substrate
JP2019187317A (en) Control method of cell adhesion strength of cell culture substrate, manufacturing method of cell culture substrate, and cell culture substrate
JP2019050777A (en) COMPOSITE AND ITS MANUFACTURING METHOD, AND CELL ADHESIVE SUBSTRATE AND ITS MANUFACTURING METHOD
Li et al. Pulmonary decellularized extracellular matrix (dECM) modified polyethylene terephthalate three-dimensional cell carriers regulate the proliferation and paracrine activity of mesenchymal stem cells
JP2019187316A (en) Cell culture substrate, and cell culture vessel using cell culture substrate, method of culturing cell, and method for testing the effectiveness or toxicity of agent
US20220213432A1 (en) Transplantable cell composition comprising eukaryotic cells in a nanofibrillar cellulose hydrogel, method for preparing thereof and use of nanofibrillar cellulose
JP2021132629A (en) Cell non-adhesive material and cell adhesion control property material
JP2007174989A (en) Cell culture carrier
McKean et al. Mimetix® electrospun scaffold: An easy‐to‐use tool for 3D cell culture in drug discovery and regenerative medicine
De Oliveira Emawodia et al. The Development and Use of Bioinks for Tissue Engineering to treat Congenital Heart

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17862785

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018546335

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17862785

Country of ref document: EP

Kind code of ref document: A1